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Chapter 1
General introduction 
Linda M.P. Loonen
Parts of this introduction were published as: ‘The role of innate signalling 
in the homeostasis of tolerance and immunity in the instestine’, J.M. Wells, 
L.M.P. Loonen and J.M. Karczewski, International Journal of Medical Micro-
biology, 2010, 300
Chapter 1
10
 
1
Chapter
11
InTRoduCTIon 
The function of the mammalian gastro-intestinal (GI) tract is the digestion and absorp-
tion of food. Most of this digestion and absorption takes place in the small intestine, 
which includes the duodenum, jejunum and ileum. The large intestine or colon com-
prises the ascending, transcending and descending colon and functions to reabsorb wa-
ter and salts from the undigested food matter, and to excrete waste material from the 
body. The GI tract is inhabited by trillions of bacteria that perform most of the digestion 
of complex carbohydrates that cannot otherwise be utilized by the host for nutrition. 
This intestinal community contains eukarya, archea and bacteria, collectively known as 
the microbiota comprising at least 500 to 1000 species.1 The total number of microbial 
cells outnumbers the total amount of host cells by around 100 fold. Bacterial numbers 
increase from the proximal GI tract to the distal colon starting with 103 to 105 bacteria 
per ml of luminal contents in the stomach and duodenum to approximately 107 to 1012 
per ml in the ileum and colon.2 The microbiota composition varies between individuals, 
and is also dependent on the intestinal site.3 In humans, the composition changes a lot 
in the first 12 months of life, but then settles into a more adult composition.4 In mam-
mals and other metazoans these host-microbe relationships have evolved over millions 
of years to become largely mutualistic and symbiotic in nature.5 The symbiotic benefits 
are diverse and include the competitive exclusion of pathogens, as well as participation 
in energy and nutrient metabolism, and tissue development and repair. In contrast, 
pathogens have by definition the capacity to cause harm to the host and may spread 
from the mucosa to other tissues in the body. 
In healthy adults, the intestinal microbiota is dominated by 2 phyla, the Gram-negative 
Bacteroidetes and the Gram-positive Firmicutes.6 Other phyla that are less abundant 
are Proteobacteria, Verrucomicrobia, Tenericutes, Deferribacteres and Fusobacte-
ria.6-10 The bacteria that reside in the outer layer of the mucosa are mainly commensal 
mucin-degrading bacteria that enzymatically degrade glycans and use the breakdown 
products as nutrients. Akkermansia muciniphila is one of the few isolated and charac-
terized mucin degrading bacterial species.11 Despite high species diversity and differ-
ences between individuals there appears to be a common ‘functional core’ of bacteria, 
which is shared among most of the community.12, 13
The coevolution of mammals with their intestinal symbionts has resulted in several ad-
aptations of the mucosal tissue which maintains tolerance to microbiota, while main-
taining effective defences against infection with opportunistic and obligate pathogens. 
The necessity to regulate immune responses to commensal organisms is evident from 
research on inflammatory bowel diseases (IBD) where loss of tolerance to the microbi-
ota is a key aspect that stimulates loss of epithelial integrity and chronic inflammation.14
The development of an individual’s immune system is partly shaped by the microbio-
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ta.15 In germ-free (GF) mice for example, the architecture of the mucosal epithelium is 
underdeveloped including the lymphoid tissues associated with the epithelium,16 with 
smaller and fewer Peyer’s patches (PP), fewer intraepithelial lymphocytes,17 reduced 
antibody production and diversity,18, 19 and reduced expression of some antimicrobial 
peptides.20-22 Colonisation of these animals with a standard mouse microbiota restores 
these differences to levels found in conventionally reared mice. 
The microbiota also makes a major contribution to host defence through their com-
petition with pathogens. GF mice for example are more susceptible to infections by 
enteric pathogens.23 Commensal as well as pathogenic bacteria have to compete for 
nutrients and binding to host surface receptors in the GI tract. Thus, colonizing com-
mensal bacteria can inhibit colonization by pathogens, a phenomenon called ‘coloniza-
tion resistance’.24, 25 For example, mice that have been treated with antibiotics to reduce 
the number of commensal bacteria were more susceptible to infection with enteric 
pathogens.24
Lastly, the microbiota contributes to host physiology and metabolism by fermenting 
otherwise non-digestible components of the host diet. Short-chain fatty acids (SCFA), 
the end products of bacterial fermentation, can contribute up to 5–15% of the total ca-
loric requirements of humans.26 A contribution of the microbiota to host energy harvest 
is evident in GF mice, which require a greater caloric intake than conventional mice to 
sustain a normal body weight.27
The multi-layered defences of the intestinal tract: physical barriers
The mucosa of the intestinal tract consists of different layers (Fig. 1.1). The outside 
layer is the serosa, which surrounds 2 layers of smooth muscle tissue, orientated in cir-
cular and longitudinal direction to facilitate peristalsis and movement of food through 
the intestine. Underneath the muscles there is a layer of submucosa, which contains 
connective tissue, blood and lymphatic vessels and nerves, followed by the muscularis 
mucosae which is a thin muscle layer separating the mucosa from the submucosa. The 
mucosa exists of the lamina propria (LP), connective tissue, containing immune cells, 
blood and lymph vessels, and nerves. A single layer of epithelial cells forms the last 
layer, forming a boundary between the mucosal compartment and the lumen of the 
intestine. The small intestine contains finger-like structures, so called villi, to increase 
the intestinal surface for more nutrient uptake. In this way the surface is increased to 
around 200 square metres, about the size of a tennis court. 
The small intestinal epithelium absorbs nutrients from the digested food stream on one 
hand, and on the other hand acts as a barrier to the intestinal microbiota and opportu-
nistic pathogens. Epithelial cells form a physical protective barrier between the luminal 
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content and the underlying LP. Tight junction (TJ) proteins are found near the apical 
surface of epithelial cells and function to keep bacteria and macromolecules outside 
the body, but allow diffusion of fluids, electrolytes and small molecules through the 
paracellular space. These proteins are composed of transmembrane proteins (occludins 
and claudins) and intracellular scaffold proteins (ZO-1, -2 and -3). Several specialized 
mucosal defence mechanisms exist to maintain the integrity of the single layer of epi-
thelial cells and are discussed in more detail below. The epithelium contains 4 different 
cell types (Fig. 1.2) that all originate from intestinal stem cells. The stem cells that are 
at the bottom of the crypts are alternated with Paneth cells,28 that can be recognized 
by the large granules in the cytoplasm that contain anti-microbial factors such as lyso-
zyme, defensins, phospholipases and RegIII proteins. Paneth cells are replaced every 30 
days and are only found in the crypts of the small intestine; they do not migrate up in 
the villus. Higher up in the crypt reside enterocytes, enteroendocrine cells and goblet 
cells, which all migrate to the top of the villus where they undergo apoptosis. The rapid 
turnover of epithelial cells in the intestine means that the intestinal epithelium is regen-
erated every 2 to 5 days in humans. 
Villi
Cryptes
Muscularis Mucosa  
Lymph vessel
Artery
Vene
Longitudinal 
muscle
Circular
muscle
Submucosa
Mucosa
Serosa
Lamina propria
Figure 1.1. Schematic representations of the different layers in the intestine. 
Enteroendocrine cells (less than 1% of the epithelial cell population29) secrete hormones 
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including serotonin and peptides in response to signalling by compounds in the lumen, 
particularly nutrients. The hormones secreted by the enteroendocrine cells play a role 
in controlling physiological and homeostatic functions in the digestive tract, like the 
modulation of host energy metabolism, mucus secretion and intestinal motility.29 The 
enterocytes are the most abundant cells present in the intestine and possess microvilli 
on the apical surface, known as the “brush-border”, which promotes the digestion and 
absorption of nutrients from the lumen. The apical surface of the epithelium is covered 
by the glycocalyx of membrane bound mucins that play a role in preventing microbial 
adhesion and colonization.
Figure 1.2. Schematic representation of the ileal epithelium with the different cell types present. 
Goblet cells in the epithelium secrete mucin polypeptides that are glycosylated and 
polymerized to form a mucus gel overlaying the epithelium. This layer is protective, 
preventing the bacteria present in the gut from being in contact with the epithelial 
cells. Mucus also serves as a lubricant, facilitating the movement of the luminal con-
tent through the intestine. Furthermore, this layer provides carbohydrates that can be 
used as a food source by mucus degrading bacteria. The mucus layer is continuously 
produced and removed by peristaltic flushing. In the colon, the mucus barrier is thicker 
than in the ileum and consists of a dense layer attached to the cells and a less dense 
mucus layer above it that is in contact with the microbiota and luminal contents. The 
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inner layer is almost devoid of bacteria, whereas the outer, loose mucus layer contains 
bacteria.30 In the ileum, the mucus layer is much thinner and it is not known whether 
the ileal mucus layer is stratified as is the mucus layer in the colon, or whether the mu-
cin composition differs between small intestine and colon. 
The vast majority of mucus in the human intestine comprises Muc2, which is a large 
(approx. 5 MDa), highly glycosylated protein (Fig. 1.3).31 Like other mucins, Muc2 con-
tains a PTS (proline, threonine and serine) protein core to which the glycan GalNAc 
(N-acteylgalactosamine) binds.32, 33 A complex mixture of glycan epitopes is made by 
extension and branching of the GalNAc residues to a series of other glycosyltransferas-
es.34, 35 Muc2 is polymerized through the N- and C-termini to form large net-like poly-
mers which form a transparent gel-like structure. 
Figure 1.3. Figure from Dekker et al.36 Schematic representation of a Muc2 molecule.
A diminished mucus layer is associated with different diseases, including colitis and 
IBD.37-39 The protective role of mucus is most evident from studies in Muc2 knockout 
mice, which start to develop colitis after weaning, leading to severe pathology in the 
colon and premature death.40 Although the absence of a mucus layer causes colitis by 
microbial induced inflammation, the microbiota seems to be important for the thick-
ness of the mucus layer, as GF mice have a thinner inner mucus layer than convention-
ally housed mice.30 
The multi-layered defences of the intestinal tract: innate and adaptive immune 
barriers
Mucosal-associated lymphoid tissue and secretory IgA
Specialized lymphoid structures, including Peyer’s Patches (PP) and isolated lymphoid 
follicles permit the sampling of luminal antigens via specialized microfold (M) cells in 
the follicular epithelium.41 In addition, non-specific secretory IgA (sIgA) produced by 
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activated B cells and transcytosed across the enterocytes into the lumen via the poly-
meric IgA transporter, limits bacterial association and penetration with the intestinal 
epithelial cells by causing agglutination of bacteria in the intestinal lumen. 42-45 SIgA can 
also interfere with assembly of intracellular viruses in the golgi apparatus during trans-
cytosis46 and remove potential inflammatory antigen complexes from the LP, by binding 
during transport via the polymeric IgG receptor. Humans secrete several grams per day 
of sIgA into the intestinal lumen highlighting its importance to mucosal protection.
Table 1.1. Microbial ligands and adapter proteins of TLRs and NOD receptors. Abbreviations used in 
this table: TIRAP, Toll/interleukin-1 receptor (TIR) domain–containing adapter protein; MyD88, My-
eloid differentiation primary response gene 88; TRIF, TIR-domain-containing adapter-inducing interfer-
on-β; TRAM, TRIF related adaptor molecule; RIP2, receptor interaction protein 2; LTA, lipoteichoic acid; 
dsRNA, double stranded RNA; LPS, lipopolysaccharide; ssRNA, single stranded RNA; CpG, C phosphate 
G; DAP, diaminopimelic acid; MDP, muramyl dipeptide; G-, gram negative; G+, gram positive
Innate signalling and regulation of the intestinal barrier 
Dendritic cells (DCs) play a key role in the induction of tolerance and immunity. They re-
side in the PP and can sample luminal antigen in the LP by extending dendrites through 
the epithelial tight junctions.47 Epithelial and immune cells such as DCs in the LP rec-
ognize microbes through common structures on microorganisms often referred to as 
pathogen-associated molecular patterns (PAMPs) or microbe-associated molecular 
patterns (MAMPs) via pathogen recognition receptors (PRRs). The best characterized 
family of PRRs is the Toll-like receptor family (TLR), which are expressed on cells of the 
myeloid and lymphoid lineages as well as on non-immune cells such as enterocytes and 
Receptor  Localization  Adaptor molecule  Ligand  Ligand origin
TLR2 Cell surface TIRAP MyD88 LTA  
Lipoproteins  
Bacteria 
Fungi 
TLR2/1 Cell surface TIRAP MyD88  Triacyl lipopeptide  G- bacteria 
TLR2/6 Cell surface TIRAP MyD88  Diacyl lipopeptide  G+ bacteria 
Mycoplasma 
TLR3 Cellular compartment TRIF  dsRNA  Viruses 
TLR4 Cell surface TIRAP MyD88  
TRAM TRIF  
LPS  G- bacteria 
TLR5 Cell surface MyD88  Flagellin  Bacteria 
TLR7 Cellular compartment MyD88  ssRNA  RNA viruses 
TLR9 Cellular 
compartment/Cell 
surface 
MyD88  CpG DNA  DNA viruses 
Bacteria 
TLR11 Cell surface MyD88  Proﬁlin  
Uropathogenic 
bacterial 
components
Toxoplasma 
Uropathogenic 
bacteria 
NOD1 Cell cytoplasm RIP2  Meso-DAP  G- bacteria 
NOD2 Cell cytoplasm RIP2  MDP  Bacteria 
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fibroblasts. 
Innate recognition of microbes and microbial-associated molecular patterns by host 
PRRs plays a pivotal role in the maintenance of intestinal homeostasis. These families of 
receptors are involved in immune cell activation, production of cytokines and chemok-
ines as well as regulation of production of components of the gut barrier such as anti-
microbials, mucin and TJ proteins. 
Mammalian PRRs includes members of the family of TLRs, nucleotide binding and oligo-
merization domain (NOD)-like receptors (NLRs) and C-type lectin receptors which in-
duce cellular responses in immune and other cells through cellular signalling pathways. 
The molecular structures recognized by the known human TLR and NOD and their cel-
lular location are shown in Table 1.1. 
TLRs participate in innate signalling on the cell surface and in endosomes whereas 
the NLRs, of which there are more than 20 family members, recognize intracellular li-
gands.48 NOD1 and NOD2 detect the bacterial peptidoglycan fragments meso-DAP and 
MDP (Fig. 1.4); the specificities of most of the other NLRs remain uncharacterized.49-51
TLRs recruit a set of adaptor proteins containing Toll/Interleukin-1 receptor (TIR) do-
mains that trigger downstream signalling cascades leading to the activation of tran-
scription factor nuclear factor-kappa light-chain-enhancer of activated B cells (NF-κb), 
which controls the induction of pro-inflammatory cytokines and chemokines that are 
instrumental in induction of inflammatory and adaptive immune responses against 
pathogens.52-55 Furthermore, NF-κb activation is linked to increased expression of some 
epithelial defensins and Reg proteins (Fig. 1.4). In the mucosal epithelium this serves 
to recruit phagocytes including neutrophils, macrophages and DCs to the site of invad-
ing pathogens. DCs play a crucial role in the induction of adaptive immune responses 
via the presentation of antigens and activation of naïve T cells in the peripheral lymph 
nodes. It became evident from different studies that TLRs control pathways involved in 
tissue repair and growth and that a basal level of TLR signalling from the luminal micro-
biota may indeed contribute to intestinal homeostasis.56 Further evidence for the role 
of TLR signalling in the regulation of homeostatic mechanisms came from studies on the 
intestinal epithelial cells (IEC)-specific deletion of components of the Iκβ kinase (IKK) 
complex, required for NF-κb activation. These knockout mice developed severe chronic 
intestinal inflammation.57 Several studies suggest that steady-state recognition of the 
normal microbiota by PRRs does occur and it contributes to homeostatic mechanisms 
and influences gene expression in IECs. 
Homeostasis of innate signalling in the mucosa 
PRR signalling is a crucial component of the innate defence against pathogens, but con-
tinued induction of inflammatory responses at the mucosal surface from contact with 
the resident microbiota would be pathological. To cope with these somewhat opposing 
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functions several adaptations of PRR signalling have evolved in the intestinal mucosa.58 
Low expression of TLRs on the apical surface of the epithelium has been suggested as a 
mechanism to regulate inflammatory responses at the mucosal surface. 
Figure 1.4. The regulation of antimicrobial peptide expression. Constitutive expression of β-defensins 
by enterocytes, TLR dependent expression of β-defensins and TLR dependent expression of RegIIIγ via 
MyD88-dependent signalling and IL-22, and NOD2 dependent expression of a subset of α-defensins 
via the MDP and the NF-κb pathway, or constitutive α-defensins production via TCF4 signalling.
The expression, distribution and cellular localization of PRRs on IEC play a role in host 
discrimination of commensals and pathogens in steady state conditions. Additionally, 
the response to surface expressed TLRs in IEC may be dependent on the polarity of the 
signalling. Moreover, the specificity of cellular responses after binding and activation of 
a PRR is governed by the differential recruitment of the adapter proteins MyD88, MAL, 
TRIF, and TRAM, that form a complex with the C-terminal domains of different TLRs.59 
Once the epithelial barrier is breached however, the initial inflammatory response may 
up-regulate PRR and co-receptors to overcome the mechanisms that are in place to 
dampen PRR signalling at the mucosal surface under steady state conditions. 
The current view of TLR expression in the intestine is not comprehensive with respect 
to tissue localization and in vivo studies. Intestinal cell lines have been frequently used 
to study PRR localization and signalling but the results can differ between cell lines and 
TCF4 NF-κβ
NOD2
MDP
TLR
MYD88
MAMP
RegIIIγ
Bacteria
IL-22R
IL-22
β- defensins
β- defensins
α- defensins
Bacteria
subset of
α- defensins
Bacteria
Paneth cellEnterocyte
Constitutive expression TLR-dependent expression
Constitutive and
NOD2-dependent expression
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between in vivo and in vitro.60, 61 
Regulation of PPR Signalling by Microbes
The relationship between humans and their intestinal microbiota is largely symbiotic in 
nature and over eons of co-evolution multiple adaptations appear to have developed to 
help maintain this peaceful co-existence. On the other hand, bacterial and viral patho-
gens have also evolved multiple mechanisms to subdue recognition by PRRs and avoid 
innate immunity.62
Short chain fatty acids such as butyrate are the main end product of fermentation for 
some species of gut commensals. Apart from being an important energy source for 
intestinal epithelial cells, butyrate plays role in the maintenance of homeostasis in the 
colon.63 Butyrate can inhibit the activation of NF-κb, probably via histone deacetylation 
and suppression of cellular proteosome activity.64 Other reported anti-inflammatory 
effects of butyrate include inhibition of the interferon (IFN)-γ production and/or sig-
nalling65, 66 and the up-regulation of peroxisome proliferator-activated receptor gamma 
(PPARγ).67-70
NF-κb pathway inhibitors may also come from intestinal pathogens. Yersinia for exam-
ple can inhibit NF-κb pathway at the level of IκB phosphoprylation whereas Salmonella 
spp. block ubiquitination and degradation of Iκβ to prevent translocation of NF-κb into 
to the nucleus.71 Recently, an uropathogenic Escherichia coli strain CFT073 was shown 
to prevent activation of the NF-κb pathway via secretion of TcPC, which inhibits bind-
ing of MyD88 to TLRs.72 This mechanism contributes to the persistence and spread of 
the pathogen by preventing recognition by the innate immune system and subsequent 
induction of adaptive immune responses. It is tempting to speculate that other patho-
gens and even commensal bacteria may possess similar mechanisms to avoid immune 
recognition and elimination from the intestinal tract. 
Antimicrobial defensins 
The epithelial cell barrier is reinforced by the mucus layer and a range of antimicrobial 
peptides and proteins that prevent intimate contact with the commensal and patho-
genic bacteria. Paneth cells secrete a diverse range of peptides and proteins with an-
timicrobial properties, referred to as antimicrobial peptides (AMPs). A major group of 
these AMPs in mammals are defensins, which  are highly basic, small antimicrobial pep-
tides of 2-6 kDa with a β-sheet structure and six cysteine residues, which are disulfide 
linked.73, 74 Defensins show antimicrobial activity against Gram-positive and Gram-nega-
tive bacteria, certain fungi, protozoa and enveloped viruses.75, 76 There are 3 subgroups 
of defensins; α-defensins, β-defensins and θ-defensins, based on structural features of 
the gene, such as the connectivity of three cysteine linkages, and precursor and mature 
peptides.77, 78 All subgroups are produced in vertebrates, but θ-defensins are only pro-
duced in non-human primates. Alpha defensins, produced by Paneth cells in a primarily 
constitutive way, are most abundant in the small intestine.77 The propeptides of α-de-
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fensins need processing to produce a mature, active peptide. Matrix metalloprotease 
(Mmp)-7, produced by mouse Paneth cells, is essential for processing the α-defensins in 
mice (also called cryptdins), but in humans trypsin is responsible for defensin process-
ing.77 Mice express more than 6 α-defensins and numerous cryptdin-related sequence 
(CRS) peptides which are not found in humans.79, 80 Humans produce 2 known Paneth 
cell α-defensins, HD5 and HD6 as well as 6 β-defensins (HBD), produced by epitheli-
al cells, such as enterocytes, in the intestine. Human β-defensin-1 is constitutively ex-
pressed in enterocytes, whereas the expression of human β-defensin-2 (HBD-2) and 
human β-defensin-3 (HBD-3) are induced by microbial products and inflammatory cyto-
kines.81-85 Inducible expression of HBD-2 and RegIII proteins (another antimicrobial) in 
enterocytes has been shown to be dependent on TLR or MyD88-dependent signalling 
(Fig. 1.4).86, 87 The bactericidal activity of defensins is obtained through interaction with 
the outer membrane of the bacteria. By the entrance of the defensin molecule in the 
bacterial membrane, attracted by local electrostatic fields, and the interposing between 
the phospholipid groups of the membrane, the defensin displaces the lipids, thereby 
weakening the membrane. This is called the carpet wormhole mechanism and eventu-
ally leads to the formation of pores and cell death (Fig. 1.5).75, 77, 88 
Another class of AMPs are the cathelicidins, which are not produced by Paneth cells 
but are produced by enterocytes on top of the colonic crypts. Cathelicidins are cationic 
peptides that kill fungi and both Gram-positive and Gram-negative bacteria by binding 
to the bacterial membranes via electrostatic interactions, creating transient pores in the 
membrane resulting in destruction.89 
Other antimicrobial factors produced by Paneth cells include, lysozyme, secretory phos-
pholipase A2, angiogenin-4 and hepatocarcinoma-intestine-pancreas/pancreatic-asso-
ciated protein (HIP/PAP).73, 74 The latter, highly similar to RegIIIγ (Regenerating gene III 
gamma) in mice, belongs to the C-type lectin superfamily based on cDNA sequence 
homologies,90, 91 and shows inducible expression in the pancreas and intestine.22 C-type 
lectins are proteins that have a C-type lectin-like domain (CTLD) and bind to carbohy-
drates, often in a calcium dependent manner (C-type).92, 93 Binding of these lectins to 
specific sugar structures mediates biological events, such as cell-cell adhesion and in-
nate immune responses to potential pathogens.94 Reg proteins, more specifically RegIII 
proteins, have shown great relevance in homeostasis and disease, both in human but 
also in animal models. Although the RegIII proteins belong to the C-type lectin family, 
their binding capacity is not calcium-dependent.95, 96 
RegIII proteins 
Reg proteins were discovered by Keim and co-workers in 198497 as proteins heavily up-
regulated in pancreatitis in rats. It was therefore named pancreatitis-associated protein 
(PAP), and during acute disease PAP accounts for about 5% of the secreted protein, but 
returns to undetectable levels when the pancreas had recovered.98 Independently from 
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them, Terazono et al. found a gene that they named reg1 (regenerating gene) implicat-
ing that this gene might be involved in island regeneration in the pancreas in rats.99 In 
1992, Lasserre et al.90 found the PAP mRNA in humans to be upregulated in liver tumors, 
where after they named it HIP (hepatocarcinoma-intestine-pancreas). 
Figure 1.5. The carpet-wormhole model of action of defensins. Most defensins are amphipathic 
molecules that have clusters of positively charged amino-acid side chains (red) and hydrophobic 
amino-acid side chains (green). This allows them to interact with microbial membranes, shown 
schematically with their negatively charged phospholipid headgroups (blue) and hydrophobic fatty 
acid chains (black). In the top panel, electrostatic attraction and the transmembrane bioelectric field 
pull the peptide molecules towards and into the membrane. As peptide molecules accumulate in 
a ‘carpet’, the membrane is strained and the peptides transition into another arrangement (shown 
in the lower panel) that lowers the strain but results in the formation of membrane ‘wormholes’ or 
pores. For defensins, the specific arrangement of peptide molecules in the pores is not yet known. 
Adapted from Ganz et al.88 
Other studies showed the presence of homologous proteins in humans99, 100 and mice101 
and in other organs than pancreas.101 Narushima and co-workers later showed the pres-
ence of 3 different RegIII genes in mice,102 and suggested that all the mouse RegIII genes 
(classes I, II and III) diverged from a common ancestral gene. Type III Regs further di-
verged into RegIIIα, RegIIIβ, RegIIIγ and RegIIIδ. All RegIII proteins, except RegIIIδ, are 
produced in the intestine. RegIIIβ and RegIIIγ are the most similar to one another shar-
ing 70% similarity.102, 103 In 2001, a fourth Reg family member was found in human intes-
Defensin
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tine, and named RegIV.104 The Reg nomenclature is quite puzzling as many genes were 
named after their first discovered function, only later to be discovered that genes were 
the same. See table 1.2 for a comprehensive overview of homologues genes. 
Table 1.2. The nomenclature of the different Reg proteins. Between brackets the names that are also 
used for the same protein. This table is based on Lieu105, Hunt106 and Graf107
The expression of RegIIIγ and several other antimicrobial factors was shown to be in-
duced in GF mice following colonization with conventional microbiota and also after 
weaning when the complexity and density of the microbiota rapidly increases.22 Studies 
in NOD2-/- and MyD88-/- mice revealed that NOD2 regulates Paneth cell expression of 
α-defensins but not RegIIIγ and vice versa for the MyD88-/- mice (Fig. 1.4).86, 108, 109 Paneth 
cells were shown to sense bacteria and induce the expression of several antimicrobial 
factors directly through MyD88 signalling pathways, using a mouse transgenic model 
in which MyD88 was expressed specifically in Paneth cells on a MyD88-/- background.86 
In this model MyD88 dependent expression of Paneth cell antimicrobials was shown to 
limit mucosal uptake of commensal and pathogenic bacteria into the mesenteric lymph 
nodes but had no effect on luminal numbers of bacteria. 
Early studies on PAP1 showed that it aggregates bacteria, suggesting a possible protec-
tive role of PAP1 in bacterial infection.110 Later studies indeed showed that intestinal 
colonization by bacteria,22 infection111 or inflammatory stimuli driven by mucosal in-
flammation and damage, as in IBD112, 113 were triggers for expression of RegIII proteins. 
The anti-inflammatory function of rat PAP1 was shown in multiple studies. Vasseur et 
al.114 showed that the anti-inflammatory response to PAP1 shared features with the 
response to interleukin (IL)-10, as both inhibit the activation of neutrophils and macro-
phages, inhibit IL-6 and TNFα expression and block translocation of NF-κb. Later, it was 
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shown by the same group115 that PAP1 inhibits the inflammatory response by blocking 
NF-κb activation through a STAT3 (signal transducers and activators of transcription) 
dependent mechanism. Closa and co-workers116 even suggested PAP1 to be a new an-
ti-inflammatory cytokine, as it shares similarities in the mode of action with cytokines, 
like signalling via the JAK/STAT3/SOCS3 pathway. Both RegIIIγ and RegIIIβ were shown 
to be upregulated by IL-22 treatment in colonic tissue ex vivo, and to be upregulated 
in the colon of mice infected with C. rodentium, but not in C. rodentium infected IL-22-
/- mice.117
In vitro studies with recombinant and refolded RegIIIγ and human HIP/PAP showed that 
RegIIIγ is not glycosylated95 and that RegIIIγ and HIP/PAP have a bactericidal role to-
wards Gram-positive bacteria through binding to peptidoglycan (PGN).22 The in vitro 
bactericidal activity of RegIIIγ or HIP/PAP is inconsistent with other publications, where 
recombinant HIP/PAP from humans and rats was not bactericidal, but induced bacterial 
aggregation.118, 119innate immunity, lectin-like protein, N-terminal proteolytic process-
ing, pancreatitis-associated protein (PAP In vivo studies showed that MyD88-mediated 
signalling increased the production of RegIIIγ after infection109 and later it was shown 
that the microbiota is in closer contact to the epithelium in RegIIIγ-/- mice,120 suggesting 
that RegIIIγ helps to minimize bacterial contact with the epithelium. Strikingly, exoge-
nous mouse RegIIIγ was also found to have a protective role in IL-22-/- mice infected with 
C. rodentium, a gram-negative bacterium.117 
Recombinant and refolded RegIIIβ has been proposed to kill Gram-negative bacteria 
and a number of Gram-positive bacteria.121, 122 The bactericidal effect is growth phase 
dependent and in the case of Gram-negative bacteria, involves RegIIIβ binding to the 
lipid A anchor of lipopolysaccharide (LPS).122 A RegIIIβ-/- mouse model was developed 
to look at the function of RegIIIβ during liver damage and showed that RegIIIβ is im-
portant in the protection against liver failure.105 Furthermore, this model was used in 
an infection study where it was shown that RegIIIβ protects against infection with the 
Gram-negative bacterium Yersinia pseudotuberculosis, which was TLR2-dependent.123
Infection models: mode of invasion of Salmonella enteritidis and Listeria 
monocytogenes
Enteric bacterial pathogens are a substantial cause of foodborne infection. The host has 
many mechanisms to avoid infection by pathogens, such as stomach acid, mucus layers, 
secretion of antimicrobial proteins, including RegIII proteins, and the innate and adap-
tive immune system, described above. In healthy individuals, an intestinal infection 
usually results in a self-limiting gastroenteritis, but in immunocompromised persons, 
infants and elderly people infection with a pathogen might result in serious disease that 
the infected person is not able to contain and clear. 
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Figure 1.6. The trigger and zipper mechanisms used by pathogens to invade non-phagocytic cells. 
Adapted from Cróinín126. The zipper mechanism uses bacterial surface proteins (adhesins) (A) that 
bind receptors on the host cell membrane (B), triggering a signalling cascade that reorganizes the actin 
cytoskeleton to internalize the bacterium (C). The trigger mechanism employs the bacterial type III se-
cretion system (T3SS)(A) to deliver proteins across the host plasma membrane (B) to directly interact 
with the cellular components that regulate actin dynamics (C).
Figure 1.7. Adapted from Cossart et al.125 The invasive strategies of enteroinvasive Salmonella and 
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Listeria. After the bacteria have crossed the epithelial barrier, they must survive being attacked by 
macrophages. The 2 bacterial species considered here have solved this issue differently: L. monocy-
togenes are phagocytosed but escape into the cytoplasm, and thus avoid being killed in lysosomal 
compartments. Salmonella remodel their phagosomes, thus avoiding its transition to a lysosome and 
creating an intracellular niche that allows their efficient replication. Having crossed the epithelial bar-
rier and circumvented the threat of phagocytosis, L. monocytogenes disseminate systemically, possibly 
inside circulating monocytes and DCs. Salmonella may enter IECs through their basolateral pole in a 
TTSS- dependent manner. Alternative routes of invasion involve IECs directly, away from the FAE. In 
particular, invasion by L. monocytogenes is mediated by internalin (InlA) and possibly InlB. In addition, 
Salmonella are able to dislocate the brush border cytoskeleton and cause an apical entry ruffle. A third 
process of translocation may involve DCs crawling between IECs or sending pseudopods to capture 
luminal bacteria and retract in a subepithelial position. Salmonella are able to translocate in this way, 
possibly followed by systemic diffusion of Salmonella-loaded DCs. 
In this thesis, two different pathogens, Salmonella enterica and Listeria monocyto-
genes, were used to study the effect of the absence of RegIIIβ or RegIIIγ during infec-
tion. Although these pathogens have different modes of infection, they both invade 
and translocate from the gut lumen to the extra-intestinal organs, like spleen and liver. 
Infection by enteric bacterial pathogens starts with adhesion to host cells, colonization 
and sometimes cellular invasion, intracellular multiplication and finally dissemination 
to other tissues or persistence can take place.124 Adhesion to host cells may be medi-
ated through pili, also called fimbriae, which are adhesive hair-like organelles that pro-
trude from the bacterial surface. In addition to pili, a broad range of different bacterial 
nonpolymeric adhesins exist which recognize diverse elements of host-cell surfaces, 
including components of the extracellular matrix like collagens, adhesive glycoproteins 
such as fibrinogen and fibronectin, and integral host membrane adhesion receptors like 
integrins, cadherins and selectins.124 After adhesion the bacterium has to be taken up by 
or actively enter the host cell, which can occur via different mechanisms. The pathogens 
used in this thesis have a different way of invading the host cells: Salmonella employs 
a so-called trigger mechanism, whereas L. monocytogenes uses a “zipper” mechanism 
(Fig. 1.6).125 
The pathogenic species of Salmonella studied in this thesis is a serovar (serotyping vari-
ant) of Salmonella enterica subspecies enterica known as S. enterica enterica serovar 
enteritidis which for reason of brevity is referred to in this thesis as Salmonella en-
teritidis. This enteric pathogen is a Gram-negative, flagellated, facultative intracellular 
enteric bacterial pathogen that can colonize a range of animal hosts.127, 128 S. enteritidis 
is equipped with a sophisticated repertoire of virulence factors that will allow it to pen-
etrate the intestinal epithelium, mainly at the distal ileum,129 after which it can dissemi-
nate systemically to colonize the spleen and the liver.127 Salmonella can invade the host 
intestine via different mechanisms (Fig. 1.7). A major route of invasion is through M 
cells in the follicle associated epithelium (FAE) overlying the Peyer’s Patches (PP), which 
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transport antigens and bacteria from the lumen to the LP. Another entry mechanism 
is via invasion of non-phagocytic enterocytes through the virulence-associated type 3 
secretion system (TTSS) encoded by the Salmonella pathogenicity Island 1 (SPI-1). Be-
sides that, Salmonella can also invade the body via dendritic cells, which intercalate 
between epithelial cells, or by paracellular pathways following disruption of TJs.130, 131 
After passing the epithelium by one of these mechanisms the bacteria encounter the 
basal membrane, where the invaders are taken up by phagocytic immune cells such 
as macrophages or dendritic cells. Salmonella then utilizes a second TTSS, encoded by 
Salmonella pathogenicity Island 2 (SPI-2), to survive and replicate within an endosomal 
or phagosomal vacuole, called the Salmonella containing vacuole (SCV).128, 132, 133 In this 
SCV Salmonella can replicate to high numbers before it leaves the cell to infect new 
cells, ultimately causing systemic spread to other organs like spleen and liver.  
Listeria monocytogenes, the other bacterial pathogen studied in this thesis, is a 
Gram-positive, facultative intracellular bacterial pathogen that infects macrophages 
and non-phagocytic cells. It is able to traverse three human barriers: the intestinal bar-
rier, the blood-brain barrier and the feto-placental barrier. L. monocytogenes utilizes 
surface molecules internalin (Inl)A and InlB and their cellular receptors E-cadherin and 
Met, a receptor tyrosine kinase, to trigger cytoskeletal rearrangements and promote 
bacterial engulfment.124, 125, 134, 135 E-cadherin is a key component of adherent junctions, 
which are situated below tight junctions making them inaccessible to L. monocytogenes 
present in the intestinal lumen. However, it was recently shown that E-cadherin around 
mucus-expelling goblet cells and around enterocytes being extruded from the tip of the 
villus is accessible to L. monocytogenes in the lumen.136, 137 Once taken up by epithelial 
cells L. monocytogenes escapes from the vacuole using the membrane toxin listeriolysin 
and phospholipases and moves through the host-cell cytoplasm using continuous actin 
assembly at one pole of the bacterium. This process is driven by expression of the sur-
face protein ActA at one pole of the cells.138 From the mucosal sites of infection L. mono-
cytogenes can spread to the liver and spleen where it replicates in phagocytes using the 
virulence mechanisms described above (Fig. 1.7). Binding of L. monocytogenes to InlA 
is specific for human E-cadherin but in mice infection occurs through M-cell mediated 
uptake into Peyer’s patches.138, 139 To develop mouse models that reflect natural routes 
of infection a transgenic mouse was constructed that expresses human E-cadherin.135 
Another approach has been to express a mutant form of InlA that recognizes mouse 
E-cadherin in L. monocytogenes.140 
Aims and outline of this thesis
The overarching goal of this thesis was to find out more about the protective role of 
RegIIIβ and RegIIIγ in the intestine. Additionally we investigated whether these proteins 
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might be candidate biomarkers of intestinal health and have a protective role in colitis 
and bacterial infection. At the outset of this thesis, murine RegIIIγ has been reported to 
be bactericidal for Gram-positive bacteria, whereas the role of murine RegIIIβ had not 
yet been investigated in vitro.  
Initially, we used Muc2 knock out (-/-) mice to investigate the effect of a reduced or ab-
sent mucus layer on expression and localization of RegIIIβ, RegIIIγ and Ang4 (Chapter 2) 
in the small intestine and the colon. The aims were to study the consequence of Muc2 
deficiency on inflammation and to analyse the effect of weaning, when the density of 
the microbiota increases, by in situ hybridization, qPCR, histology and immunohisto-
chemistry. In Chapter 3, we investigated this Muc2-/- model in more detail, to gain more 
insights into the role of mucus in the ileum. The age-dependent changes in morphology 
and temporal gene expression patterns in the ileum and proximal colon were compared 
in wild type (WT) and Muc2-/- mice at 3 different time points by micro-array analysis, 
qPCR, and histology. 
In chapter 4 we expressed recombinant RegIII proteins and characterized their poten-
tial bactericidal properties in vitro. We also investigated binding of RegIII proteins to 
different species of bacteria and the influence of proteolytic processing by trypsin on 
their activity. Additionally, we sought to generate structural models of RegIII proteins 
binding to reported ligands in order to gain further insights into potential ligand binding 
sites and the amino acid residues conferring ligand specificity. It was difficult to produce 
large quantities of RegIII proteins in soluble form without resorting to refolding of insol-
uble inclusion bodies produced in E. coli, and these proteins lacked bactericidal activity. 
Therefore, we performed infection studies in knockout mice to further elucidate the 
role of these proteins in infection (Chapters 5 and 6).
An infection study was performed in RegIIIβ-/- mice in Chapter 5 to learn more about 
the protective mechanism of RegIIIβ in the intestine and whether this is specific for 
Gram-negative pathogens. Mice were orally infected with either a Gram-positive patho-
gen (Listeria monocytogenes) or a Gram-negative pathogen (Salmonella enteritidis), 
after which the translocation of the pathogens to different organs was examined. Ad-
ditional ex-vivo experiments were performed to gain insights into the mechanisms in-
volved in the protective function of RegIIIβ. In Chapter 6 we performed a comparable 
infection study in a newly constructed RegIIIγ-/- mouse model. The aim of this study was 
to determine the in vivo contribution of RegIIIγ to protection of the mouse mucosa from 
infection with the same pathogens as used in Chapter 5, Listeria monocytogenes and 
Salmonella enteritidis. We first generated and characterized a RegIIIγ-/- mouse, including 
histological and immuno-histochemical investigations of the mucus and spatial com-
partmentalization of bacteria in the intestine. Additionally, we investigated the effects 
of RegIIIγ deficiency in infection using microarray gene expression, qPCR and measure-
ments of bacterial translocation and serum biomarkers. 
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Finally, Chapter 7 completes this thesis with a general discussion and conclusions on the 
obtained results, with recommendations and perspectives for future studies.   
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ABSTRACT
Background: Mucin Muc2 is the structural component of the intestinal mucus layer. Ab-
sence of Muc2 leads to loss of this layer allowing direct bacterial-epithelial interactions. 
We hypothesized that absence of the mucus layer leads to increased expression of in-
nate defense peptides. Specifically, we aimed to study the consequence of Muc2 defi-
ciency (Muc2-/-) on the expression of regenerating islet-derived protein III beta (RegIIIβ), 
regenerating islet-derived protein III gamma (RegIIIγ), and angiogenin-4 (Ang4) in the 
intestine shortly before and after weaning. 
Methods: Intestinal tissues of Muc2-/- and wild-type (WT) mice were collected at post-
natal day 14 (P14, i.e. pre-weaning) and P28 (i.e. post-weaning). RegIIIβ, RegIIIγ, and 
Ang4 expression was studied by quantitative real-time PCR, Western-blot, in situ hy-
bridization, and immunohistochemistry. 
Results: RegIIIβ and RegIIIγ were expressed by diverging epithelial cell types; namely 
enterocytes, Paneth cells, and goblet cells. Additionally, Ang4 expression was confined 
to Paneth cells and goblet cells. Expression of RegIIIβ, RegIIIγ, and Ang4 differed be-
tween WT and Muc2-/- mice before and after weaning. Interestingly, absence of Muc2 
strongly increased RegIIIβ and RegIIIγ expression in the small intestine and colon. Final-
ly, morphological signs of colitis were only observed in the distal colon of Muc2-/- mice 
at P28, where and when expression levels of RegIIIβ, RegIIIγ, and Ang4 were the lowest. 
Conclusions: Expression of RegIII proteins and Ang4 by goblet cells point to an import-
ant role for goblet cells in innate defense. Absence of Muc2 results in up-regulation of 
RegIIIβ and RegIIIγ expression, suggesting altered bacterial-epithelial signaling and an 
innate defense response in Muc2-/- mice. The inverse correlation between colitis devel-
opment and RegIIIβ, RegIIIγ, and Ang4 expression levels might point toward a role for 
these innate defense peptides in regulating intestinal inflammation.
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InTRoduCTIon
The mucus layer that covers the intestinal epithelium forms a physical barrier against 
bacteria and is thereby an important component of the innate defense. The mucin 
MUC2 is the structural component of the colonic mucus layer. Interestingly, particular 
bacteria can use the glycan-chains of mucins as a nutrient source or bind to the mucins 
as a foothold for colonization. Previously, it has been demonstrated that the intestinal 
mucus layer exists of two separate layers.1, 2 The inner layer is densely packed, firmly 
attached to the epithelium, and devoid of bacteria. In contrast, the outer layer is colo-
nized by bacteria, and has a less firm structure. Breaches in this protective mucus layer 
allow for direct contact between bacteria and the epithelial cells,3 which leads to an 
inflammatory response. Muc2-/- mice lacking the mucus layer develop colitis sponta-
neously.1, 4
In human intestinal inflammatory diseases such as ulcerative colitis and necrotizing 
enterocolitis (NEC), the synthesis of MUC2 mucin is decreased,5-9 which might lead to 
increased bacterial-epithelial interaction. Bacteria are known to play a key role in the 
development of colitis as the development of colitis in genetically engineered rodent 
models of inflammatory bowel diseases (IBD) such as Il-10 deficient mice and HLA-B27 
transgenic rats is not observed when these animals are maintained under germ-free 
conditions.10-12 However, colonization of Il-10 deficient mice and HLA-B27 transgenic 
rats with normal enteric microbiota leads to severe and chronic colitis. IBD and NEC are 
not caused by specific intestinal bacterial species, but altered microbial profiles might 
be involved in the pathogenesis of these diseases. In the pathophysiology of IBD and 
NEC, a dysbiosis of the microbiota is strongly implicated.13, 14 
The composition of the microbiota is shaped in part by specific epithelial proteins, e.g. 
defensins and antimicrobial C-type lectins.15 Some antimicrobial proteins, such as most 
α-defensins, are expressed constitutively and do not require bacterial signals for their 
expression.16 However, expression of a subset of bactericidal proteins is, at least partly, 
controlled by recognition of microbe associated molecular patterns by pattern recogni-
tion receptors expressed by the epithelial cells.17 For example, expression of the anti-
microbial C-type lectin regenerating islet-derived protein III gamma (RegIIIγ, also called 
HIP/PAP in humans), is up-regulated in the small intestine and colon after bacterial re-
constitution of germ-free mice.18, 19 It has recently been demonstrated that RegIIIγ re-
stricts bacterial colonization of the intestinal epithelial surface and consequently limits 
activation of adaptive immune responses by the microbiota.20 In this respect, the mucus 
layer is of great importance as it functions as a mesh that retains bactericidal proteins 
such as RegIIIγ, and also molecules with immunologic properties such as sIgA.21 Inter-
estingly, RegIIIγ-/- mice exhibited a marked increase in numbers of mucosa associated 
Gram-positive bacteria.20 Expression of the bactericidal peptide angiogenin-4 (Ang4), 
the orthologue of human ANG, is induced upon colonization with Bacteroides thetaio-
Chapter 2
40
taomicron, an anaerobe Gram-negative microbe that belongs to the normal mouse 
and human microbiota.22 Furthermore, in conventionally raised mice the expression 
of RegIIIγ and Ang4 increases substantially after weaning,19, 22 when the complexity of 
the microbiota increases, and during experimental intestinal infection.23-25 Regenerat-
ing islet-derived protein III beta (RegIIIβ), RegIIIγ and HIP/PAP appear to be important 
in inflammatory diseases and intestinal injury as their expression is increased in IBD 
patients and in dextran sulfate sodium models of mouse colitis.18 Finally, RegIIIβ-/- mice 
show impaired clearance of Gram-negative bacteria Yersinia pseudotuberculosis26 and 
Salmonella enteritidis.27 Yet, both unchallenged RegIIIβ-/- and RegIIIγ-/- mice do not show 
gross morphological changes in the intestines.
The aim of this study was to investigate the effect of the mucus layer on RegIIIβ, RegIIIγ, 
and Ang4 expression and localization in the small intestine and colon using the Muc2-/- 
mouse as a model. With this approach we aimed to i) study the consequence of Muc2 
deficiency, i.e. absence of a protective mucus layer and, ii) analyze the effect of weaning 
(i.e., transfer from breast milk to pelleted food), when the density and complexity of the 
microbiota increases significantly. This study demonstrates that the expression of the 
innate defense genes RegIIIβ, RegIIIγ, and Ang4 differed between wild-type (WT) and 
Muc2-/- mice before and after weaning. Additionally, it highlights a new role for goblet 
cells in host innate immunity by demonstrating that they can produce the bactericidal 
peptides RegIIIβ, RegIIIγ, and Ang4. 
MeThodS
Animals
Muc2-/- mice were bred as previously described.4 All mice were housed in the same 
specific pathogen-free environment with free access to standard rodent pellets (Special 
Diets Services, Witham, Essex, England) and acidified tap water in a 12-hour light/dark 
cycle. All animal experiments were reviewed by and performed with approval of the 
Erasmus MC Animal Ethics Committee (approval number: EUR 1074), Rotterdam, the 
Netherlands. WT and Muc2-/- mice were tested negative for Helicobacter hepaticus and 
norovirus infection.
experimental setup
Wild-type (WT) and Muc2-/- littermates were housed together with their birth mothers 
until weaning at the age of 21 days. After weaning, male WT and Muc2-/- mice remained 
housed with their littermates. Male WT and Muc2-/- mice were sacrificed at the postna-
tal ages of 14 days (P14) and 28 days (P28). Intestinal tissues were excised and either 
fixed in 4% (w/v) paraformaldehyde in phosphate-buffered saline (PBS), stored in RNAl-
ater® (Sigma-Aldrich Chemie, Zwijndrecht, the Netherlands) at -20°C, or frozen in liquid 
nitrogen and stored at -80°C.
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Quantitative real-time PcR 
Total RNA was prepared using the RNeasy midi-kit (Qiagen, Venlo, the Netherlands). 
Total RNA (1.5 mg) was used to prepare cDNA using a standard protocol. The mRNA 
expression levels of RegIIIβ, RegIIIγ, Ang4 and Lysozyme type P (lysozyme-P), as well 
as the ‘housekeeping’ gene β-Actin (Actb) were quantified using real-time PCR analysis 
based upon the intercalation of SYBR® Green on an ABI prism 7900 HT Fast Real Time 
PCR system (PE Applied Biosystems) as previously described.4 All primer combinations 
were designed using OLIGO 6.22 software (Molecular Biology Insights) and purchased 
from Invitrogen. An overview of all primer sequences is given in Table 2.1.
gene Forward primer Reverse primer
RegIIIβ TGG GAA TGG AGT AAC AAT G GGC AAC TTC ACC TCA CAT
RegIIIγ CCA TCT TCA CGT AGC AGC CAA GAT GTC CTG AGG GC
Ang4 TTG GCT TGG CAT CAT AGT CCA GCT TTG GAA TCA CTG
Lysozyme-P CAG GGT GGT GAG AGA TCC AAG CGA GGA AGT GTG ACC
Actb GGG ACC TGA CGG ACT AC TGC CAC AGG ATT CCA TAC
Table 2.1: Primer sequences for quantitative real-time PCR
Western-blot analysis
Jejunal and distal colonic samples were homogenized in 500 μl HIS buffer (50 mM Tris/
HCl pH 7.5, 5 mM EDTA pH 8.0, 1% Triton X-100, 10 mM iodacetamide, 100 μg/ml soy 
bean trypsin inhibitor, 10 μg/ml pepstatine A, 10 μg/ml leupeptin, 1% (w/v) aprotinin 
and 1 mM PMSF). Total protein concentration was quantified using the bicinchonin-
ic acid assay (Pierce assay, Perbio Science, Etten-Leur, the Netherlands). Twenty µg of 
total protein was denatured at 95°C for 5 min in Laemmli loading buffer and subject-
ed to 12% (w/v) SDS-polyacrylamide gel electrophoresis. The separated proteins were 
transferred to nitrocellulose membranes (Protan BA 83, 0.2 μm) and the blots were 
blocked for 1 h at room temperature in 5% (w/v) non-fat dry milk (Campina Melkunie, 
Eindhoven, the Netherlands) dissolved in phosphate-buffered saline containing 0.1% 
(v/v) Tween-20 (PBST). Blots were incubated overnight at 4oC with anti-β-Actin anti-
body (1:10,000 in PBST, Abcam, ab6276) or with the custom made primary antibodies 
against RegIIIβ and RegIIIγ (1:20,000 in PBST, Eurogentec, Seraing, Belgium). These an-
tibodies were generated in rabbits against the synthetically produced peptides, using 
the peptide sequences GEDSLKNIPSARISC (RegIIIβ) and MIKSSGNSGQYVC (RegIIIγ). The 
chosen peptide sequences correspond to unique sequences within the respective RegIII 
proteins, and allow for differentiation between the RegIIIβ and RegIIIγ proteins. Serum 
from immunized rabbits was affinity purified using the respective peptides. Selectivity 
and cross reactivity of the generated antibodies for the RegIII proteins were checked 
by ELISA. Finally, blots were incubated with the secondary antibody goat-anti-rabbit 
IRDye® 800CW (1:20,000, Li-cor, Westburg, Leusden, the Netherlands) for RegIIIβ and 
RegIIIγ, and goat-anti-mouse IRDye®680CW (1:20,000, Li-cor) for β-Actin. Signals were 
detected with the Odyssey scanner (Li-cor). Serial dilution series of the protein samples 
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were analyzed to ensure that the quantification of each protein by its cognate antibody 
was performed in the linear range of this technique. Expression of each protein is ex-
pressed relative to the expression of β-Actin.
histology
Tissue fixed in 4% (w/v) paraformaldehyde in PBS was prepared for light microscopy, 
and 4-mm-thick sections were stained with hematoxylin and eosin (H&E) and period-
ic acid Schiff’s (PAS) staining to study morphological changes and detect goblet cells, 
respectively. To detect differences in mucosal thickness in the colon, 10 well-oriented 
crypts were chosen per intestinal segment and measured using calibrated Leica Appli-
cation Suite software, version 3.2.0 (Leica Microsystems BV, Rijswijk, the Netherlands). 
Immunohistochemistry
Four-micrometer-thick sections were prepared for immunohistochemistry as described 
previously28 using the Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA) and 
the staining reagent 3,3’-diaminobenzidine. The antigens were unmasked by heating 
the sections for 20 min in 0.01 M Tris/HCl (pH 9.0) supplemented with 0.05% (v/v) EGTA 
at 100°C. Expression of RegIIIb was detected using a commercial anti-mouse RegIIIb 
antibody (1:500 diluted in PBS containing 1% bovine serum albumin and 0.1% Triton 
X-100, R&D Systems Europe Ltd., Abingdon, United Kingdom, AF5110) and with the 
above described custom-made antibody against RegIIIb (1:25,000 in PBS). RegIIIγ was 
detected using the above described custom made antibody against RegIIIγ (1:25,000 in 
PBS). Expression of angiogenin-4 was detected using an anti-human-angiogenin anti-
body (1:50 diluted in PBS containing 1% bovine serum albumin and 0.1% Triton X-100, 
R&D Systems Europe Ltd., Abingdon, United Kingdom, AF265). To identify goblet cells 
HA1 antibody, which is specific for Muc4 was used as described previously.29 As the 
commercial and the custom-made RegIIIb antibody gave similar staining patterns only 
data obtained with the commercial RegIIIb antibody are shown.
Probe preparation 
Digoxigenin-11-UTP-labelled RNA probes were prepared according to the manufac-
turer’s instructions (Boehringer Mannheim GmbH, Biochemica, Mannheim, Germany) 
using T3 and T7 RNA polymerase. Gene fragments of Ang4, RegIIIβ and RegIIIγ were 
amplified, using the primers listed in Table 2.2, and cloned in pBluescript II SK. 
In situ hybridization (ISh)
Non-radioactive ISH was performed according to a previously described method 30. The 
digoxigenin-labeled hybrids were detected by incubation with anti-digoxigenin (Fab, 
1:1000 in TBS/1% BA + 1% v/v sheep serum, Roche) conjugated to alkaline phosphatase 
for 2.5 h at room temperature. Thereafter, sections were washed in 0.025% (v/v) Tween 
in Tris-buffered saline (pH 7.5). For staining, sections were layered with detection buffer 
(0.1 M Tris/HCl, 0.1 M NaCl, 0.05 M MgCl
2
, pH 9.5) containing 0.33 mg/ml 4-nitroblue 
tetrazolium chloride, 0.16 mg/ml 5-bromo-4-chloro-3-indolyl-phosphate, 8% (v/v) poly-
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vinyl alcohol (Mw 31,000–50,000, Aldrich Chemical, Milwaukee, WI, USA), and 1 mM 
levamisole (Sigma). The color reaction was performed overnight in the dark and was 
stopped when the desired intensity of the resulting blue precipitate was reached. Fi-
nally, sections were washed in 10 mM Tris/HCl pH 9.5 containing 1 mM EDTA, washed 
in distilled water, and mounted with Aquamount improved (Gurr, Brunschwig, Amster-
dam, the Netherlands).
Gene Forward primer Reverse primer Amplified product (bp)
RegIIIβ
TGG GAA TGG AGT 
AAC AAT G
ATG TGA GGT GAA 
GTT GCC
146
RegIIIγ
CAA TCA CTG TGG 
TAC CCT G
GAT TTT CTC CTT 
CTC TGG C
229
Ang4
CCA GCT TTG GAA 
TCA CTG T
CTA TGA TGC CAA 
GCC AA
151
Table 2.2: Primer sequences for probe preparation for ISH
Statistical analysis
All data are expressed as median. Statistical significance was assessed using the 
Mann-Whitney U test (Prism, version 5.00; GraphPad software, San Diego, CA). The 
data were considered statistically significant at P < 0.05.
ReSuLTS
clinical symptoms and intestinal morphology
At P14, when the mice received breast milk, there were no significant differences in 
body weights between Muc2-/- and WT mice (Fig. 2.1A). However, at P28, when mice 
had been transferred from breast milk to solid food, the body weights of Muc2-/- mice 
were significantly lower than that of WT mice (P = 0.0108). Clinical signs of colitis like 
rectal bleeding, bloody stools or rectal prolapse were not observed in Muc2-/- mice at 
P14 nor at P28. Morphological signs of colitis were only observed in the distal colon of 
Muc2-/- mice at P28, but not in the distal colon at P14, neither in the proximal colon and 
small intestine at P14 or P28 (Fig. S2.1). More specifically, at P28 the distal colonic tissue 
from Muc2-/- mice showed increased crypt lengths, (Fig. 2.1B and Fig. S2.1K and S2.1L) 
and flattening of the epithelial cells (Fig. 2.1C). 
Localization of RegIIIβ, RegIIIγ, and Ang4 mRnAs and proteins in the small intestine
We first determined the expression pattern of the RegIII proteins in the small intestine 
of WT and Muc2-/- mice by immunohistochemistry. Interestingly, we did find differenc-
es in the localization of the RegIII proteins, although there were no major differenc-
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es in small intestinal morphology between WT and Muc2-/- mice. Specifically, RegIIIβ 
and RegIIIγ were not expressed in the duodenum of WT mice at P14 (Fig. 2.2 and 2.3). 
However, the jejunum and ileum of WT mice clearly express RegIIIβ and RegIIIγ at this 
time point. At P28 RegIIIγ was still expressed in the jejunum and ileum of WT mice, but 
the expression was weak. RegIIIβ expression at P28 was also weak but present in each 
region of the small intestine of WT mice. In sharp contrast, in Muc2-/- mice the RegIII 
proteins were strongly expressed in the entire small intestine from duodenum till ileum 
(Fig. 2.2 and 2.3) at P14 as well as P28.
Figure 2.1. Clinical symptoms and intestinal morphology. Body weights (A) and crypt lengths in the 
distal colon (B) of WT and Muc2-/- mice at P14 and P28. Crypth length values are depicted as box-and-
whiskers diagrams (maximum value, upper quartile, median, lower quartile and minimal value, re-
spectively) P values are indicated when body weights/crypt lengths differ statistically between groups. 
(C) H&E staining of distal colonic tissue of Muc2-/- mice at P28.
Figure 2.2. Localization of RegIIIβ protein in the small intestine. Immunohistochemical staining of 
RegIIIβ in the duodenum, jejunum, and ileum of WT (A, C, E, G, I, K) and Muc2-/- mice (B, D, F, H, J, L) 
at P14 (A-F) and P28 (G-L). Bar represents 75 mm. Arrowheads indicate RegIIIβ-positive Paneth cells.
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Figure 2.3. Localization of RegIIIγ protein in the small intestine. Immunohistochemical staining of 
RegIIIγ in the duodenum, jejunum, and ileum of WT (A, C, E, G, I, K) and Muc2-/- mice (B, D, F, H, J, L) 
at P14 (A-F) and P28 (G-L). Bar represents 75 mm. Arrowheads indicate RegIIIγ positive Paneth cells. 
Figure 2.4. Localization of RegIIIβ mRNA in the jejunum. ISH for RegIIIβ mRNA in the jejunum 
of WT and Muc2-/- mice at P14 (A & B) and P28 (C & D) (arrowheads in insert in panel D indicate 
RegIIIβ mRNA-positive cells at the bottom of the crypts in Muc2-/- at P28). Bar represents 50 mm.
To determine the expression pattern of RegIII mRNAs and proteins in more detail we 
focused on the jejunum. In both, WT mice and Muc2-/- mice, RegIIIβ mRNA was detect-
ed by ISH and observed in epithelial cells at the base of the villi at P14 (Fig. 2.4A and 
B). In contrast, at P28 the expression pattern of RegIIIβ mRNA remained limited to the 
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villus base in WT mice, but had extended to the upper part of the villi in Muc2-/- mice 
(Fig. 2.4D). Interestingly, in Muc2-/- mice RegIIIβ mRNA was also observed in epithelial 
cells at the base of the crypts (Fig. 2.4D). RegIIIγ mRNA was observed in epithelial cells 
at the crypt bottom till the tips of the villi in WT and Muc2-/- mice at P14 and P28 (data 
not shown).
Immunohistochemical analysis revealed that in WT as well as Muc2-/- mice enterocytes 
were RegIIIβ- and RegIIIγ-positive (P14 and P28) (Fig. 2.2 and 2.3). Moreover, in WT 
mice at P14 and in Muc2-/- mice at P14 and P28, RegIIIβ- and RegIIIγ-positive cells had 
a ‘bell/goblet’ shape suggesting that these cells could be goblet cells. Staining of serial 
section of the jejunum with the goblet cell marker Muc429 or PAS demonstrated that 
the bell/goblet-shaped RegIIIβ- and RegIIIγ-positive cells in WT and Muc2-/- mice were 
indeed goblet cells (Fig. S2.2). Furthermore, in WT mice at P14 as well as in Muc2-/- mice 
at P14 and P28 Paneth cells at the bottom of the crypts were RegIIIγ-positive (Fig. 2.3). 
Yet, RegIIIβ-positive Paneth cells at the bottom of the crypts were only observed in 
Muc2-/- mice, but not in WT mice (Fig. 2.2). 
Finally, small intestinal Ang4 mRNA was localized in Paneth cells of both WT and Muc2-
/- mice at both ages studied (Fig. S2.3, showing Ang4 mRNA in Muc2-/- mice at P14). Yet, 
at P14, Ang4 mRNA was not only observed in the Paneth cells but also at the apical side 
of the villus enterocytes in both types of mice. Ang4 protein expression patterns were 
similar to the Ang4 mRNA expression patterns with expression localized to Paneth cells 
at P14 and P28, and to enterocytes along the villi at P14 in both WT and Muc2-/- mice 
(Fig. 2.5). Moreover, the abundance of Ang4-positive Paneth cells increased from P14 
to P28 in both types of mice.
Localization of RegIIIβ, RegIIIγ, and Ang4 proteins in the colon
We also determined the expression pattern of the RegIII and Ang4 proteins in the colon 
of WT and Muc2-/- mice by immunohistochemistry. Both RegIIIb and RegIIIγ were unde-
tectable in the distal colon of WT and Muc2-/- mice at P14 or P28 (data not shown). How-
ever, in the proximal colon of WT and Muc2-/- mice these RegIII proteins were expressed 
within the epithelial cells in the crypt epithelium as well as the surface epithelium at 
both time points investigated (Fig. 2.6). Interestingly, in the proximal colon of WT mice 
RegIIIb and RegIIIγ were only expressed by enterocytes, whereas in Muc2-/- mice these 
proteins were expressed by enterocytes as well as putatively by goblet cells, as based on 
the ‘goblet’ shape of the RegIIIb- and RegIIIγ -positive cells in the Muc2-/- mice. Analysis 
of serial sections stained with the goblet cell marker Muc4 or with PAS revealed that 
these RegIIIb- and RegIIIγ -expressing cells with a goblet shape were indeed goblet cells 
(data not shown). The abundance of cells with the typical bell/goblet shape seemed to 
decrease progressively from P14 to P28 in the proximal colon of the Muc2-/- mice.
Ang4 was hardly detectable in the distal colon of WT and Muc2-/- mice (data not shown). 
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However, in the proximal colon Ang4 was clearly expressed within the crypts and sur-
face epithelium of both WT and Muc2-/- mice at P14 and only in WT mice at P28, where 
it was expressed by goblet cells (Fig. 2.7B and 2.7C). Detection of Ang4 mRNA by ISH 
demonstrated that Ang4 was indeed expressed by goblet cells in the proximal colon of 
WT mice (Fig. 2.7A).
Quantitative analysis of RegIIIβ, RegIIIγ, Ang4, and lysozyme-P mRnA levels
We next analyzed the mRNA expression levels of RegIIIb, RegIIIγ, Ang4, and lysozyme-P 
in the intestinal tissues of WT and Muc2-/- mice. In the jejunum RegIIIβ and RegIIIγ mRNA 
levels were comparable between WT and Muc2-/- mice at P14 (Fig. 2.8A and 2.8B). In 
contrast, at P28 RegIIIβ, and RegIIIγ mRNA levels significantly increased in the Muc2-
/- mice, whereas these remained stable in the WT mice. The mRNA levels of Ang4 and 
lysozyme-P, genes which in the small intestine are synthesized by Paneth cells, were 
comparable between the jejunum of WT and Muc2-/- mice at P14 as well as P28 (Fig. 
2.8C and 2.8D). Remarkably, from P14 to P28 mRNA levels of both Ang4 and lysozyme-P 
significantly increased in the jejunum of both types of mice.
A comparison of RegIIIβ, RegIIIγ and Ang4 mRNA levels within colonic tissue of WT mice 
and Muc2-/- mice revealed six important findings (Fig. 2.9). 1) In WT as well as Muc2-/- 
mice, higher RegIIIβ, RegIIIγ, and Ang4 mRNA levels were found in the proximal colon 
compared to the distal colon at P14 and P28. 2) During aging from P14 to P28, RegIIIβ, 
RegIIIγ, and Ang4 mRNA levels in the proximal colon increased in WT as well as Muc2-/- 
mice. 3) Muc2-/- mice had significantly increased RegIIIβ and RegIIIγ mRNA levels in the 
distal colon at P14 and P28 compared to WT mice, a similar trend was also observed in 
the proximal colon. 4) In the distal colon, RegIIIβ and RegIIIγ mRNA expression levels 
were hardly detectable in WT mice. 5) RegIIIβ, RegIIIγ, and Ang4 mRNA levels in the dis-
tal colon of Muc2-/- mice seemed to decrease during aging from P14 to P28. 6) Colonic 
expression levels of RegIIIβ, RegIIIγ, and Ang4 mRNA showed considerable mouse to 
mouse variation.
Quantitative analysis of RegIIIβ and RegIIIγ protein levels
Expression of RegIIIβ and RegIIIγ protein was studied by Western-blot analysis. At P14 
protein expression levels were below the detection limit in the jejunum of WT as well 
as Muc2-/- mice (data not shown). At P28, expression of both RegIIIβ (Fig. S2.4A) and 
RegIIIγ (Fig. S2.4B) was significantly increased in Muc2-/- mice compared to WT mice, in 
which RegIIIβ and RegIIIγ protein levels remained undetectable. These data correlate 
with the jejunal RegIIIβ and RegIIIγ mRNA expression levels as presented in Fig. 2.8A 
and B. Expression of RegIIIβ and RegIIIγ protein in the distal colon was not detectable 
by Western-blot (results not shown).
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Figure 2.5. Localization of Ang4 protein in the jejunum. Localization of Ang4 in the jejunum of WT and 
Muc2-/- mice at P14 (A & B) and P28 (C & D). Arrowheads indicate Ang4-positive Paneth cells, and the 
insert in panel B shows enterocyte-specific Ang4 expression at P14. Bar represents 50 mm. 
Figure 2.6. Localization of RegIIIβ protein in the proximal colon. RegIIIβ (A, B, E, F) and RegIIIγ (C, D, G, 
H) expression in the proximal colon at P14 (A-D) and P28 (E-H). Note, in WT mice RegIIIb and RegIIIγ 
were only expressed by enterocytes, whereas in Muc2-/- mice these proteins were expressed by en-
terocytes and putative ‘goblet’ cells. Bar represents 50 mm.
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dIScuSSIon
In the present study we examined the expression pattern and localization of RegIIIβ, 
RegIIIγ and Ang4 in intestinal tissue of WT and Muc2-/- mice at the age of 14 days and 
post weaning at 28 days. We demonstrated that the expression of these genes, which 
play a role in innate defense and shaping of the bacterial community in the intestine, 
differs between WT and Muc2-/- mice before and after weaning. These changes might 
be related to alterations in the composition of the microbiota during this time frame 
and in Muc2-/- mice also to the altered interactions between bacteria and the intestinal 
epithelial cells in the absence of the intestinal mucus layer.
Figure 2.7. Goblet cell-specific expression of Ang4 mRNA and protein in the proximal colon. Local-
ization of Ang4 mRNA in goblet cells of WT mice by ISH (A) at P28. Localization of Ang4 protein by 
immunohistochemistry in WT (B) and Muc2-/- (C) mice at P28. Arrows indicate Ang4 mRNA in goblet 
cells. Bar represents 50 mm. 
Although there were no morphological changes in the small intestine and proximal co-
lon of Muc2-/- mice, these mice did show major differences in the expression pattern 
and localization of the C-type lectins RegIIIβ and RegIIIγ compared to WT mice. Specif-
ically, in WT mice the RegIII proteins were only clearly expressed at P14 in the jejunum 
and ileum. Moreover, expression of the RegIII proteins was weak or below detection 
level in this type of mice at P28. In contrast, in Muc2-/- mice these RegIII proteins were 
strongly expressed in the entire small intestine from duodenum till ileum at P14 as well 
as P28. The differences in RegIII protein expression pattern within WT mice between 
P14 (i.e., before weaning) and P28 (i.e., after weaning) suggests that bacterial coloniza-
tion, which is known to change during the weaning period, is highly likely to influence/
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regulate RegIIIβ and RegIIIγ expression, which is supported by the findings of other 
authors.18, 19 Along the same line, differences in RegIII protein expression between WT 
mice and Muc2-/- mice might point to a difference in the composition of the microbiota 
between these mice and thus that mucins, in particular mucin Muc2, also influence the 
composition of the microbiota.
Figure 2.8. RegIIIβ, RegIIIγ, Ang4 and lysozyme-P mRNA levels in the jejunum. Small intestinal ex-
pression of RegIIIβ (A), RegIIIγ (B), Ang4 (C) and lysozyme-P (D) mRNA expression. The relative mRNA 
expression levels were normalized to Actb and expressed as median. P values are indicated when 
expression levels between groups differ statistically. Groups are depicted as: WT, P14 ♦; Muc2-/-, P14 
◊; WT, P28 ●; and Muc2-/-, P28 ○.
It was previously shown that RegIIIγ and Ang4 are expressed in small intestine and lo-
calized in Paneth cells19, 22 and RegIIIβ mRNA was shown in colonic goblet cells and co-
lumnar cells.18 Our immunohistochemical analysis revealed that in the small intestine of 
WT mice and Muc2-/- mice RegIIIγ and Ang4 are indeed expressed by Paneth cells. Yet, 
in Muc2-/- mice Paneth cells also express RegIIIβ. These data suggest that in the absence 
of Muc2, and thus in the absence of a mucus layer, Paneth cells increase their innate de-
fense capacity by expressing RegIIIβ. Even more importantly, we also demonstrated that 
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during initial colonization RegIIIβ and RegIIIγ are not exclusively expressed by Paneth 
cells, but also by enterocytes and goblet cells in the small intestine and proximal colon 
of WT and Muc2-/- mice. Additionally, goblet cells in the proximal colon also appeared to 
synthesize Ang4. Besides secreting Relmβ, which is suggested to have an immune effec-
tor function,31-33 goblet cells were until now not known to play a role in innate defense 
responses via the secretion of bactericidal proteins. Our demonstration that RegIIIβ, 
RegIIIγ, and Ang4 are expressed by goblet cells highlights a new and important role for 
goblet cells in innate defense and in helping to shape the bacterial community. Overall, 
the spatial RegIIIβ and RegIIIγ expression is remarkable in the sense that these proteins 
are expressed in at least 3 different epithelial cell lineages within the intestine, namely 
goblet cells, enterocytes, and Paneth cells. 
Focusing on RegIII expression levels, we demonstrate that small intestinal expression 
of RegIIIβ and RegIIIγ mRNAs and proteins were increased in Muc2-/- mice compared to 
WT mice at P28 just after weaning. These data imply that loss of a protective mucus lay-
er as in Muc2-/- mice leads to an increased innate defense response, probably as a result 
of increased epithelial-bacterial interactions and altered bacterial colonization as wean-
ing is known to alter the composition of the microbiota. Small intestinal expression 
levels of Ang4 mRNA were also increased after weaning in WT as well as Muc2-/- mice. 
We additionally showed that expression levels of Ang4 in the small intestine resemble 
lysozyme-P levels over time. As it is known that Paneth cell development occurs after 
birth in mice, with a complete constitution of the Paneth-cell lineage from the age of 3 
to 4 weeks,34 the increased expression of lysozyme-P and Ang4 mRNAs at P28 compared 
to P14 is most likely due to increased Paneth cell numbers during development from 
P14 to P28.
Expression levels of RegIIIβ, RegIIIγ, and Ang4 mRNA in the proximal colon were consid-
erably higher compared to expression levels in the distal colon of WT and Muc2-/- mice at 
both time points investigated. An explanation for this could be that an intrinsic program 
encoded in the epithelial cells controls the segmental expression of the studied innate 
defense molecules. On the other hand, altered expression of the RegIII and Ang4 genes 
might be related to changes in the composition of the microbiota as demonstrated for 
RegIIIγ in a simplified model where germ-free mice are sequentially colonized with Bac-
teroides thetaiotaomicron and then Bifidobacterium longum.35 Specifically, colonization 
of germ-free mice with Bacteroides thetaiotaomicron induced RegIIIγ expression, but 
this was lowered by the subsequent introduction of Bifidobacterium longum. Thus the 
observed differences in RegIIIβ, RegIIIγ, and Ang4 gene expression levels between the 
proximal and distal colon might be related to differences in the composition of the mi-
crobiota in these parts of the intestine. Indeed, it has been shown that the composition 
of mucosa-associated bacterial species may differ up to 4% between the right colon (i.e. 
proximal colon) and left colon (i.e. distal colon).36, 37
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Figure 2.9. RegIIIβ, RegIIIγ and Ang4 mRNA levels in the colon. Expression of RegIIIβ (A,B), RegIIIγ 
(C,D), Ang4 (E,F) mRNA in colonic tissue of WT and Muc2-/-. Proximal and distal colonic expression 
levels are shown in the left and right panels, respectively. The relative mRNA expression levels were 
normalized to Actb and expressed as median. P values are indicated when expression levels between 
groups differ statistically. Groups are depicted as: WT, P14 ♦; Muc2-/-, P14 ◊; WT, P28 ●; and Muc2-/-, 
P28 ○. 
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Regardless of the mechanisms of RegIII gene and Ang4 gene regulation, there seems 
to be an inverse correlation between RegIIIβ, RegIIIγ, and Ang4 gene expression levels 
and the location of colitis in Muc2-/- mice. Namely, morphological signs of colitis are 
only observed in the distal colon of Muc2-/- mice at P28, where and when the expres-
sion levels of RegIIIβ, RegIIIγ, and Ang4 were the lowest, but not in the proximal colon, 
where RegIIIβ, RegIIIγ, and Ang4 levels were the highest. These findings could imply 
that RegIII proteins and/or Ang4 regulate intestinal inflammation directly or indirectly. 
Interestingly, studies from Folch-Puy et al. indicate that PAP-I (also known as HIP, p23, or 
Reg2 protein) directly inhibits the inflammatory response by blocking NF-κB activation 
through a STAT3-dependent mechanism.38 When RegIII proteins and/or Ang4 indeed 
limit intestinal inflammation one might even speculate that the distal colon is more 
prone to develop colitis than the proximal colon because RegIIIβ, RegIIIγ, and Ang4 
expression levels are lower in the distal colon than in the proximal colon. However, the 
inflammatory modulating capacities of the RegIII and Ang4 proteins still remain to be 
proven.  
Expression levels of RegIIIβ and RegIIIγ mRNAs were consistently higher in Muc2-/- mice 
compared to WT mice in both the proximal and distal colon. This is most likely due to 
increased commensal bacterial-epithelial interactions in Muc2-/- mice compared to WT 
mice, which has been demonstrated before.1 Given that the glycans on mucins are a 
nutrient source for bacteria,39 loss of Muc2 is likely to influence the composition of the 
microbiota. Differences in the composition of the colonic microbiota between WT and 
Muc2-/- mice might in their turn also influence RegIII and Ang4 protein expression. 
After weaning, expression levels of RegIIIβ, RegIIIγ, and Ang4 mRNAs in the proximal 
colon were increased in WT and Muc2-/- mice. Cash et al. showed that RegIIIγ mRNA 
expression increased during the weaning period in the small intestine of conventionally 
raised mice, but not in germ-free mice.19 The same accounts for Ang4 expression in the 
small intestine.22 It is known that the density and complexity of the microbiota increases 
significantly after weaning. This can be explained by the food source itself, serving as a 
substrate for specific bacteria, but also by the loss of protective factors that are present 
in mother’s milk but not in plant-based chow e.g. sCD14, sTLR2, TGFβ, IL-10, and lacto-
ferrin.40-43 Anyway, increased expression of RegIIIb and RegIIIγ at P28 in WT as well as 
Muc2-/- mice might be regarded as an innate response to alterations in the number and 
composition of the microbiota that are related to the weaning process.
In summary, this study demonstrates that RegIIIβ and RegIIIγ can be expressed in di-
verging cell lineages, namely enterocytes, Paneth cells, and goblet cells. This study also 
highlights a new role for goblet cells in host innate immunity by demonstrating that they 
can produce the bactericidal peptides RegIIIβ, RegIIIγ, and Ang4. Additionally, absence 
of Muc2 resulted in strong up-regulation of RegIIIβ and RegIIIγ mRNAs in the small in-
testine and colon, suggesting altered bacterial-epithelial signaling in Muc2-/- mice, lead-
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ing to increased innate defense capacity. Alterations in RegIII and Ang4 gene expression 
were related to weaning from mother’s milk, which is known to alter the composition 
of the microbiota. Therefore an important role for bacteria in regulation of RegIII and 
Ang4 gene expression is suggested. Furthermore, morphological signs of colitis were 
observed in the distal colon of Muc2-/- mice, where expression levels of RegIIIβ, RegIIIγ, 
and Ang4 mRNAs were the lowest, but not in the proximal colon where expression lev-
els of these genes were the highest. These findings might point toward a role for RegIII 
proteins and/or Ang4 in regulating intestinal inflammation. 
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 ABSTRACT
Muc2-/- mice develop spontaneous colitis after around 4 weeks of age but the effects 
of lack of mucus in the ileum have not been previously reported. We investigated mor-
phological and gene expression changes in the proximal colon and ileum in Muc2-/- mice 
from before weaning (2 weeks) after weaning (4 weeks) and at 8 weeks of age. Lack of 
mucin resulted in mucosal tissue damage in colon at weeks 4 and 8 whereas in the ile-
um we observed signs of hyperplasia at week 8. In the proximal colon, network biology 
approaches showed expression of innate and adaptive immune pathways associated 
with colitis, increasing with time. Based on expression of IBD-related genes, the colitis 
observed in the Muc2-/- model was similar to that observed in the DSS-model, where 
mucus barrier function is also compromised. In contrast to the colon, many immune 
signalling pathways were down-regulated in the ileum at weeks 2, 4 and 8. Neverthe-
less, RegIIIβ and RegIIIγ were significantly upregulated in the ileum, suggesting their 
proposed antimicrobial and/or anti-inflammatory activities might be related to the sup-
pression of immune pathways and avoidance of immune-mediated damage. Further-
more, we showed that RegIIIβ could specifically bind to mucin and fucosylated glycans 
in vitro, which may serve to inhibit bacterial binding to membrane bound mucins on the 
epithelium and also enable RegIIIβ to be retained in the secreted mucin.
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InTRoduCTIon
A key element of the mammalian intestinal strategy for maintaining homeostasis with 
the microbiota is to minimize contact between luminal microorganisms and the intes-
tinal epithelial cell surface. This separation between bacteria and epithelia is accom-
plished by a physical barrier that consists of mucus, antimicrobial proteins and IgA, se-
creted into the lumen.1, 2 Mucus in the intestine, primarily composed of glycosylated 
mucin 2 (Muc2), is secreted by goblet cells in the epithelium. In the mouse colon two 
distinct layers can be distinguished; a stratified inner layer which is attached to the 
epithelium and largely devoid of bacteria, and a less dense outer mucus layer that is 
accessible for commensal microbes. Both mucus layers have essentially the same mu-
cus composition suggesting the outer mucus layer arises from proteolytic cleavage and 
volumetric expansion of the inner layer. The density and stratified organization of the 
inner mucus layer is proposed to prevent penetration by bacteria thereby minimizing 
contact between bacteria and the epithelium.3 In the small intestine, the mucus layer is 
thinner than in the colon, of uniform density and has a propensity to detach from the 
epithelium in histological procedures.
Increased contact between microbiota and epithelia is a feature of inflammatory bowel 
disease (IBD).4 Mice with gene knockouts for Toll like receptor (Tlr)5, interleukin 10 (IL-
10) and Slc9a3 (Nhe3) develop spontaneous colitis and the colonic mucin was shown 
to be more penetrable to fluorescent beads and bacteria.5 In these knockout mouse 
models, some bacteria were seen in contact with the colonic epithelial surface, which 
was not observed in wild-type (WT) mice.5 In humans, the colonic mucus in biopsy sam-
ples from ulcerative colitis (UC) patients was highly penetrable to fluorescent beads, 
whereas biopsies from healthy individuals and most of the UC patients in remission 
had a mucus layer that was seemingly impenetrable to beads.5 The diminished barrier 
functionality of the mucus layer in colitis may result from the structural changes in the 
glycoprotein core and/or the sulphation and sialylation of mucins oligosaccharide res-
idues, which have been reported in IBD patients.6 Additionally, endoplasmic reticulum 
stress and a defective unfolded protein response have been proposed to play a role in 
mediating functional changes in mucus secretion and its functional properties.7 The 
results, taken together with earlier studies showing increased association of bacteria 
with the epithelium in UC patients than in healthy persons,8 suggests that at least in UC, 
defects in the organization of the inner mucus layer allow bacteria to reach the epithe-
lium in larger quantities than normal. Excessive bacterial contact with the epithelium 
is known to trigger inflammatory responses through recognition of microbe-associated 
molecular patterns (MAMPs) by pattern recognition receptors (PRRs) of the innate im-
mune system, including TLRs and nucleotide-binding oligomerization domain (NOD)-
like receptors (NLRs) and increasing epithelial permeability.9 The influx of bacteria and 
their products across the epithelium increases the inflammatory response, resulting in 
the influx of immune cells, further loss of epithelial integrity and activation of adaptive 
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immune responses. All the above listed symptoms are characteristic for mouse colitis 
and for human IBD, which includes both UC and Crohn’s disease (CD).4 In human IBD, 
clinical pathology is associated with the altered transcription of 32 common genes.10 
Many of these genes are also differentially expressed in mouse models of colitis that 
share pathologic features with either CD or UC.
An abnormal composition and decreased complexity of the microbiota are common 
features in IBD patients.4, 11 This has led to the identification of pathobionts such as the 
adherent invasive E. coli (AIEC), that in IBD patients increase in abundance, invade and 
persist intracellularly within epithelial cells and macrophages.12 The genetic polymor-
phisms associated with IBD compromise the innate mechanisms that normally combat 
these pathogens. 
The protective properties of mucus are evident in Muc2-/- mice, which develop spon-
taneous colitis after about 4 weeks, due to the lack of a mucus layer in the intestine.13 
In these mice, bacteria are found in the colonic crypts and in direct contact with the 
epithelial cells, something that is not observed in WT mice. The inflammatory respons-
es occurring in Muc2-/- mice prior to the development of colitis have been studied in 2 
and 4 week old mice.14, 15 Distinct phases were observed in colitis development, which 
might be related to the expansion of the microbiota after weaning, and/or loss of pro-
tective factors in the mother’s milk. The most notable changes observed in Muc2-/- mice 
were the exacerbation of inflammatory gene expression after weaning and a decline in 
regulatory T cells.14 Muc2-/- mice do not develop ileitis but it is not known if there are 
adaptations in the host that compensate for lack of mucus layer in the small intestine, 
for instance increased production of antimicrobial peptides. 
None of the previous studies in Muc2-/- mice mentioned above have investigated the 
effects of the lack of Muc2 in the ileum in detail, or the phenotype of heterozygote (Hz) 
mice, which are anticipated to secrete less Muc2. Our research interest was to inves-
tigate how the intestine responds to a reduction in mucus production over time as it 
might provide valuable information on homeostatic mechanisms and early indicators of 
gut barrier dysfunction and colitis. A further aim was to investigate the ileal responses 
to a mucus barrier defect as it might reveal differences between the ileum and colon 
with respect to homeostatic mechanisms, including regulation of innate responses and 
antimicrobial gene expression. Hereby we focussed mainly on RegIII proteins, as we 
have previously shown that RegIIIγ and RegIIIβ are upregulated in the intestine of Muc2-
/- mice,16 which might have a protective role in the intestine. We were also interested 
to analyse the expression mouse orthologues of a panel of known human IBD related 
genes in the Muc2-/- ileum and colon.  
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MATeRIALS And MeThodS
Animals 
Muc2-/- mice were bred as previously described13 on a 129SV genetic background. All 
mice were generated from breeding Hz (Muc2+/-) mice and genotyped as previously 
described.17 Mice were housed together in a specific pathogen-free environment with 
ad libitum access to standard rodent pellets (Special Diets Services, Witham, Essex, En-
gland) and acidified tap water in a 12-hour light/dark cycle. The Erasmus MC Animal 
Ethics Committee approved all the animal experiments described in this paper (Rotter-
dam, The Netherlands).
experimental set up
Groups of WT, Hz and Muc2-/- littermates were housed together with their birth mother 
until weaning at the age of 21 days and sacrificed at 14, 28 and 56 days post-natally. 
Small intestinal and colonic tissues were excised immediately and either fixed in 4% 
(w/v) paraformaldehyde in phosphate-buffered saline (PBS), stored in RNAlater (Qia-
gen, Venlo, The Netherlands) at -20°C, or frozen in liquid nitrogen and stored at -80°C.
histology
Tissue fixed in 4% (w/v) paraformaldehyde in PBS was prepared for light microscopy, 
and 4 μm-thick sections were stained with hematoxylin and eosin (H&E) to study histo-
logical changes. To detect differences in mucosal and epithelial thickness in the ileum, 
10 well-oriented villi were chosen per intestinal segment and their length was mea-
sured.
Pas/Alcian Blue staining
Five micron-thick paraffin sections of ileum and colon tissue were attached to poly-
sine-coated glass slides (Thermo scientific, Germany). After overnight incubation at 
37˚C, slides were deparaffinised using a series going from xylene to distilled water with 
decreasing ethanol steps. Sections were stained in 3% Alcian Blue (8GX Acros Organics, 
New Jersey, USA) for 35 min, rinsed in running tap water for 2 min and then rinsed 
in distilled water. The sections were submerged in periodic acid 0.5% for 10 min and 
rinsed for 1 min in distilled water. After this washing step the sections were incubated 
in Schiff's reagents (Merck, Germany) for 45 min and washed in freshly prepared SO
2
 
water (10 ml of 10% K
2
S
2
O
5
 (Merck, Germany), 10 ml of HCl (1 mol/L) and 180 ml of 
distilled water) for 3 times 2 min, followed by a washing step in tap water for 5 min. 
After this step the sections were submerged 2 times for 3 min in 100% ethanol followed 
by submersion in xylene for 3 times 5 min, and then finally mounted in DPX mounting 
reagent (BDH Gurr Certistain, England) and air-dried overnight at 37˚C.
Muc2 staining
Paraffin sections of both ileum and colon were cut at 5 µm and attached to poly-
sine-coated slides (Thermo scientific). After overnight incubation at 37˚C, slides were 
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deparaffinised as above. An antigen retrieval step was performed by heating the sec-
tions for 20 min in 0.01 M sodium citrate (pH 6.0) at 100˚C. Sections were washed for 
3 h with 3 changes of PBS. A blocking step to reduce non-specific binding was included 
using 5% goat serum (Invitrogen, Life technologies Ltd, Paisley, UK) in PBS with 0.1% 
Triton X-100 for 30 min at room temperature. Muc2 expression was detected by in-
cubating the sections with custom designed anti-Muc2 antibody3 diluted 1:500 in PBS 
containing 1% goat serum and incubated overnight at 4˚C. After primary incubation, 
sections were washed 3 times in PBS for 10 min, and the staining was visualized using 
the Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA) and 3,3’–diaminoben-
zidine (DAB) as staining reagent. Finally, sections were mounted in DePeX and stored at 
room temperature. 
RnA isolation, cdnA synthesis and qPcR
Total RNA was isolated using the RNeasy kit (Qiagen, Venlo, the Netherlands) with a 
DNase digestion step according to the manufacturer's protocol. One µg of RNA was re-
verse transcribed using a qScript cDNA synthesis kit (Quanta Biosciences, Gaithersburg, 
MD, USA) according to the manufacturer’s protocol. 
For qPCR 5 µl cDNA (1:20 diluted from cDNA synthesis mixture) was used, together with 
300 nM forward and reverse primer, 6.25 µl 2x Rotor-Gene SYBR Green PCR kit (Qiagen), 
and demineralized water up to a total volume of 12.5 µl. QPCR was performed (2 min 
95˚C, then 40 cycles of 15 sec at 95˚C, 1 min at 60˚C, and a final step of 2 min at 60˚C) on 
a Rotorgene 2000 real-time cycler (Qiagen). (see Table 3.1 for qPCR primer sequences).
Forward primer Reverse primer
Gapdh GGTGAAGGTCGGTGTGAACT CTCGCTCCTGGAAGATGGTG
Hprt GTTAAGCAGTACAGCCCCAAA AGGGCATATCCAACAACAAACTT
Muc2 ACCTGGGGTGACTTCCACT CCTTGGTGTAGGCATCGTTC
Reg3γ TTCCTGTCCTCCATGATCAAAA CATCCACCTCTGTTGGGTTCA
Reg3β ATGCTGCTCTCCTGCCTGATG CTAATGCGTGCGGAGGGTATATTC
FUT2 AGTCTTCGTGGTTACAAGCAAC TGGCTGGTGAGCCCTCAATA
Table 3.1. QPCR primer sequences
The raw data was analysed using the Rotorgene Analysis Software V5.0. Changes in 
transcript levels were calculated relative to the housekeeping genes according to the 
following equation: 
Ratio = (Ereference)^ Ctreference /(Etarget)^ Cttarget  
Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) and hypoxanthine phosphoribo-
syltransferase (Hprt) were incorporated in all qPCR experiments as internal reference 
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genes; results were similar following normalization to either gene. Expression of the 
housekeeping genes, Gapdh and Hprt, was not different between WT, Muc2-/- and Hz 
mice. Reactions lacking reverse transcriptase or template were included as controls in 
all experiments and no amplification above background levels was observed for these 
controls. The melting temperature and profile of each melting curve was checked to 
ensure specificity of the amplification product. The PCR product of each template was 
also checked by sequencing. 
Transcriptome analysis
RNA quantity and quality was assessed on the total RNA obtained from ileum and co-
lon using spectrophotometry (ND-1000, NanoDrop Technologies, Wilmington, USA) and 
the Bionanalyzer 2100 (Agilent, Santa Clara, CA, USA), respectively. RNA was judged as 
being suitable for array hybridisation only if samples showed intact bands correspond-
ing to the 18S and 28S ribosomal RNA subunits, displayed no chromosomal peaks or 
RNA degradation products, and had a RIN (RNA integrity number) above 8.0.
The Ambion WT Expression kit (Life Technologies Ltd, Paisley, UK) in conjunction with 
the Affymetrix GeneChip WT Terminal Labelling kit (Affymetrix, Santa Clara, CA, USA) 
were used for the preparation of labelled cDNA from 100 ng of total RNA without rRNA 
reduction. Labelled samples were hybridised on Affymetrix GeneChip Mouse Gene 1.1 
ST arrays, provided in plate format. Hybridisation, washing and scanning of the array 
plates was performed on an Affymetrix GeneTitan Instrument, according to the man-
ufacturer’s recommendations. Detailed protocols can be found in the Affymetrix WT 
Terminal Labelling and Hybridisation User Manual.
Quality control (QC) of the datasets obtained from the scanned Affymetrix arrays was 
performed using Bioconductor18 packages integrated in an on-line pipeline.19 Various 
advanced quality metrics, diagnostic plots, pseudo-images and classification methods 
were applied to ascertain only excellent quality arrays were used in the subsequent 
analyses.20 An extensive description of the applied criteria is available upon request. The 
more than 825.000 probes on the Mouse Gene 1.1 ST array were redefined according 
to Dai et al.21 utilising current genome information. In this study, probes were reor-
ganised based on the Entrez Gene database, build 37, version 1 (remapped CDF v13). 
Normalised expression estimates were obtained from the raw intensity values using the 
Robust Multi-array Analysis (RMA) pre-processing algorithm available in the Biocon-
ductor library affyPLM using default settings.22 Differentially expressed probe sets were 
identified using linear models, applying moderated t-statistics that implemented em-
pirical Bayes regularization of standard errors.23 The moderated t-test statistic has the 
same interpretation as an ordinary t-test statistic, except that the standard errors have 
been moderated across genes, i.e. shrunk to a common value, using a Bayesian mod-
el. To adjust for both the degree of independence of variances relative to the degree 
of identity and the relationship between variance and signal intensity, the moderated 
Chapter 3
70
t-statistic was extended by a Bayesian hierarchical model to define an intensity-based 
moderated T-statistic (IBMT).24 IBMT improves the efficiency of the empirical Bayes 
moderated t-statistics and thereby achieves greater power while correctly estimating 
the true proportion of false positives. P-values were corrected for multiple testing using 
a false discovery rate (FDR) method proposed by Storey et al.23 Only probe sets with a 
fold-change (FC) of at least 1.2 (up/down) and FDR < 0.05 were considered to be signifi-
cantly regulated.
glycan microarray binding assays
Glycan microarray experiments were performed in the Biofunctionals Nanomaterials 
Unit from CICbiomaGUNE (Donostia, Spain). Chemoenzymatic synthesis of 5-amino-
pentyl glycans structures and glycan array preparation was performed as described 
previously.25, 26 Briefly, 50 µM glycan solutions in 300 mM sodium phosphate buffer 
(pH 8.5), were spatially arrayed on NHS activated glass slides (Nexterion® H, Schott AG, 
Germany) employing a robotic non-contact spotter sciFLEXARRAYER S11 (Scienion AG, 
Berlin, Germany). After printing, the slides were placed in a 75% humidity chamber 
(saturated NaCl solution) at 25˚C for 18 h. The unreacted NHS groups were quenched by 
placing the slide in a 50 mM solution of ethanolamine in 50 mM sodium borate buffer 
(pH 9.0) for 1h. The slides were then washed with PBS, nanopure water and dried in a 
slide spinner.
RegIIIβ protein was labelled with Hilyte PlusTM 555 protein labelling kit (AnaSpec, 
Freemont, USA) following the instructions of the manufacturer. A solution (100 µL) of 
RegIIIβ-555 protein (50 µg/mL in 25 mM TrisHCl, 150 mM NaCl, 1 mM CaCl2, 2 mM 
MgCl2, pH=8.5) was applied to the glycan array and the incubation was performed in 
the dark at 4˚C for 18 h. The slide was washed with water and bound fluorescent pro-
tein was measured in an Agilent G265BA microarray scanner (Agilent Technologies, 
Santa Clara, USA). Fluorescence quantification was achieved by ProScanArray® Express 
software (Perkin Elmer, Shelton, USA).
Statistics
All statistical tests were performed using GraphPad Prism 5.0 software (GraphPad, 
San Diego, CA, USA). Data shown are the means and the standard errors of the means 
(SEM). QPCR data were analysed with the non-parametric Mann-Whitney test. Differ-
ences were considered statistically significant when P<0.05.  
ReSuLTS
Intestinal expression of Muc2 
Before the onset of colitis, at approximately 4 weeks of age, Muc2 production in mice 
was quantified and visualized in the proximal colon and ileum of Muc2-/-, Hz and WT 
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mice (Fig. 3.1). The amount of Muc2 RNA was highly variable between mice in each 
group (Fig. 3.1A and B). No transcription of Muc2 could be measured in ileum or colon 
of Muc2-/- mice as expected. In the ileum of Hz mice Muc2 transcription was interme-
diate to WT and Muc2-/- at all weeks of age. Expression of Muc2 was not significantly 
different between Hz and WT in the colon at 4 and 8 weeks, possibly due to the influ-
ence of inflammatory processes and up-regulation of Muc2 transcription as a protective 
mechanism. Muc2 was visualized in the proximal colon using immunohistochemistry 
and PAS-Alcian Blue staining (Fig. 3.1C). In Hz mice fewer Muc2 stained goblet cells were 
observed than in WT mice and no goblet cells containing mucus were observed in the 
Muc2-/- mice. QPCR analysis and histology results together showed that there is less 
Muc2 production in both the ileum and colon of Hz mice compared to WT mice. 
changes in the intestinal morphology in Muc2-/- and hz mice 
No morphological differences in colon were observed between WT and Hz at 2, 4 and 
8 weeks (not shown), whereas Muc2-/- mice displayed a marked change in the architec-
ture of the colon epithelium at week 4 and 8 compared to WT (Fig. 3.2). As reported in 
previous studies on Muc2-/- mice there were histological signs of colitis in the colon from 
4 weeks of age onwards.13, 15 We observed altered crypt architecture, increased crypt 
length and mild infiltration of immune cells in the lamina propria (LP) of Muc2-/- mice 
(Fig. 3.2). No differences in epithelial morphology were observed in the ileum of Muc2-/-
, Hz and WT mice at 2 weeks of age, but from 4 to 8 weeks of age elongation of the villus 
length was apparent in Muc2-/- mice compared to WT (Fig. 3.3). 
Altered gene expression in the proximal colon of Muc2-/- mice
Muc2-/- mice showed altered gene expression at all ages compared to WT mice. Most 
differentially expressed genes were found from week 2 to 4 comparing Muc2-/- to WT 
mice (Fig. 3.4). To gain more insights into the pathways affected in Muc2-/- mice, a gene 
set enrichment analysis (GSEA)27 was performed and the results were visualised as net-
works using the Enrichment Map plugin28 that is part of Cytoscape 2.8.29 
The networks in figure 3.5 show the major cellular processes and pathways that were 
differentially induced (nodes coloured in more intense shades of red depending on 
strength of induction) or repressed (nodes coloured in more intense shades of blue 
depending on strength of repression) in Muc2-/- mice compared to WT at week 4 com-
pared to week 2 (Fig. 3.5A), week 8 compared to week 2 (Fig. 3.5B) or week 8 compared 
to week 4 (Fig. 3.5C). From week 2 to week 4 there was an induction of diverse im-
mune pathways involving innate signalling, B and T cell activity, antigen processing, viral 
response, and IgA production, compatible with immune activation and inflammatory 
responses in the mucosa. The increased induction of pathways involved in cell cycle 
and mitosis may indicate increased immune or epithelial cell turnover. The only path-
way down-regulated at week 4 in Muc2-/- mice was involved in neurotransmitter and 
G protein-couples receptor (GPCR) activity. When comparing week 8 to week 2 (Fig 
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3.5B), similar pathways were increased in Muc2-/- mice with the addition of induced 
expression of genes linked to Mip-2 (macrophage inflammatory protein 2, a chemokine 
attractant for macrophages and neutrophils) and interleukin (IL)-12 signalling pathways. 
GSEA of pathways differentially expressed in Muc2-/- mice vs WT between week 4 and 8 
showed repression of GPCR signalling and metabolic pathways (Fig. 3.5C). 
In Hz mice, 333 genes were differentially expressed (241 upregulated, 92 down-regulat-
ed) in the colon compared to WT and these were observed only at week 4. Two genes 
were down-regulated in Hz mice at week 2 and no genes were differentially expressed 
at week 8. 
Heatmaps were generated for a selection of immunity genes of which only those dif-
ferentially expressed in proximal colon of Muc2-/- vs WT at week 2, 4 and 8 are shown 
in figure 3.6. This included any of differentially expressed genes for TLRs, Nod1, Nod2, 
chemokines (e.g. granulocyte macrophage colony-stimulating factor (GM-CSF), mono-
cyte chemotactic protein (MCP)-1, MCP-3, macrophage inflammatory protein (Mip)-1al-
pha, Mip-1beta and Regulated on Activation, Normal T cell Expressed and Secreted 
(RANTES)), cytokines (e.g. IL-22, IL-10, IL-6, IL-12, and inflammatory tumour necrosis 
factor (Tnf)-α and IL-1β), antimicrobial (poly)peptides and components of the NF-κb 
pathway. Additionally general T cell markers such as CD3e and subset markers for T 
helper cells (CD4), Tregs (Foxp3) and Th17 (RORγδ) were included. In Muc2-/- mice 
transcription of several TLR genes was upregulated (Tlr 4, 7, 8, 9, 12, 13), except Tlr2 and 
Tlr5, which were strongly repressed at week 4 and 8. Antimicrobial RegIIIβ and RegIIIγ 
were strongly upregulated, but beta-defensin (Defb)37 was down-regulated. The up-
regulated Tnf, CD3e, CD4 and CD8 suggest an increased infiltration or activity of T cells.
Altered gene expression in the ileum of Muc2-/- mice
Compared to the proximal colon, there were more differentially expressed genes at 
week 4 in the ileum between Muc2-/- and WT mice (Fig. 3.7). At week 8 the number of 
genes differentially expressed in Muc2-/- mice compared to WT mice was similar to that 
of the colon. The networks representing the pathways that were significantly modu-
lated based on GSEA using the differentially expressed ileal genes as GSEA input were 
different to the colon. In the ileum, diverse pathways had been repressed at weeks 2, 
4 and 8, including pathways involving TLR, immune, and chemokine signalling. In the 
ileum of the Muc2-/- mice, pathways involved in mitosis, cell cycle control and oxidative 
phosphorylation had been induced at all weeks compared to WT. At week 8, but not 
week 4, adaptive immune response pathways had been repressed compared to week 
2. At both week 4 and 8, peroxisome proliferator-activated receptor (PPAR)α and lipid 
metabolism pathways were repressed compared to week 2. In general there were more 
pathway changes over time in the ileum than in the colon. In the ileum of Hz mice there 
were only 14 genes differentially expressed (9 increased, 5 decreased) compared to 
WT and these were all observed only at week 4. At week 8 and week 2 no genes were 
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differentially regulated in ileum of Hz mice compared to WT. 
Figure 3.1. Relative Muc2 expression determined by qPCR in colon (A) at week 2 and ileum (B) at week 
2. * p<0.05, ** p<0.01 C: representative pictures of Muc2 specific staining and PAS/AB staining of 
mucins in colon of wild-type (WT) Muc2 knockout (KO) and heterozygote (Hz) mice at 8 weeks of age. 
Of all the immunity genes selected for heatmap analysis in colon tissue (Fig. 3.6), only 
12 were differentially expressed in the ileum of Muc2-/- vs WT at all time points. As in 
the colon, ileal expression of Tlr5 was repressed at weeks 2, 4 and 8. The gene encoding 
Iκβ, the inhibitor of NF-κb, was induced at weeks 2, 4 and 8, whereas the gene encod-
ing the NF-κb transcriptional activating protein (Nκap) was down-regulated, compatible 
with the attenuation of inflammatory signalling and immune activation shown in the 
GSEA network maps (Fig. 3.8). Similar trends in gene expression were observed in Hz 
and Muc2-/- mice although the magnitude of the changes was greater in the Muc2-/- 
mice. 
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Figure 3.2. H&E staining of proximal colon in wild-type (A) and Muc2 knockout (C) mice at 4 weeks of 
age, and staining of proximal colon in WT (B) and KO (D) mice at 8 weeks of age. 
Figure 3.3. H&E staining of ileum in wild-type (A) and Muc2 knockout (C) mice at 4 weeks of age, and 
staining of ileum in WT (B) and KO (D) mice at 8 weeks of age. 
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Figure 3.4. Venn diagram of the number of genes up-regulated (A) and down-regulated (B) in the prox-
imal colon of Muc2 knockout (KO) mice compared to wild-type (WT) mice (p value < 0.05) at weeks 
2, 4 and 8.
Figure 3.5. Network representation of gene set enrichment analysis (GSEA) profile of up-regulated 
(red) or down-regulated (blue) pathways in the proximal colon of Muc2 knockout (KO) mice compared 
to wild-type mice (WT) at A) week 2 versus week 4, B) week 2 versus week 8 and C) week 4 versus 
week 8. 
differential expression of mouse orthologues of human IBd-related genes in the colon 
of Muc2-/- and hz mice
The clinical colitis symptoms that develop in the Muc2-/- mice display similarity to the 
clinical IBD symptoms in humans. We thus investigated the expression of 32 genes en 
coding cytokines and their receptors, TLRs, T cell markers and antimicrobials, which 
were previously shown to be significantly altered in IBD.10 Seven of the 32 IBD-related 
genes were differentially expressed in the colon of Muc2-/- mice at week 2 compared to 
WT mice (Table 3.2). At week 4, 13 IBD-related genes were upregulated, and 14 were 
upregulated at week 8, concomitant with tissue damage. The main differences in ex-
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pression of IBD-related genes in Muc2-/- mice at week 4 and 8 were matrix metallo-
protease (Mmp)3, Mmp9, Cxcl10, IL-22ra2 and IL-22ra1, which were all upregulated 
except for IL-22ra1 at week 8. Relative expression of the receptor for IL-22 (IL-22ra1) 
was increased at week 4 and week 8 compared to week 2 whereas the IL-22ra2 gene, 
encoding a soluble antagonist of IL-22ra1, was significantly down-regulated at week 4 
and at week 8 compared to week 2 (Table 3.2). At week 2, only 2 IBD genes were differ-
entially expressed in Hz mice compared to WT; this increased to 5 genes at week 4, and 
4 genes at week 8. Notably, the differentially expressed IBD-related genes in Hz mice 
at week 8 were different to those at week 4. Similar to the Muc2-/- mice, the Hz mice 
showed up-regulation of the genes encoding Th1 cytokines, lymphotoxin B (Ltb), Ccl22, 
Reg3, and tissue inhibitor of metalloproteinase (Timp)1 at week 8 (Table 3.2).
Figure 3.6. heat map of immunity related genes differentially expressed in proximal colon, using genes 
differentially expressed in Muc2 knockout (KO) versus wild-type (WT) mice with week 8 as a reference.
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Figure 3.7. Venn diagram of the number of genes up-regulated (A) and down-regulated (B) in the ile-
um of Muc2 knockout (KO) mice compared to wild-type (WT) mice (p value < 0.05) at weeks 2, 4 and 8. 
Figure 3.8. Network representation of gene set enrichment analysis (GSEA) profile of up-regulated 
(red) or down-regulated (blue) pathways in the ileum of Muc2 knockout (KO) mice compared to wild-
type mice (WT) at A). week 2 versus week 4, B). week 2 versus week 8 and C). week 4 versus week 8. 
differential expression of human IBd-related genes in ileum of Muc2-/- mice
In general, fewer IBD-genes were differentially expressed in the ileum of Muc2-/- mice 
than in the colon (Table 3.3). Two of the 3 upregulated genes at week 2 were the same 
as those upregulated in the colon at week 2, namely Mmp7 and RegIIIγ, which are in-
volved in antimicrobial defence. At weeks 4 and 8 the overlap with differentially ex-
pressed IBD genes in the colon was less. Five genes differentially expressed in the ileum 
of Muc2-/- mice at weeks 4 and 8 were also differentially expressed in the colon (Timp1, 
Ccl3, IL-22ra1, IL-6ra and Ltb; Table 3.3). Fewer genes were differentially expressed in 
the heterozygous Hz mice than in the Muc2-/- mice compared to WT (Table 3.3).
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Table 3.2. A comparison of the differentially expressed genes, involved in IBD,  in the colon of Muc2-
/- (KO) and heterozygote (HZ) mice. Up- or down-regulated genes compared to WT, at different 
timepoints. Ns = non-significant. 
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Table 3.3. A comparison of the differentially expressed genes, involved in IBD,  in the ileum of Muc2-
/- (KO) and heterozygote (HZ) mice. Up- or down-regulated genes, compared to WT, at different 
timepoints. Ns = non-significant. 
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differential expression of RegIII proteins and Fut2 in Muc2-/- and hz mice 
An increase in the relative transcript amounts of both RegIII genes was measured in the 
colon of Muc2-/- mice at weeks 2, 4 and 8 by qPCR, yet failed to reach statistical signifi-
cance due to high inter-individual variation in expression levels (Fig. 3.9 and Fig. 3.10). 
The relative expression of RegIII genes was higher in the ileum than in the colon and 
increased in Muc2-/- mice compared to WT or Hz. Interestingly, increased amounts of 
RegIIIγ and RegIIIβ transcripts were present in Hz mice compared to WT mice and Muc2-
/- mice at week 4. In week 8, the relative expression of RegIIIγ and RegIII in the ileum was 
significantly increased in Muc2-/- mice compared to WT mice.
Figure 3.9. QPCR measurement of RegIIIβ expression in proximal colon and ileum of wild-type (WT), 
heterozygote (HZ) and knock-out (KO) mice at week 2, 4 and 8. * p< 0.05, ** p<0.01. 
The Fut2 gene encodes α-1,2-fucosyltransferase, which is responsible for expression 
of α1,2-linked fucose-containing glycans on the epithelial cell surface to which specific 
bacteria can bind.30 Using qPCR, expression of Fut2 was shown to significantly increase 
in the ileum of Muc2-/- mice at weeks 4 and 8 compared to WT mice (Fig. 3.11). 
RegIIIβ binds to fucosylated glycans 
As fucosylated glycans on the gut epithelial surface can serve as receptors for pathogen-
ic viruses and bacteria for Norovirus,31 human immunodeficiency virus (HIV),32 Helico-
bacter pylori33 and Campylobacter jejuni34 we hypothesized that RegIII proteins, which 
are induced during infection, might bind to these targets. RegIIIβ was produced as a na-
tive secreted protein using a baculovirus expression system in insect cells and purified. 
The protein was labelled with 555 Alexa Fluor, re-purified and hybridized to a glycan 
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array. As expected, RegIIIβ showed significant binding to several fucosylated glycans 
(Fig. 3.12).
Figure 3.10. QPCR measurement of RegIIIγ expression in proximal colon and ileum of wild-type (WT), 
heterozygote (HZ) and knock-out (KO) mice at week 2, 4 and 8. * p< 0.05, ** p<0.01.
Figure 3.11. FUT2 expression in ileum at 2-week-old, 4-week-old and 8-week-old, in wild-type (WT) 
and Muc2 knock-out (KO) mice. * p<0.05, ** p<0.01.
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Figure 3.12. A) N-Glycan structures included in this study. The panels underneath the structures in-
dicate binding of labelled RegIIIβ to the glycan structures. B) Fluorescence intensities for binding of 
RegIIIβ to the glycan structures. C) Exemplary bisfucosylated oligosaccharide, pictogram representa-
tion according to Consortium of Functional Glycomics guidelines, and a legend of used figures. D) Bind-
ing of labelled RegIIIβ to human colonic mucin (HCM) printed on the array. - CTR is negative control. 
dIScuSSIon 
Muc2 is the major secreted intestinal mucin and its absence in Muc2-/- mice leads to 
colitis, which starts in the distal colon.13, 14 Previously, microarray analysis and qPCR of 
innate signalling receptors and cytokines were employed to reveal distinct phases in 
colitis development pre- and post-weaning, presumably as a consequence of changes in 
microbiota diversity and density.14 The effect of Muc2 deficiency has not been previous-
ly investigated in the small intestine, and it is not known if and how adaptive responses 
compensate for the lack of a mucus layer. To gain more insights into the role of mucus 
in the ileum we compared age-dependent changes in morphology and temporal gene 
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expression patterns in the ileum and compared them to the proximal colon.
As previously reported Muc2-/- mice develop colitis in the proximal colon after about 
4 weeks as evidenced by the increased thickness of the mucosa, an abnormal mor-
phology, flattening of the epithelial cells and ulceration accompanied by blood in the 
faeces and weight loss.13, 14 The histological changes are characteristic of the murine 
models for IBD and the clinical symptoms of inflammatory bowel disease in humans. 
Microarray analysis of the proximal colon of WT and Muc2-/- mice revealed induction of 
pathways involved in TLR signalling, production of cytokines and chemokines including 
Tnf-α, Interferon (Ifn)-γ, Ltb, IL-1β, NF-κb signalling activity and immune pathways re-
lated to B and T cell activity and antibody production. Additionally, there was increased 
transcription of the T cell markers Cd4 and the T cell maturation marker Cd3e in Muc2-
/- mice, consistent with the mild influx of immune cells that we observed by histology. 
We compared the genes that were differentially expressed in the colon of Muc2-/- mice 
(compared to WT) at week 4 and week 8 with 32 genes known to be up or down regu-
lated in IBD.10 Similar genes and numbers of IBD genes were affected in the Muc2-/- mice 
(weeks 4 and 8) as in the mouse DSS model of colitis where altered mucus permeabil-
ity allows increased contact of the epithelium with microbiota.5, 10 The most strongly 
down-regulated gene was Abcb1a, a gene expressing an epithelial cell surface-located 
transporter that is proposed to export toxins from the mucosa into the lumen. Abcd1a 
is also down-regulated in UC, which most likely impacts on the capacity of the epi-
thelium to detoxify compounds in the mucosa. The most strongly up-regulated genes 
include genes encoding MMPs, which are involved in the tissue remodelling and leuko-
cyte infiltration in UC and CD. 
Neurotransmitter and GPCR signalling pathways were down-regulated in Muc2-/- mice, 
which may reflect damage to or disappearance of interstitial cells of Cajal and cells of 
the myenteric nerve system; damage to these cells is observed in inflamed colon and 
may be at the basis of the reduced gastrointestinal motility in IBD.35 
Hz mice do not develop colitis, although qPCR data showed that Muc2 expression is 
lower in Hz mice than WT mice at week 2 before the onset of colitis. There is also less in-
tense staining of mucus in the colon Hz mice compared to WT. Although the Hz mice do 
not develop colitis, several immunity genes and 4 IBD-related genes were differentially 
expressed in the colon at week 8, compared to WT mice. The differentially expressed 
genes included Ltb, that encodes a protein produced by Th1 cells to promote diapedes-
is, and suggests that Hz mice have increased mucosal inflammation compared to WT 
mice, even though tissue damage was not apparent by histological examination. The 
up-regulation of Mmp3 and Mmp7 in Hz mice suggests increased epithelial cell turn-
over, as Mmp3 is involved in tissue remodelling, perhaps due to the reduced production 
of mucus and increased damage to the epithelium. Lack of secreted Muc2 was not com-
pensated by increased expression of two other secreted mucins Muc5AC and Muc6 in 
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either colon or ileum. In contrast to the colon, lack of Muc2 did not induce histological 
signs of tissue damage in the ileum; instead we observed an increased villus length at 
week 4 and in week 8, suggesting increased cell proliferation. We did not observe in-
creased cell sizes; increased cell proliferation was in agreement with induction of path-
ways involved in cell cycle and mitosis, protein translation and the induced expression 
of genes involved in cell division and differentiation, including the S100a family of genes 
and Timp1, that can promote cell proliferation. In the ileum of Muc2-/- mice immune 
signalling pathways including B and T cell receptor signalling were repressed compared 
to WT, whereas such pathways were upregulated in the colon at week 4 and 8. This may 
be related to an increased proliferation and differentiation status of the epithelium, 
influencing expression of TLR and innate response pathway genes. One of the strongly 
down-regulated genes in the ileum was Tlr5, which induces NF-κb activation upon bind-
ing of bacterial flagellin. Indeed, down-regulation of Tlr5 in colitis has been previously 
observed.36 Furthermore Nfap, a transcriptional activator of NF-κb, was down-regulat-
ed whereas Iκβ, a NF-κb inhibitor that binds to cytosolic NF-κb to prevent nuclear trans-
location, was among the most strongly upregulated genes. This apparent repression 
of innate inflammatory signalling via NF-κb appeared to be an important mechanism 
preventing immune-mediated pathology in the ileal mucosa of Muc2-/- mice.
Another factor that may have contributed to the protection of the ileum in the ab-
sence of a protective mucus layer was the increased expression of RegIIIγ and RegIIIβ. 
At week 8 both genes were significantly upregulated in the ileum of Muc2-/- mice and 
in the ileum of Hz mice at week 4. This correlates with decreased expression of se-
creted IL-22ra2, a soluble inhibitor of IL-22, which is an inducer of RegIII expression. 
RegIIIγ has been reported to be bactericidal against Gram-positive bacteria, whereas 
in vitro killing activity against Gram-negative bacteria has been shown for RegIIIβ.37, 38 
In vivo, RegIIIβ has also been shown to protect against infection with Gram-negative 
Salmonella enteritidis, but not Gram-positive Listeria monocytogenes.39 Expression of 
RegIII proteins is induced by infection or inflammation, which is in agreement with the 
increased expression of immunity genes in Muc2-/- mice. Defb37, a beta-defensin, was 
also upregulated in Muc2-/- mice, further emphasising important roles of RegIII proteins 
and other defensins in protection of the gut barrier function. Expression of the RegIII 
proteins was also increased in the colon, but the overall amount of transcription in co-
lon was much lower due to the absence of Paneth cells, which express relatively high 
amounts of these proteins. This lower expression of RegIII proteins in mouse colon than 
in ileum was also shown by Burger-van Paassen et al.16 Defensins were not upregulated 
in the colon of Muc2-/- mice, presumably due to the effect of inflammatory cytokines 
and nitric oxide on protein folding, which causes the accumulation of unfolded proteins 
inside the endoplasmic reticulum, which affects the function and localization of several 
proteins, including defensins.40 
Apart from their reported bactericidal effects the RegIII proteins may have anti-inflam-
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matory properties. In IBD patients increased hepatocarcinoma-intestine-pancreas/pan-
creatitis-associated protein (HIP/PAP, similar to murine RegIIIγ and RegIIIβ) transcription 
and serum levels of the protein are correlated with disease severity, and secretion of 
pro-inflammatory cytokines by colonic tissue of patients with active CD was inhibited 
by addition of purified native HIP/PAP.41 Furthermore PAP has been shown to atten-
uate NF-κb signalling in human monocytes and epithelial cells.41 Additional evidence 
for an anti-inflammatory function of RegIII proteins comes from studies in rats where 
administration of anti-PAP antibodies increased inflammation in an experimental model 
of taurocholate-induced acute pancreatitis.42 In endothelial cells, purified human PAP 
decreased expression of surface receptors involved in leukocyte recruitment suggesting 
that PAP might dampen inflammatory responses by inhibiting leukocyte recruitment 
into the intestine.41 It is currently not known whether murine RegIIIγ or RegIIIβ have 
similar anti-inflammatory effects but if so, induction of high amounts of RegIII proteins 
in the ileum of Hz and Muc2-/- might be a major mechanism preventing inflamma-
tion-mediation tissue damage, or promoting tissue repair. 
Although we did not observe tissue damage in the ileum at all weeks, in agreement 
with the repression of inflammatory pathways, mouse orthologues of human IBD-re-
lated genes were differentially expressed in the ileum of Muc2-/- mice compared to WT 
mice. These genes included members of the S100a family of genes involved in cell cycle 
progression and differentiation, Mmp3 and Timp1, which regulates MMP activity and 
promotes cell proliferation (see also above). Other IBD-related genes involved in che-
motaxis and activity of granulocytes such as Mip-1a (Ccl3), Tnf-α and Ccl17 were also 
up-regulated in the ileum of Muc2-/- mice suggesting a heightened inflammatory status.
Fut2, encoding an α-1,2-fucosyltransferase, responsible for expression of α1,2-linked 
fucose containing glycans on the cell surface of the intestinal mucosa,30 was significant-
ly upregulated in the ileum of Muc2-/- mice at week 8. Human genetic variants of FUT2 
that have a non-secretor phenotype have been reported to be to be more resistant 
to gastro-intestinal infection with Norovirus but more susceptible to CD and certain 
bacterial infections due to bacterial binding to fucosylated glycans.31 As expression of 
RegIII proteins is known to be strongly induced during mouse intestinal infection or in-
flammation16, 37 we hypothesised that RegIII proteins might bind to fucosylated glycans, 
for instance to inhibit bacterial colonization. Using a glycan array, we indeed found that 
RegIIIβ was able to strongly bind to several glycan structures containing one or more 
fucosyl groups. Both Fut2 and Muc2 are upregulated during colonization of germ-free 
mice and have been proposed to promote growth and attachment of beneficial sym-
bionts such as Bacteroides thetaiotaomicron which metabolize fucose containing gly-
cans.43 It might seem paradoxical that RegIII proteins bind to fucosylated mucin as they 
would compete with symbionts. Possible explanations are that RegIII proteins regulate 
availability of fucosyl binding sites through competition for binding, or that the mucus 
is also a matrix for retaining RegIII proteins throughout the mucus and on the mucosal 
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epithelial surface. Support for the latter hypothesis comes from recent molecular dock-
ing experiments showing that RegIII proteins have at least two different glycan binding 
sites, of which one can bind fucosylated carbohydrates (unpublished, Chapter 4). 
Muc2 deficiency causes colitis, which is most severe in the distal colon where RegIII 
gene expression is lowest16 but also involves the proximal colon. In contrast, no tissue 
damage is observed in the ileum, where RegIII protein expression is substantially higher 
than in the colon, suggesting the involvement of RegIII proteins in protection of the 
ileum against tissue damage. Thus the reported antimicrobial and anti-inflammatory 
properties of RegIII proteins may be involved in protection against tissue damage in the 
ileum. RegIIIβ was shown to bind to glycan structures containing N-acetyl glucosamine 
sugars linked to fucose, which may be a novel mechanism to prevent pathogen infec-
tion or colonisation. Further studies are in progress to investigate the protective role of 
RegIII proteins in the Muc2-/- model. Additionally, microbiota profiling is being used to 
reveal how mucus and inflammatory responses modify microbial ecology before and 
after the onset of colitis, which may enable us to correlate the gene expression changes 
to specific components of microbiota. 
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AbstrAct
Mammalian RegIII proteins, including mouse RegIIIβ and RegIIIγ and human HIP/PAP, 
are expressed predominantly in the small intestine. RegIII proteins have been suggest-
ed to have a role in intestinal defences against bacteria as these proteins are known to 
be upregulated by bacterial colonization and inflammatory stimuli driven by mucosal 
inflammation and damage. Recombinant RegIIIβ has been proposed to kill Gram-neg-
ative bacteria and a number of Gram-positive bacteria, whereas recombinant RegIIIγ 
and human HIP/PAP have been reported to be bactericidal for Gram-positive bacte-
ria through binding to peptidoglycan. In this study recombinant RegIII proteins were 
produced either in insect cells using the baculovirus expression system and purified 
from the supernatant, or in E. coli and isolated as inclusion bodies and refolded. Assays 
were performed with recombinant RegIIIβ and RegIIIγ to determine their possible bac-
tericidal or bacteriostatic effects, and their binding characteristics to different bacteria. 
Additionally, we generated structural models of RegIII proteins for in silico docking ex-
periments with known ligands. 
Our results showed binding of both RegIIIβ and RegIIIγ to L. monocytogenes, E.coli and 
S. enteritidis. Cleavage of the N-terminus enhanced the binding, but this processed 
RegIIIβ was not found to be bactericidal or bacteriostatic for L. monocytogenes and 
S. enteritidis based on CFU plate counts. Thus, the in vitro bactericidal effects RegIIIβ 
reported in the literature appear to be dependent on the exact preparation of protein, 
bacteria and methodology. Furthermore, molecular docking experiments suggest the 
presence of two ligand binding sites on RegIIIβ, which may allow for binding to lipid A 
and/or peptidoglycan and mucus simultaneously. Thus RegIIIβ may be able to immobi-
lize bacteria in the intestinal mucus layer.
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InTRoduCTIon
The consortium of intestinal microbes colonizing the mammalian intestine provides 
benefits to the host through the antagonism of pathogens and by degrading complex 
carbohydrates to produce sugars and metabolites that can be utilized by the host for 
energy. Several adaptations of the host mucosa have evolved to maintain a beneficial 
relationship with the microbiota and to prevent damage from pathogens. One of the 
mechanisms involves sequestering of bacteria in the luminal compartment to avoid col-
onisation of the epithelial cell surface and invasion by opportunistic pathogens. Here 
the secreted mucus layer overlaying the epithelium plays an important role. In humans 
the mucus layer is most dense in the colon where microbial numbers are highest and 
can reach 1012 colony forming units (CFU) per gram of luminal content.1 There are rela-
tively small numbers of bacteria in the duodenum and jejunum but in the ileum densi-
ties reach around 107 to 108 CFU bacteria per gram of luminal content. Here, the mucus 
barrier is thinner but IgA and the secretion of several Paneth and epithelial cell-pro-
duced antimicrobial factors enhance the mucus barrier.2 
A key human antimicrobial factor secreted in the intestinal lumen is HIP/PAP (Hepa-
tocarcinoma-intestine-pancreas/pancreatic associated protein), which was originally 
identified in rats as an abundant secretory protein expressed during pancreatitis.3 Fur-
ther studies revealed expression in mice, where it was called RegIII,4 in humans5, 6 and in 
rats.7, 8 The family of RegIII proteins is divided into 4 subclasses, RegIIIα, RegIIIβ, RegIIIγ 
and RegIIIδ,4, 9based on the primary structures of the proteins. 
Mammalian Reg proteins consist of a carbohydrate recognition domain (CRD) and an 
N-terminal secretion signal. Several RegIII family members are expressed predominant-
ly in the small intestine, including mouse RegIIIβ and RegIIIγ8, 10, 11 and human HIP/PAP.12, 
13 The known environmental triggers for inducing expression of RegIII proteins are in-
testinal colonization by bacteria,11 infection14 or inflammatory stimuli driven by mucosal 
inflammation and damage15 implicating roles for RegIII proteins in mucosal defence and 
immune homeostasis. 
Recombinant and refolded RegIIIβ has been proposed to kill Gram-negative bacteria 
and certain species of Gram-positive bacteria,16, 17 although the reasons for specificity 
are unknown. The bactericidal effect was reported to be optimal in early logarithmic 
phase of growth and in the case of Gram-negative bacteria, involves RegIIIβ binding to 
the lipid A anchor of lipopolysaccharide,17 although the precise mechanisms leading to 
bacterial death are not known. Apart from binding to lipid A and peptidoglycan (PGN), 
we showed previously that RegIIIβ can also bind to mucus and fucosylated glycans 
(Chapter 3 this thesis, unpublished data). 
Another RegIII family member expressed in the mouse intestine is RegIIIγ. Recombinant 
and refolded RegIIIγ protein and human HIP/PAP have been reported to be bactericid-
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al to Gram-positive bacteria in vitro, through binding to PGN.11 RegIIIγ possesses an 
N-terminal pro-segment sequence that is proposed to interact with a charged surface 
on RegIIIγ and HIP/PAP to prevent antimicrobial activity.18, 19 Proteolytic cleavage of this 
pro-segment in RegIIIγ and HIP/PAP by trypsin was shown to enhance bactericidal ef-
fects and generate an active polypeptide.18, 19 Similar regulation of RegIIIβ antimicro-
bial activity by trypsin processing of a flexible N-terminal pro-segment has also been 
proposed, but not been conclusively demonstrated. The in vitro bactericidal activity of 
RegIIIγ or HIP/PAP is inconsistent with other publications where recombinant HIP/PAP 
from humans and rats was reported to lack bactericidal activity but induced bacterial 
aggregation.19, 20
Both HIP/PAP and RegIIIγ proteins have been reported to have anti-inflammatory ef-
fects in pancreatitis and colitis.15, 21, 22 Administration of recombinant RegIIIγ reduced 
mortality and weight loss due to colitis caused by Citrobactor rodentium infection in 
mice.22 Protection was attributed to anti-inflammatory effects in vivo as the recombi-
nant protein lacked bactericidal activity in vitro.   
The aim of this study was to use recombinant RegIIIβ and RegIIIγ from inclusion bodies 
produced by Escherichia coli and RegIIIβ secreted by insect cells via baculovirus trans-
fection and characterize the bactericidal, bacteriostatic and binding properties using 
flow cytometry and CFU counts. Additionally we sought to investigate their potential 
to attenuate inflammatory signalling in vitro. Structural models of RegIII proteins were 
generated for docking experiments with known ligands, including fucosylated glycans 
in order to gain further insights into the binding sites and residues conferring ligand 
specificity.  
MATeRIAL And MeThodS
Production of recombinant RegIII proteins
Recombinant RegIII proteins were produced and refolded by GenScript (GenScript Corp., 
New Jersey, USA). Both RegIIIβ and RegIIIγ, possessing an N-terminal histidine-contain-
ing peptide tag (HIS-tag), were over-expressed in E. coli and refolded from purified in-
clusion bodies. Additionally, soluble RegIIIβ was secreted from insect cells using a bacu-
lovirus vector with a C-teminal HIS-tag to facilitate affinity purification.
In vitro processing of RegIII proteins
Trypsin (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in 1M HCl (pH 3) according to 
the manufacturers protocol to a concentration of 1 mg/ml. Trypsin was added to RegIII 
protein solutions at a concentration of 1/20 (w/w) and incubated at 37˚C for 1 h. 
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SdS-PAge and Western blot
Protein was denatured by heating it at 95˚C for 5 min in 1x Laemmli buffer (4x buffer 
containing 160 mM Tris (pH6.8), 8% SDS, 40% glycerol, 0.05% (w/v) bromophenol blue) 
with 0.1M DTT and loaded onto a 12% SDS-PAGE gel (Bio-rad, Hercules, CA, USA). The 
gel was either stained with Coomassie blue (Instant blue, Westburg, Leusden, the Neth-
erlands) or used for Western blotting by transferring the proteins to a PVDF membrane 
(Immobilon, Millipore, MA, USA). Western blots were first incubated for 1 h with block-
ing buffer (Li-cor, Lincoln, NE, USA) and then with custom made polyclonal antibodies 
(Eurogentec, Belgium)10, 23 diluted 1:20 000 in PBS-T 1:1 diluted with blocking buffer 
for 1 h. Antibodies to RegIIIβ and RegIIIγ-specific peptides were generated in rabbits 
by conjugation to keyhole limpet hemocyanin (KLH) and then affinity purified by chro-
matography using the immobilized peptides. For RegIIIγ antibodies were raised against 
the N-terminus of the protein (EVAKKDAPSSRSSC) or a peptide sequence near the mid-
dle of the protein (MIKSSGNSGQYVC). RegIIIβ was detected using polyclonal antibodies 
recognizing the N-terminus (GEDSLKNIPSARISC) or a peptide sequence near the middle 
of the protein (STALDRAFCGSLS). The latter antibodies did not detect RegIIIβ effectively 
therefore we used a commercially available antibody recognising an epitope located in 
the middle of the protein (1:2000, R&D systems, Minneapolis, MN, USA). The primary 
antibodies were detected using donkey anti-rabbit IRDye800 or goat anti-rat IRDye680 
(both diluted 1:20 000, Li-cor) and an Odyssey scanner (Li-cor).
RegIII binding to bacteria
Binding of RegIII proteins to bacteria was carried out with both processed (trypsin 
cleaved as described above) and unprocessed (uncleaved) RegIII proteins. Bacteria 
were grown to stationary or mid-exponential phase from a diluted overnight culture, 
washed once in PBS by centrifugation (5 min at 3300g) and re-suspension of the bac-
terial pellet. Approximately 107 CFU bacteria were resuspended in a mixture of 20 µg 
RegIIIβ produced in insect cells or RegIIIγ produced in E. coli, in a total volume of 200 µl 
PBS containing 0.1% bovine serum albumin (BSA, Sigma-Aldrich). This mixture was incu-
bated at for 1 h in a slowly shaking heating block at 25˚C, after which the bacteria were 
washed once in PBS as described above. Primary antibody (anti-RegIIIβ, R&D systems, 
1:1000, or anti-RegIIIγ, custom made, 1:10 000) was then added to the bacteria and 
incubated for 30 min at room temperature (RT). Subsequently, bacteria were washed 
and incubated with the secondary antibody (anti-rat or anti-rabbit with APC label, 1:50, 
Jackson ImmunoResearch) for 30 min at room temperature in the dark. Finally, bacteria 
were washed once more and measured by flow cytometry (FACS Canto, Becton Dickin-
son (BD), NJ, USA).   
Bactericidal assays
Bacteria were grown to stationary or mid-exponential phase from a diluted overnight 
culture and washed once in MES buffer (25 mM MES, 25 mM NaCl, pH 6) by centrifuga-
tion for 5 min at 3300g. Approximately 107 CFU bacteria (Salmonella enterica subspe-
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cies enteritidis, Listeria monocytogenes, E. coli Nissle, E. coli LF82) were pelleted and re-
suspended in MES buffer containing 20 µg processed RegIIIβ produced in insect cells or 
refolded RegIIIγ in a final volume of 200 µl. The solution was incubated for 1 h at 37˚C in 
a slowly shaking heating block and then the bacteria were recovered by centrifugation 
for 5 min at 3300g and 150 µl of supernatant was removed. The bacterial pellet was re-
suspended in the remaining 50 µl from which serial dilutions were made. To determine 
CFU, 100 µl of each dilution was spread on agar plates as follows: L. monocytogenes on 
BactoTM Brain Heart Infusion agar (BHI, BD), S. enteritidis, E. coli LF82 and E. coli Nissle 
on Luria Bertani (LB) agar (Merck KGaA, Darmstadt, Germany) and incubated overnight 
at 37˚C. Colonies were counted the next day. 
Bactericidal activity of RegIII proteins was also investigated using live/dead staining kit 
(Invitrogen, molecular probes) according to the manufacturer’s protocol. Briefly: bacte-
ria (E. coli VE7108 and E. coli Nissle) were resuspended in a 0.85% NaCl buffer, stained 
with SYTO 9 and propidium iodide for 15 minutes in the dark, and analysed by flow 
cytometry (FACS Canto, BD). 
Bacterial growth curves
Processed refolded RegIIIβ or RegIIIγ (20 µg) were added to an overnight culture of 
bacteria diluted 1:200 in a total volume of 200 µl in a flat bottom 96 well plate (Costar, 
Corning Incorporated, NY, USA). Due to the lower concentration of baculovirus pro-
duced RegIIIβ we used 10 µg of protein and 100 µl of bacteria from a 1:200 dilution 
of an overnight culture, in a total volume of 200 µl per well. To control for dilution of 
culture medium 100 µl of PBS was added to 100 µl of bacteria. Growth was measured 
very 10 min by optical density (OD)
(600 nm)
 in a Spectramax M5 (Molecular devices, CA, 
USA) during an 8 hour incubation. Plates were shaken briefly in the machine prior to 
measurement. 
Molecular docking and evolutionary conservation estimation
Homology models of RegIIIβ and RegIIIγ were obtained from the Database of Structure 
& FUNction Predictions of Proteins from Representative Organisms (SUNPRO) 1. The 
‘GAEPNGG’ and ‘LKWNDMT’ motifs of RegIIIβ and ‘GYEPNRG’ and ‘LKWRENYC’ of RegIIIγ 
were treated as flexible regions of the protein, while the remaining parts were treated 
as ‘rigid body’ during the docking simulations. Molecular docking was performed us-
ing AutoDock VINA24 and the graphical front-end AutoDockTools (ADT).25 Glycan ligand 
structures (obtained in Chapter 3, this thesis) were converted into the SMILE format 
using Marvin Sketch and optimized with eLBOW.26 ADT were employed to protonate 
the ligands and identify rotatable bonds in the ligands. Grid maps of 32x32x32 Å, were 
defined to include sugar recognition sites and Ca2+-coordination motifs (i.e. loop1 and 
loop2) conserved in different C-type lectins. The default settings in AutoDock VINA were 
used for other variable parameters. The contacts between the lowest energy pose of 
each glycan and RegIIIβ and/or RegIIIγ were calculated using Contact CCP4.27 The limits 
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for contact calculation were set at 4.1 Å. The molecular models were visualized using 
PyMOL or Chimera. ConSurf was employed to estimate the evolutionary conservation 
of amino acid positions in RegIIIβ based on the phylogenetic relationship between ho-
mologous sequences.28 
ReSuLTS 
Structural models of RegIIIβ and RegIIIγ
Like other members of the mammalian RegIII protein family, the protein sequences of 
RegIIIβ and RegIIIγ possess secretion signal peptides, which target the protein to the en-
doplasmic reticulum membrane for secretion. The overall amino acid identity between 
the secreted pro-proteins of human PAP and mouse RegIIIβ is 70% and between PAP 
and RegIIIγ is 67%. Given the high sequence identity we generated predictive structural 
models for the secreted proteins based on the crystal structure of human PAP. The three 
dimensional structure of human HIP/PAP exhibits a C-type lectin fold with its character-
istic ‘long loop’ structure,29 comprising two distinct sub-domains, commonly designated 
as ‘loop 1’ (residues 107-121) and ’loop 2’ (residues 131-145)30 which are also apparent 
in the predicted structures of RegIIIβ and RegIIIγ. The N-terminal region of secreted 
RegIIIβ has sequence similarities to the N-terminal region of RegIIIγ and human HIP/PAP 
(Fig. 4.1A), which are processed by trypsin to induce a conformational switch and sub-
sequent bactericidal activity.18 Indeed, the predicted cleavage site of RegIIIβ, 37R-38I is 
identical to human PAP 37R-38I. 
Antibodies generated against variable peptide sequences found in the N-terminus and 
exposed regions of the RegIII proteins (loop) are shown in figure 4.1B. The amino acid 
sequence identity between RegIIIβ and RegIIIγ is 71% and several areas of variable se-
quence reside in within the exposed loops 1 and 2 of the folded protein (Fig. 4.1C and 
D). The ‘EPN’ motif in loop 1 is involved in Ca2+-independent recognition of PGN by HIP/
PAP30 and is conserved in RegIIIβ and RegIIIγ (Fig. 4.2). Moreover, RegIIIβ and RegIIIγ 
also possess a ‘DPT’ motif in loop 1 which is identical to human PAP (Fig. 4.2), similar to 
the ‘DPQ’ motif in the loop 1 region of Reg4, another human Reg family lectin involved 
in Ca2+-independent mannan binding31 (Fig.4.2). 
In the carbohydrate binding domain of the mannose-specific Ca2+-dependent C-type 
lectins such as DC-SIGN (Dendritic Cell-Specific Intercellular adhesion molecule-3-Grab-
bing Non-integrin) and MBP-A (mannose binding protein) A, the ‘EPN’ motif in loop 1 
and the ‘WND’ motif in the β4 strand are conserved (Fig. 4.1B, 4.2). These motifs coor-
dinate the principal Ca2+ contacts with the sugar hydroxyls involved in sugar binding.29, 
30, 32, 33 RegIIIβ and RegIIIγ lack the ‘WND’ motif in the β4 strand, which is consistent with 
their Ca2+-independent binding to sugars.11, 17 The ‘ERN’ motif in loop 2 of RegIIIβ, which 
is involved carbohydrate recognition and Lipid A binding, is conserved in human PAP, 
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but variable among other members of the C-type lectin family.
Figure 4.1. A) Amino acid sequence of the N-terminus of RegIIIγ and RegIIIβ, with the trypsin cleavage 
site (arrowed) and peptides used to generate antibodies recognizing the N-terminus (indicated in red). 
B) Cartoon structures of calcium-independent C-type lectins RegIIIβ, RegIIIγ and human PAP and the 
calcium-dependent DC-SIGN. Regions involved in carbohydrate recognition are shown in magenta. The 
ligand-binding loops of RegIIIβ and RegIIIγ are indicated, and the antibodies recognition regions are 
shown in red. C) Cartoon showing the conserved regions in around 70 different C-type lectins. Blue is 
variable, white is average, and pink is conserved. D) Cartoons showing the regions of the proteins that 
are variable between RegIIIβ and RegIIIγ in purple. 
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Figure 4.2. Sequence alignment of mouse RegIIIγ, mouse RegIIIβ, human PAP I, human Reg IV, human 
Langerin, DC-SIGN and MBP-A. Site I mannan-binding site residues are labelled in light blue and site 
II mannan-binding site residues are in light green. The ¨EPN¨ motif of PAP I and ¨DPQ¨ motif of Reg 
IV are highlighted in magenta frames. The ¨EPN¨ and ¨WND¨ motifs responsible for Ca2+ coordination 
are highlighted in red frames. The “ERN” motif of RegIIIβ and PAP I are highlighted in a purple frame. 
Residues predicted to be involved in contacts with glycans binding to RegIIIβ and RegIIIγ are in Bold 
and labelled according to the number of glycans interacting with a particular residue following the 
presented colour scheme (modified from Ho et al.31).
Production and refolding of recombinant RegIII proteins 
SDS-PAGE of soluble and insoluble fractions revealed that both RegIII proteins were 
absent from the soluble fraction of E. coli lysates and were found in inclusion bodies. 
The inclusion bodies were partially purified by centrifugation and further purified by HIS 
tag affinity chromatography under denaturing conditions and subsequently refolded by 
step-wise dilution and dialysis. Both proteins were estimated to be at least 75% pure by 
SDS-PAGE gel with a yield of about 3 mg/L LB culture and a final concentration of 0.47 
mg/ml for RegIIIβ and 0.43 mg/ml for RegIIIγ.  
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RegIIIβ, containing its native signal secretion leader and a C-terminal HIS affinity tag, 
was also expressed in insect cells transfected with a baculovirus expression vector. Solu-
ble secreted RegIIIβ protein was recovered from the supernatant by affinity chromatog-
raphy to more than 90% purity as judged by Coomassie stained SDS-PAGE. The protein 
was stored in aliquots at -80oC at a concentration of 0.12 mg/ml. 
Soluble RegIIIβ produced in the baculovirus system and E.coli were centrifuged at 10 000 
g for 10 min and the supernatant and pellet were analysed by SDS-PAGE and Coomassie 
staining with or without DTT in the loading buffer. Most of the protein was present in 
the supernatant but a proportion was recovered from the pellet suggesting precipita-
tion and/or the formation of aggregates after purification. A proportion of the soluble 
protein appeared to form multimers (Fig. 4.3A) in the absence of DTT. RegIIIβ produced 
in either E. coli or insect cells was of the expected sizes. The RegIIIβ protein produced 
in E.coli was larger (18.8 kDa) than the RegIIIβ from insect cells (17.4 kDa) due to the 
presence of an enterokinase cleavage site between the HIS-tag and RegIIIβ protein.
RegIIIβ and RegIIIγ are proteolytically processed by trypsin in vitro 
The bactericidal activity of mouse RegIIIγ and human HIP/PAP was previously shown to 
be regulated by an N-terminal pro-segment that is removed by trypsin.18, 19 High con-
servation of amino acids in the cleavage site of the pro-segment suggested that RegIIIβ 
would also be proteolytically activated by trypsin (Fig. 4.1A). To confirm this prediction 
we generated two different peptide-specific antibodies for each RegIII protein, one rec-
ognizing the N-terminal pro-segment and the second recognizing an internal domain 
expected to be surface exposed (Fig 4.1B). 
After treatment of RegIIIγ protein with trypsin the protein is not recognized by the an-
tibody binding to the small cleaved N-terminal pro-segment (Fig. 4.3B, left panel), indi-
cating the expected cleavage. Similarly, RegIIIβ proteins from both sources (insect cells 
and E. coli refolded) were also reduced in size by treatment with trypsin (Fig. 4.3B, right 
panel) and could not be detected by the antibody recognizing the N-terminal peptide. 
The soluble RegIIIβ protein from insect cells shows the predicted small reduction in 
molecular weight after cleavage with trypsin and is present as a single protein band. 
Strikingly, trypsin treatment of the refolded RegIIIβ protein generated multiple protein 
bands (Fig. 4.Bb, right panel) suggesting increased susceptibility to trypsin proteolysis. 
Detection of refolded RegIIIβ produced in E. coli with an antibody that recognizes the 
N-terminal pro-segment showed that processing was incomplete (Fig. 4.3B, right panel) 
and a small portion of the protein remained uncleaved. 
n-terminal processing enhances binding of RegIIIβ and RegIIIγ to bacteria
Soluble RegIIIβ produced using the baculovirus system and refolded RegIIIγ were tested 
for binding to different bacteria using a flow cytometric assay. Different concentrations 
of RegIII proteins were incubated for 1 h with bacteria from stationary or exponential 
growth phases in PBS, containing BSA as a non-specific binding inhibitor. Detection of 
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RegIIIβ binding was gated using bacteria incubated with RegIII antibodies without RegIII 
protein as a control (Fig. 4.4A) and binding events (e.g. ‘stained’ bacteria, thus bound 
to RegIII) were calculated as a percentage of the total bacteria. Trypsin cleavage of the 
N-terminal pro-segment of RegIIIβ was required for efficient binding to S. enteritidis 
and L. monocytogenes (Fig. 4.4B and C) with approximately 20-fold less binding detect-
ed using unprocessed RegIIIβ. Similarly, binding of RegIIIγ to bacteria was also greatly 
enhanced by processing of RegIIIγ with trypsin. Binding of RegIIIβ to both S. enteritidis 
and L. monocytogenes was dose-dependent and not appreciably affected by bacterial 
growth phase or the inclusion of reducing agents (data not shown). Similarly, RegIIIγ 
bound to the tested bacteria, although the percentage of bound bacteria was lower 
(around 20%) and more variable than for RegIIIβ. 
Bactericidal assays with RegIII proteins 
The growth phase of bacteria can influence their susceptibility to antimicrobials, there-
fore bacteria at the mid-exponential phase and the stationary phase were used in our 
killing assays with N-terminally processed RegIII proteins. Addition of 6 µM RegIIIβ or 
RegIIIγ to S. enteritidis harvested in exponential growth phase did not reduce the CFU 
after 1 h incubation at 37oC (Fig. 4.5A). Although RegIIIβ did not kill L. monocytogenes, 
RegIIIγ did reduce CFU of L. monocytogenes in two out of three experiments. Bacteri-
cidal assays with stationary phase bacteria showed reduction of E.coli Nissle CFU by 
RegIIIγ, but no effect on viability of adherent invasive E. coli strain LF82. Stationary 
phase S. enteritidis and L. monocytogenes were not killed by incubation with either 
protein (Fig. 4.5B). 
We also investigated the bactericidal effects of RegIIIβ on exponentially growing E.coli 
VE7108 and E.coli Nissle using a live/dead stain and flow cytometry to quantify the dif-
ferent populations. In absence of RegIIIβ protein, the percentage of dead exponential 
phase bacteria was around 4% to 15%, depending on the strain. Addition of RegIIIβ for 
1 h increased this percentage of dead E.coli VE7108 from 15% to 42%, whereas the per-
centage of dead E.coli Nissle increased from 4% to 10%. Similar results were obtained in 
a second, separate experiment. Taken together, these results show that the bactericidal 
effect of the recombinant RegIII proteins are at best modest under these conditions 
and are dependent on bacterial growth phase as well as on the strain and species of the 
bacteria investigated. 
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Figure 4.3. A) Coomassie-blue stained SDS-PAGE gel showing recombinant RegIIIβ produced using 
baculovirus (bac) or E. coli. Supernatant (sup) or pellet after centrifugation of protein solution, with 
or without DTT in the buffer. B) Western blot showing N-terminal cleavage of RegIIIγ (left panel) or 
recombinant RegIIIβ proteins (right panel). RegIII proteins were detected using antibodies recognising 
the N terminus (N-term) or other parts of the protein predicted to be surface exposed (middle). 
effect of RegIII protein on bacterial growth in vitro
As an additional assay for the antimicrobial activities of recombinant RegIII proteins we 
measured the effect of RegIIIγ or RegIIIβ on bacterial growth. S. enteritidis or L. mono-
cytogenes were grown for 8 hours in 96-wells plates at 37oC, with or without processed 
RegIIIβ or RegIIIγ. Neither of the refolded RegIII proteins (Fig. 4.6A and B), or soluble 
RegIIIβ produced in insect cells (Fig. 4.6C and D) inhibited the growth of bacteria com-
pared to the control. In fact, the bacteria incubated with refolded RegIIIβ or RegIIIγ 
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reached higher numbers than untreated samples in the lag phase and early log phase. 
Based on these results there appears to be no inhibitory effect of RegIII proteins on the 
growth of S. enteritidis and L. monocytogenes. However, in L. monocytogenes cultured 
with RegIIIγ the final OD was lower than that of the control without RegIIIγ, indicative 
of a lower final number of bacteria. 
Figure 4.4. Flow cytometrical analysis of A) Negative control: S. enteritidis and L. monocytogenes in-
cubated without RegIII protein. B) S. enteritidis incubated with different concentrations of RegIIIβ. 
C) L. monocytogenes incubated with different concentrations of RegIIIβ. Percentage of total bacteria 
detected using fluorescent anti-RegIIIβ antibody are indicated in the gated area.
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Figure 4.5: A) CFU of mid-log phase cultures of S. enteritidis (salm) and L. monocytogenes (list) incu-
bated with and without RegIIIβ (B) and RegIIIγ (G). B) CFU counts with stationary phase cultures of S. 
enteritidis, L. monocytogenes, E. coli LF82 or E. coli Nissle incubated with and without RegIIIβ (B) and 
RegIIIγ (G).
Figure 4.6. Growth curves of S. enteritidis (A) and L. monocytogenes (B) for 8 hours with or without 
processed RegIIIγ or RegIIIβ. The two lower panels show incubation of S. enteritidis (C) and L. monocy-
togenes (D) with the secreted RegIIIβ produced using the baculovirus system. 
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Molecular docking
The binding modes of the previously identified fucose-containing glycans 20, 23, 24, 26 
(Chapter 3), the carbohydrate part of Lipid A and the carbohydrate repeat unit of PGN 
(β-(1,4) linked N-acetylglucosamine and N-acetylmuramic acid) to RegIIIβ were mod-
elled by molecular docking (Table 4.1). The lowest energy predicted binding poses of all 
carbohydrates dock into one of two binding sites on RegIIIβ, designated as binding site 
1 (BS1) and binding site 2 (BS2). 
Interestingly, the lowest energy binding poses of PGN and the fucose-containing glycans 
20 and 24 docked into BS1 whereas lipid A, and the glycans 23 and 26 docked into BS2. 
The only known ligand of RegIIIγ, PGN, was shown to dock into a region in loop 1 which 
is largely conserved in RegIIIβ (BS1, Table 4.1). A space-filling model of RegIIIβ shows the 
binding of glycan 20 to BS1 and lipid A to BS2, and also shows that BS2 is not conserved 
in RegIIIγ (Fig. 4.7).
Table 4.1 Glycans and their predicted binding sites in RegIIIβ. * BS1 involves interactions in and 
around the ‘EPN’ and the DPT’ motives in loop 1. ** BS2 involves interactions in and around the ERN 
motif in loop 2
Glycan
 
Monosaccharides
 
Links
 Predicted Binding 
Site  in RegIIIβ   
20  GlcNAc, Man, Fuc  Manβ1-4(Fucα1-
3)GlcNAcβ1-
4GlcNAcβ-
O(CH2)5NH2  
BS 1*
23 GlcNAc, Man, Fuc  Manα1-3Manβ1-
4(Fucα1-3)GlcNAcβ1-
4(Fucα1-6)GlcNAcβ-
O(CH2)5NH2  
BS 2**  
24 GlcNAc, Man, Fuc  GlcNAcβ1-2Manα1-
3Manβ1-4(Fucα1-
3)GlcNAcβ1-4(Fucα1-
6)GlcNAcβ-
O(CH2)5NH2  
BS 1*
26 GlcNAc, Man, Fuc  GlcNAcβ1-2Manα1-
3Manβ1-4GlcNAcβ1-
4(Fucα1-6)GlcNAcβ-
O(CH2)5NH2  
BS 2**  
Lipid A GlcNAc  GlcNAcβ1-6GlcNAc BS 2**  
peptidoglycan MurNAc, GlcNAc  MurNAcβ1-4GlcNAc  BS  1 *  
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dIScuSSIon 
The goal of this study was to characterize the binding properties and bactericidal or 
bacteriostatic effects of recombinant RegIIIβ and RegIIIγ. Additionally we compared the 
predicted structure and ligand binding sites using molecular docking tools in silico. 
High-level expression of RegIIIβ and RegIIIγ in E. coli leads to formation of inclusion 
bodies, which could be isolated, denatured, affinity purified and refolded to generate 
soluble RegIII proteins. In contrast, secretion of soluble recombinant RegIIIβ could be 
achieved in insect cells using the baculovirus expression system. The size of RegIIIβ pro-
duced in insect cells and of RegIIIβ produced in E. coli was as predicted, suggesting 
that the proteins were not post-transcriptionally modified by glycosylation. This is in 
agreement with the lack of a consensus sequence for N and O-glycosylation (Asn-Xaa-
Ser/Thr) in RegIIIβ and with the reported data on RegIIIγ.34 In the absence of reducing 
agents, the recombinant RegIII proteins form multimers, which were evident in SDS-
PAGE. Indeed, RegIIIβ was previously reported to form aggregates after N-terminal 
processing.35-36 Aggregation of bacteria by PAP has been reported previously and was 
proposed as an antimicrobial function.19, 20 However, we did not observe aggregation 
of bacteria in our bactericidal assays. Previously, Hassanain et al.37 demonstrated that 
aggregates of PAP had a different function than non-aggregated PAP. 
Figure 4.7. Space-filling model of RegIIIβ. Residues which are different from RegIIIγ are shown in pur-
ple. Ligands (glycan number 20 in BS1 and Lipid A in BS2) are shown as sticks. Rotation of RegIIIβ by 
180o is indicated by an arrow.
A structural model of RegIIIβ showed the N-terminal pro-segment sequence that is pro-
posed to interact with a charged surface on in RegIIIγ and HIP/PAP to prevent antimi-
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crobial activity. Cleavage of this pro-segment by trypsin was shown to enhance bacte-
ricidal activity of RegIIIγ.18, 19 This may be a mechanism to allow the host to restrict the 
binding activity of RegIII proteins to the lumen or to avoid detrimental effects inside 
host cells during storage or secretion. We demonstrated in this study that the predicted 
pro-segment was also cleaved from RegIIIβ by trypsin. Immunoblotting showed that 
trypsin treatment of soluble RegIIIβ produced in insect cells generated a single major 
protein whereas the refolded RegIIIβ produced in E. coli appeared to be cleaved into at 
least 3 polypeptides of different sizes. Analysis of the potential trypsin cleavage sites 
within the RegIIIβ primary protein sequence indicated several possible cleavage sites 
(not shown), which may have become accessible to trypsin in alternative protein con-
formations. These results point to the fact that refolding of RegIIIβ may have increased 
its susceptibility to proteolysis by trypsin. In contrast to RegIIIβ, recombinant RegIIIγ 
yielded a single protein band upon cleavage with trypsin as previously described.18 One 
explanation for the difference in trypsin digestion patterns of RegIIIβ and RegIIIγ might 
be the fewer number of potential trypsin cleavage sites in RegIIIγ. For this reason the 
RegIIIβ protein produced in insect cells was used in the bactericidal and binding assays 
although refolded RegIIIβ was included in some assays for comparison.
We showed that an important consequence of N-terminal processing is enhanced bind-
ing of both RegIIIβ and RegIIIγ to bacteria, further supporting the idea that cleavage of 
the N-terminal peptide indeed activates the protein. Unexpectedly, we observed bind-
ing of RegIIIγ to Gram-negative bacteria although the only known bacterial ligand is 
PGN11 which is not exposed in Gram-negative bacteria. This suggests that RegIIIγ may 
bind to another glycan, possibly in the carbohydrate O-antigen of LPS.
RegIIIβ bound to L. monocytogenes, E. coli and S. enteritidis as did RegIIIγ, despite hav-
ing only a reported bactericidal activity on Gram-positive L. monocytogenes.11 Although 
processed RegIIIβ bound to all bacteria tested, it was not bactericidal for L. monocyto-
genes and S. enteritidis based on CFU plate counts. Using flow cytometry and live/dead 
staining on logarithmically growing E. coli strains we did measure moderate killing of 
E. coli strain VE7108 and small effects on E. coli Nissle in the absence of any apparent 
bacterial aggregation. The conditions for binding and bactericidal assays were the same 
as those described previously for RegIIIγ11 and RegIIIβ.16 Addition of reducing agent DTT 
had no effect on binding activity. Recently, recombinant RegIIIβ was shown to reduce 
CFU of E. coli harvested in late log phase to about 20% of the starting value16 after 30 
min incubation. Clostridium butyricum was also killed by RegIIIβ, but not the more aero-
tolerant Gram-positive bacteria Lactobacillus murinus and Enterococcus feacalis, sug-
gesting bactericidal activity against some, but not all, Gram-positive bacterial species. 
In a follow up paper by the same group the bactericidal effect of RegIIIβ on Salmonella 
typhimurium was reported to be optimal in early logarithmic growth phase,17 for rea-
sons that are not yet fully understood. However, the bacterial growth phase appeared 
to have no effect on RegIIIβ binding or bactericidal activity against S. enteritidis, E. coli 
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or L. monocytogenes in our experiments. In recent studies RegIIIβ was shown to bind 
lipid A17 and PGN.17, 30 This would explain binding of this protein to both Gram-positive 
and Gram-negative bacteria although RegIIIβ would need to penetrate the hydropho-
bic outer carbohydrate part of the LPS to reach the lipid A component near the outer 
membrane. 
To investigate potential bacteriostatic effects of RegIII proteins on bacterial growth we 
added N-terminally processed and unprocessed proteins to low density bacterial cul-
tures. This had no influence on bacterial growth, as judged by the growth curve. With 
L. monocytogenes, the final OD is lower after addition of RegIIIγ compared to the con-
trol, even though the growth rate was not influenced. A disadvantage of this method 
is that we cannot rule out aggregation of the bacteria, which could interfere with the 
OD measurement. The added RegIII proteins could still be detected in the supernatant 
after completion of the growth curve measurements as was shown by western blot 
(data not shown). However, it might be that the RegIII proteins are not active under 
these conditions.
Degradation of our RegIII proteins during different incubation steps was not observed, 
but it is possible that they lose activity over time. Although our Reg3 proteins showed 
binding to bacteria, it is possible that the refolded Reg3 proteins produced in E. coli 
were incorrectly folded explaining the inconsistencies with published results on their 
bactericidal activity. The latter is difficult to check, as crystallization and X-ray crystallog-
raphy was not possible. Inconsistencies in the bactericidal role of human PAP have also 
been reported by others.19, 20 The different results found by Medveczky,19 Mukherjee18 
and us could be related to different bacterial strains used, different PGN preparations, 
possible interference of bacterial aggregation with viability assays and proteolytic in-
stability of the PAP pro-segment.19 In particular, measurement of reduction in bacterial 
CFU as a method for assessing bactericidal activity, does not exclude the possibility of 
bacterial aggregation unless this is carefully checked by other methods.
Overall, these results support a role for binding of RegIII proteins to bacteria but the in 
vitro bactericidal effects described in the literature appear difficult to reproduce, even 
using the same assay conditions and bacterial strains. The bactericidal effects reported 
to date were in any case relatively modest suggesting that the assay conditions were 
not optimal or that refolded recombinant RegIII proteins were not fully active in vitro. 
Therefore, future efforts to optimize the expression of soluble RegIII proteins in mam-
malian cells, seems warranted.
Structural models of RegIIIβ and RegIIIγ were generated based on the crystal struc-
ture of human PAP.38 The carbohydrate binding domains of the C-type lectin family 
involves the characteristic long loop (comprising loop 1 and loop 2), which is surface 
exposed and these loops are also present in RegIIIβ and RegIIIγ. To investigate the 
ligand binding sites in RegIIIβ and RegIIIγ the ligands known to bind (unpublished 
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data, Chapter 3) were docked to the predicted structures. In RegIIIβ two binding 
sites were identified, the results suggest that BS2 binds to lipid A and two other 
glycans and the BS1 binding to PGN and 3 different fucose-containing glycans pre-
viously identified. PGN was predicted to dock in BS1 containing an EPN motif that 
was shown to be necessary for binding of HIP/PAP to PGN. Indeed, both RegIIIβ and 
RegIIIγ show this EPN motif. However, mutation of this motif in RegIIIβ was shown 
previously not to affect binding to PGN.17 The so-called BS2 interacts with residues 
within and around the ERN motif in loop 2, as previously shown.17 These interacting 
resides are not conserved in RegIIIγ. The variability of the ERN motif and the sur-
rounding residues in loop 2 might therefore determine the differences between car-
bohydrate recognition and bactericidal activity between RegIIIβ and other C-type 
lectins, including RegIIIγ, which is in agreement with the findings of Miki et al.17 
RegIIIβ and RegIIIγ were found to contain a BS1 involving different interacting resi-
dues including the EPN and DPT motifs in loop1 that are conserved in both proteins, 
which would explain the finding that RegIIIβ and RegIIIγ can both bind PGN.11, 17, 30 
The other important implication of these results is that RegIIIβ has two ligands bind-
ing sites. As the BS1 was shown to dock to fucose-containing glycans, we hypoth-
esize that RegIIIβ could bind to both mucus and bacterial lipid A, thereby trapping 
bacteria in the mucus. The binding of RegIIIβ to mucus might also have an effect on 
mucus structure and or penetrability of bacteria. Further work is in progress to test 
these hypotheses and identify other possible ligands of RegIIIγ. 
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AbstrAct
background: The RegIII protein family, including the human member designated pan-
creatitis-associated protein, are secreted proteins that contain a C-type lectin domain 
involved in carbohydrate binding. They are expressed by intestinal epithelial cells. Col-
onization of germ-free mice and intestinal infection with pathogens increases the ex-
pression of RegIIIγ and RegIIIβ in the murine ileum. RegIIIγ is directly bactericidal for 
Gram-positive bacteria but the exact role of RegIIIβ in bacterial infections is unknown.
Methods: To investigate the possible protective role of RegIIIβ in intestinal infec-
tion RegIIIβ-knockout(-/-) mice and wild-type (WT) mice were orally infected with the 
Gram-negative Salmonella enteritidis or the Gram-positive Listeria monocytogenes. At 
day 2 (Listeria infection) and at day 4 (Salmonella infection) after oral infection mice 
were sacrificed to collect intestinal and other tissues for pathogen quantification. Pro-
tein expression of RegIIIβ and RegIIIγ was determined in intestinal mucosal scrapings of 
infected and non-infected mice. In addition, ex-vivo binding of ileal mucosal RegIIIβ to 
Listeria and Salmonella was investigated.
results: Whereas recovery of Salmonella or Listeria from feces of RegIIIβ-/- and WT 
mice was not different, significantly higher numbers of viable Salmonella, but not Liste-
ria, were recovered from the colon, mesenteric lymph nodes, spleen and liver of the 
RegIIIβ-/- mice than from those of WT mice. Mucosal RegIIIβ binds to both bacterial 
pathogens and may interfere with their mode of action. 
conclusion: RegIIIβ plays a protective role against intestinal translocation of the 
Gram-negative bacterium S. enteritidis in mice, but not against the Gram-positive bac-
terium L. monocytogenes.
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InTRoduCTIon 
In many countries in the industrialized world, foodborne intestinal infections are con-
tinuing to increase.1 For example, outbreaks of salmonellosis and listeriosis have been 
reported for decades, but within the past 25 years their incidence has increased on 
many continents.2 To inhibit the colonization (adhesion to the intestinal epithelium) 
and translocation (invasion of host tissues) of foodborne pathogens and commensals 
the intestinal mucosal surfaces are armed with an array of physical and chemical de-
fence mechanisms. The low pH of the gastric compartment, and bile acids secreted in 
the proximal intestine, reduce the number of bacteria that will survive within the gut.3, 
4 Other important defence mechanisms against pathogens include competition for nu-
trients and adhesion sites from commensal bacteria, a thick mucus layer on the luminal 
side of the epithelium and the rapid innate response of the intestinal epithelium.5, 6
Studies in rodents indicate that innate recognition of bacteria or bacterial components 
triggers epithelial expression of secreted C-type lectins RegIIIγ and RegIIIβ.7-10 In rodents 
mucosal and faecal levels of RegIII protein are associated with the severity of infection.9 
The human homologue of this protein, i.e. they are on the amino acid level the most 
identical genes between two species (bidirectional best hit), is pancreatitis-associated 
protein (PAP). PAP is also detectable in faeces and its use as biomarker to monitor or 
discriminate human intestinal disease is the subject of ongoing studies.
Currently, the role and function of the Reg3 family members is of much interest. The 
murine RegIIIγ and human PAP have been shown to have antimicrobial activity against 
Gram-positive bacteria but not the Gram-negative Escherichia coli.8 PAP and RegIIIγ 
were shown to bind peptidoglycan carbohydrate, which is critical for bacterial killing.11 
Expression of RegIIIγ is greatly reduced in mice deficient in MyD88, an intracellular 
adaptor protein involved in most Toll-like receptor (TLR)-mediated signalling. MyD88-
deficient mice have been shown to be more susceptible to L. monocytogenes infection 
compared with wild-type (WT) mice.12 Injection of recombinant RegIIIγ into the lumen 
of MyD88-deficient ligated ileal loops before inoculation with L. monocytogenes was 
shown to reduce L. monocytogenes survival in the gut. Other in vivo studies showed 
that genetic ablation of RegIIIβ, which is another RegIII murine isoform, resulted in im-
paired clearance of the bacterial load in ileal Peyer’s patches during Yersinia pseudotu-
berculosis infection without affecting luminal bacterial levels.13 It remains unclear, how-
ever, how RegIIIβ protects against bacterial translocation and whether this is specific for 
Gram-negative pathogens. 
In this study we used RegIIIβ-knockout(-/-) mice and their WT littermates to investigate 
the protective role of RegIIIβ following oral challenge with Gram-negative Salmonel-
la enteritidis or Gram-positive L. monocytogenes. Additional ex-vivo experiments were 
performed to gain insights into the mechanisms involved in the protective function of 
117
Chapter 5
118
RegIIIβ.
MATeRIALS And MeThodS
Animals and diet
The experimental protocol was approved by the animal welfare committee of Wagenin-
gen University (Wageningen, the Netherlands). RegIIIβ-/- mice with a C57Bl/6 x 129O1a 
background were generated as described.14 Knock-out mice were obtained by breeding 
heterozygote mice. Genotyping was performed as described previously14 and -/- mice 
were used as knockout and +/+ littermates were used as WT control. The mice were 
selected on genotype and age and were fed a semi-purified AIN93-G15 diet (Abdiets, 
Woerden, The Netherlands). At 7-9 weeks of age mice with an average body weight of 
22 g (range 16–31 g) were housed individually. They received a purified diet containing 
per kg: 200 g acid casein, 326 g cornstarch, 174 g glucose, 160 g palm oil, 40 g corn oil, 
50 g cellulose, and vitamin and mineral mix (without calcium) according to AIN93.15 
Diets were supplemented with CaHPO4.2H2O (Merck, Darmstadt, Germany) to a final 
concentration of 30 mmol/kg. To mimic the composition of a Western human diet, the 
prepared diets were relatively low in calcium and high in fat compared to standard 
rodent diets.15 Food and demineralized drinking water were supplied ad libitum. Mice 
were separated into groups and age and gender were randomized over all groups as 
much as possible. The power analysis used to calculate the minimal number of ani-
mals needed per group was based on previously performed infection studies in this 
model (unpublished results). In total 3 RegIIIβ-/- and 3 WT groups were formed. From 
each mouse strain one group was orally infected with Salmonella (-/-: n=10, WT: n=12), 
a second group of each strain was orally infected with Listeria (-/-: n=7, WT: n=8) and a 
final group was sham treated (-/-: n=5, WT: n=6). Body weight was measured every two 
days before infection and daily after infection.
nramp1 genotype of Salmonella infected mice
To monitor equal susceptibility to Salmonella infection the natural resistance-associated 
macrophage protein 1 (Nramp1) genotype was determined in the Salmonella infected 
RegIIIβ+/+ and RegIIIβ-/- mice. A PCR product was created from the genomic DNA by using 
primers 5’GGAATGAATGTCAAGCAGCCAG 3’ and 5’ATCCCACCTCATAGCCGAAG 3’ in order 
to sequence the area of the gene that is known to vary between different mouse strains 
(G or A at position 596) in the Nramp1 gene.16 The PCR cycle was 3 min at 95˚C, 35 cycles 
of 30 s at 95˚C, 30 s at 58˚C and 1 min at 72˚C, ending with 5 minutes at 72˚C. The PCR 
product was subsequently sequenced by Baseclear (Leiden, the Netherlands), using the 
following primers 5’ CACCCCATTTCCAGTAGGG 3’ and 5’ CCTGTGACACCTGGATGTTC 3’, 
to determine the Nramp1 genotype of the Salmonella infected mice.  
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Infection
After adaptation to individual housing and diet for 8 days, mice were orally infected by 
gavage with 0.2 mL saline containing 5*108 CFU of S. enteritidis (clinical isolate, phage 
type 4; strain NIZO1241, NIZO food research, Ede, the Netherlands) or L. monocytogenes 
(animal isolate, EGD-e, serotype 1/2a, NIZO food research). The virulence of each strain 
was sustained by routine oral passage in RegIIIβ+/- mice and subsequent isolation of 
the pathogen from extra-intestinal organs. S. enteritidis was grown on BGAM agar plus 
Sulphamandalate supplement (Oxoid, Basingstoke, United Kingdom) and quantified as 
described.17 L. monocytogenes was grown and determined by similar culturing methods 
but by using PALCAM agar18 plus PALCAM selective supplement (Oxoid).
collection of biological samples and bacterial quantification
A pilot study indicated that determination of the number of L. monocytogenes and S. 
enteritidis in organs of mice was optimal, which means that Listeria and Salmonella 
CFU could be detected in organs, at 2 and 4 days after oral infection, respectively (un-
published results). Non-infected mice were sacrificed 3 days after oral sham treatment. 
Mice were anaesthetized by isoflurane and blood was collected via an orbital puncture 
to isolate heparin plasma. After cervical dislocation the colon and the distal 1/3 of the 
small intestine, representing the ileum, were excised. Approximately 1 cm was cut from 
the middle of each intestinal segment to quantify the number of viable Salmonella or 
Listeria present in colonic and ileal tissue. This piece was cut open longitudinally, briefly 
flushed in sterile saline, homogenized in 250 μl of saline and 10-fold dilutions were plat-
ed for bacterial growth on selective agar for Salmonella or Listeria (as described above). 
The remaining parts of the ileum and colon were cut open longitudinally, flushed with 
saline and the mucosa was isolated by scraping with a spatula. Mucosal samples were 
immediately frozen in liquid nitrogen for protein analysis. Furthermore, the mesenteric 
lymph nodes (MLN), spleen and liver were removed, and after homogenization in sterile 
saline, directly used for Salmonella or Listeria quantification as described above. Bacte-
rial counts were expressed as the total log
10
 CFU per gram tissue.
RegIIIβ and RegIIIγ protein analysis in the ileal mucosa
RegIIIγ and RegIIIβ expression were determined in the ileum because this is the area 
where expression is upregulated during infection of rats9, 10 and upon microbial coloni-
zation of germ-free mice.8 Frozen mucosal scrapings of the ileum were pulverized un-
der liquid nitrogen. Approximately 2/3 of the pulverized tissue was suspended in a 0.2 
mol/l sucrose buffer of pH 7.4 containing 20 mmol/l trishydroxymethylaminomethane 
(Tris) and a protease inhibitor cocktail (Complete, Roche Diagnostics). To homogenize 
the samples they were sonicated on ice for 30 s at level 4 (Sonicator XL2020, Heat Sys-
tems, Farmingdale, NY, USA) and protein concentrations were determined using the BC 
Assay (Omnilabo, Breda, the Netherlands) according to the manufacturer’s protocol. 
Samples from each group were pooled per group and 100 µg protein was denatured at 
95°C for 10 min in sample buffer (4x buffer: 160 mM Tris, pH 6.8, 8% SDS, 40% glycerol, 
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0.05% w/v bromophenol blue), subjected to SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) (4.8% stacking-gel, pH 6.8, 12.5% separation-gel, pH 8.8) and transferred 
to a PVDF membrane (Immobilon-P, Millipore, Billerica, MA, USA). After blocking, the 
membranes were incubated with polyclonal anti-RegIIIβ (1:50 000) or anti-RegIIIγ (1:10 
000) antibodies (custom made by Eurogentec, Seraing, Belgium). These antibodies 
were generated in rabbits against synthetically produced peptides, using the peptide 
sequences GEDSLKNIPSARISC (RegIIIβ) and EVAKKDAPSSRSSC (RegIIIγ). The chosen pep-
tide sequences correspond to unique sequences within the RegIII protein and allow 
differentiation between the RegIIIβ and RegIIIγ proteins. Serum from immunized rabbits 
was affinity purified using the same peptides. The signal of the secondary HRP-conju-
gated antibody (Goat-anti-Rabbit HRP, 1:100 000, Jackson ImmunoResearch, Suffolk, 
UK) was detected by using the ECL Plus chemiluminescent detection kit (GE Healthcare, 
Den Bosch, the Netherlands).
Myeloperoxidase analysis in ileal mucosa and serum amyloid A detection in plasma
A mouse myeloperoxidase (MPO) ELISA test kit (Hycult biotechnology, Uden, the Neth-
erlands), was used according to the manufacturer’s guidelines to determine the con-
centration of MPO in ileal mucosal scrapings.
Serum amyloid A (SAA) 2, an acute phase apolipoprotein present in plasma,19 was de-
termined to investigate systemic inflammation. A mouse SAA2 ELISA kit (Life Diagnos-
tics, Inc. West Chester, Pennsylvania, USA) was used according to the guidelines of the 
manufacturer.
Pull-down assay
To investigate the possible mode of action it was evaluated whether RegIIIβ present 
in the ileal mucosa binds to S. enteritidis or L. monocytogenes in a pull-down assay. S. 
enteritidis and L. monocytogenes, identical to the strains used in the infection study, 
were grown overnight (37°C in a horizontal shaker at 250 rpm) in LB and BHI broth, 
respectively.
Overnight grown bacteria were spun down (3 min at 2350 g) and 1*108 bacteria were 
resuspended in 20 μl ileal mucosal scraping extracts from Salmonella infected RegIIIβ-/- 
or WT mice, which were diluted 1:5 in the above described sucrose buffer. The bacteria 
were incubated for 30 min at 37°C. After spinning down the bacteria (5 min at 1500 
g) presence of RegIIIβ was investigated in the supernatant (15 μl) by SDS-PAGE as de-
scribed above. Proteins were transferred to an Immobilon-FL membrane (Millipore) and 
after blocking exposed to rat anti-mouse RegIIIβ antibodies (MAB5110; R&D systems, 
Minneapolis, USA, 1:2000). The secondary antibody used was Goat-anti-Rat IRDye® 
680CW (Li-Cor, Nebraska, USA, 1:20 000) and the blots were scanned by using the Od-
yssey scanner (Li-Cor). Experiments were performed in triplicate.
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Statistics
All data are expressed as mean ± SEM and statistical analysis was performed by using 
Prism 5.0 Software (GraphPad, San Diego, California, USA). Our aim was to investigate 
the role of RegIIIβ in infection. Therefore the pre-defined comparisons were RegIIIβ-/- 
versus WT. Except for in vitro investigations to evaluate binding of RegIIIβ to Salmonel-
la and Listeria when binding to these pathogens were investigated. Data were tested 
for normality by Kolmogorov-Smirnov normality test and Shapiro-Wilk normality test. 
If normally distributed, differences were tested for significance using Student’s t test 
(two-tailed). Data with unequal variances were tested by using the Mann-Whitney U 
test. Salmonella output in feces was determined at multiple time points and therefore 
these data were analyzed by repeated-measures two-way ANOVA (mixed-model). Dif-
ferences were considered statistically significant when P<0.05.
ReSuLTS
Body weight
To monitor the general condition of the mice, body weight was determined during the 
experiment. At the start of the experiment average body weight was 22 ± 0.7 g. During 
the study there was no significant difference between the body weight of RegIIIβ-/- and 
WT mice (data not shown). Average body weight before infection (average weight 
during 2 weeks prior to infection) was 22.8 ± 1.4 g and 23.1 ± 1.4 g for WT and RegIIIβ-/- 
groups, respectively. Post-infection body weight of WT and RegIIIβ-/- groups was 23.2 ± 
1.4g and 23.2 ± 1.5 g (average of the post infection period).  
Bacterial infection increases RegIIIβ and RegIIIγ in the ileum mucosa 
To evaluate presence of RegIIIβ and RegIIIγ protein in the ileal mucosa of WT and RegIIIβ-/- 
mice, and subsequent levels upon oral infection, mucosal scrapings were evaluated by 
immunoblotting using antibodies specific for RegIIIβ and RegIIIγ. As expected, RegIIIβ 
was not detected in the ileal mucosa of RegIIIβ-/- animals (Fig 5.1). After Salmonella and 
Listeria infection the protein level was higher in the mucosal samples of WT mice than 
before infection (Fig 5.1). The isoform RegIIIγ was not detectable in mucosal scrapings 
of non-infected RegIIIβ-/- mice (Fig 5.1). In contrast, the WT mice had detectable levels 
of this Reg3 isoform and levels increased during Salmonella and Listeria infection in WT 
and RegIIIβ-/- mice.
RegIIIβ-/- mice are more susceptible to Salmonellosis but not to Listeriosis than WT 
mice
In order to ensure similar Nramp1 genotypes in all Salmonella infected animals these 
mice were sequenced for a previously reported point mutation in this gene, which could 
affect infection susceptibility.16 All mice were shown to be homozygous for the Nramp1 
susceptibility allele (data not shown). To investigate the role of RegIIIβ in intestinal colo-
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nization, the numbers of viable Salmonella were investigated in fresh faecal samples 
of infected WT and RegIIIβ-/- mice. Colonization of Salmonella in RegIIIβ-/- mice was not 
different from that of WT mice (Fig 5.2). In the colonic tissue, which was first flushed 
with saline to remove intestinal content, higher numbers of Salmonella were recovered 
in RegIIIβ-/- mice than in WT mice (Fig 5.3A; P<0.05). In the ileal tissue Salmonella levels 
were identical in RegIIIβ-/- and WT mice. Furthermore, in MLN, spleen and liver these 
levels were higher in RegIIIβ-/- mice than in their WT counterparts (Fig 5.3B; P<0.05).
Figure 5.1. Western blot analysis of RegIIIβ and RegIIIγ in pooled ileal mucosa samples of RegIIIβ-/- mice 
(KO) or WT mice (WT). RegIIIβ-/- mice (n=10) and WT mice (n=12) were orally infected with S. enteritidis 
(S) or RegIIIβ-/- mice (n=7) and WT mice (n=8) were orally infected with L. monocytogenes (L). Non-in-
fected mice (n=5) received saline as control treatment. 
Figure 5.2. Salmonella (   , Δ) and Listeria (●, ○) excretion in faeces. Individually housed mice were 
orally infected at day 0. RegIIIβ-/- mice (closed symbols) were infected with 5*108 colony-forming units 
(CFU) of S. enteritidis (n=10) or L. monocytogenes (n=7) and WT littermates (open symbols) with iden-
tical CFU of S. enteritidis (n=12) or L. monocytogenes (n=8). Values are means ± SEM. Mucosal and 
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systemic inflammation.
Intestinal colonization of Listeria was identical in RegIIIβ-/- and WT mice as found for 
Salmonella (Fig 5.2). To further investigate effects of RegIIIβ on Listeria translocation the 
CFU in ileal and colonic tissue and extra-intestinal organs were determined. The num-
ber of Listeria recovered from WT did not differ from RegIIIβ-/- mice in ileal and colonic 
tissues, (Fig 5.3C) and in MLN, spleen, and liver (Fig 5.3D). 
The role of RegIIIβ in inflammation was investigated by measuring the levels of the in-
flammation marker myeloperoxidase (MPO) in the ileum mucosa at 2 and 4 days after 
oral infection of Listeria and Salmonella groups, respectively. MPO levels of Salmonella 
(0.49± 0.05 ng/mg protein) and Listeria (0.39 ± 0.06 ng/mg protein) infected groups did 
not differ significantly from the non-infected groups (0.35 ± 0.05 ng/mg protein; data 
not shown). To study systemic inflammation SAA levels in plasma were determined at 
the same time points. The levels were elevated from 0.1 ± 0.001 µg/ml (non-infect-
ed mice) to 1164 ± 186 and 502 ± 174 µg/ml upon Salmonella and Listeria infection, 
respectively (P<0.05; data not shown). However, there were no significant differences 
between WT and RegIIIβ-/- mice.
Figure 5.3. Salmonella (A, B) and Listeria (C, D) in intestinal and extra-intestinal tissues at 4 and 2 days 
after oral infection, respectively. CFU of pathogens in the ileal and colonic mucosa (A, C) and in mesen-
teric lymph nodes (MLN), spleen and liver (B, D) of RegIIIβ-/- mice (n=10; black bars) or WT mice (n=12; 
white bars). Values are means + SEM. *Different from WT, P<0.05. 
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RegIIIβ binds to Salmonella and Listeria
To investigate the possible mode of action it was evaluated whether RegIIIβ present 
in the ileal mucosa binds to S. enteritidis and L. monocytogenes in a pull-down assay. 
Upon ex-vivo incubation of mucosal samples from infected mice with these bacteria 
it was shown that RegIIIβ protein levels decreased in the supernatant (Fig 5.4). It was 
mainly the lower-molecular-weight form of the proteolitically processed protein that 
decreased after incubation with bacteria. This indicated that it is the cleaved form of 
RegIIIβ that binds to the pathogens and not the full length polypeptide. We have shown 
previously that the RegIII protein is not precipitated even when centrifuged at 15000 
g.9 Therefore, the results presented here indicate that ileal mucosal RegIIIβ is able to 
directly bind both Salmonella and Listeria.
Figure 5.4. Listeria and Salmonella pull-down assays. Presence of RegIIIβ, detected by Western blot 
analysis, in supernatant fractions of ileal mucosa samples from S. enteritidis infected WT (WT) or 
RegIIIβ-/- (KO) mice incubated with Salmonella or Listeria. Mucosal samples incubated without bacteria 
served as negative control (-). The pre-stained protein marker is indicated by M. 
dIScuSSIon
Both microbial infections of conventional mice and intestinal colonization of germ-free 
mice by commensals increases ileal expression of the secreted C-type lectins RegIIIγ and 
RegIIIβ.7-10 While RegIIIγ has been shown to have a bactericidal activity against Gram-
positive bacteria,8 the physiological function of RegIIIβ remains unknown. This study 
demonstrates a role for RegIIIβ in protection against infection with the Gram-negative S. 
enteritidis. Despite the fact that similar levels of viable Salmonella were recovered from 
faeces higher numbers were present in MLN, spleen and liver of infected RegIIIβ-/- mice 
compared to WT mice, indicating that the translocation and dissemination of Salmo-
nella in host tissues is increased in the absence of RegIIIβ. As the mice were bred on a 
mixed background (C57Bl/6 and 129O1a) and these strains differ in their susceptibility 
to Salmonella infection due to a mutation (G → A) in the Nramp1 gene, all mice were 
genotyped individually.16 All the Salmonella infected animals were shown to be ho-
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mozygous for the Nramp1 susceptibility allele, ruling out the possibility that the Nramp 
status would affect the results. In colonic tissue Salmonella levels were also increased 
in RegIIIβ-/- mice compared with WT mice. The MLN drain the small intestine, which is a 
main site of Salmonella invasion.20 Therefore reduced levels of Salmonella in the MLN of 
WT mice suggest protective effects of RegIIIβ on Salmonella translocation in the ileum. 
Although we did not observe differences in Salmonella counts in the ileal tissues of WT 
and RegIIIβ-/- mice, this may be due to lack of statistical power in this assay, as SEM levels 
are higher in ileal tissue than those in colonic tissue. Moreover the investigated ileal 
tissue did not contain Peyer’s patches and M cells, which are considered, in addition to 
absorptive enterocytes, to be important sites of Salmonella translocation.21, 22 Together 
the experimental infection data strongly suggest that RegIIIβ inhibits Salmonella trans-
location from the gut lumen into intestinal tissues and further extra-intestinal tissues 
but does not kill Salmonella in the gut lumen. These results are supported by recent 
findings of Dessein et al., who showed that genetic ablation of RegIIIβ did not affect 
the bacterial load of the Gram-negative pathogen Yersinia pseudotuberculosis in the 
intestinal lumen13 but significantly increased bacterial burden in the Peyer’s patches, 
which are the main route of entry for this pathogen. In contrast, RegIIIβ did not to influ-
ence resistance to infection with the Gram-positive Listeria monocytogenes, as identical 
numbers of this pathogen were recovered from intestinal and extra-intestinal tissues in 
RegIIIβ-/- and WT mice as found in our study.
As murine RegIIIγ and human PAP are directly bactericidal for Gram-positive bacteria in 
vitro8, 23 it seemed possible that RegIIIβ would have similar antimicrobial activity. How-
ever, in this study there was no effect of RegIIIβ on the colonization and translocation 
of L. monocytogenes. The strain of L. monocytogenes used in our infection study was 
identical to that used previously for in vitro antibacterial assays with RegIIIγ.8 Previous 
investigations with rat PAP1, which is the homologue of the murine RegIIIβ, also showed 
no direct bactericidal effect against L. monocytogenes in vitro.9 Others also report a lack 
of bactericidal effect of this protein.13 The co-existence of the two closely related RegIII 
proteins in the mouse strongly suggests a different function for each of these proteins. 
Here we provide evidence that RegIIIβ has a protective role against Gram-negative Sal-
monella translocation but not Listeria infection. The exact mechanism by which RegIIIβ 
inhibits Salmonella translocation into host tissues is unclear. 
The observed difference of RegIIIβ functionality between Listeriosis and Salmonellosis 
might be due to differences in physical appearance and host invasion mechanisms of 
the two pathogens but might also be related to differences in host responses induced 
by these pathogens. We can only speculate about the latter as we did not monitor the 
exact (immune) response of the mice. Previous studies by Brandl et al.12 indicated that 
the innate immune defence against L. monocytogenes, which requires Toll-like recep-
tor (TLR)-mediated signals, plays a crucial role in RegIIIγ related protection against this 
pathogen. As S. enteritidis and L. monocytogenes may trigger different (TLR-mediated) 
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innate immune signals,24 this might be a cause of differential regulation of RegIIIβ ex-
pression and therefore the subsequent protective effects of this protein. On the other 
hand, it might be that RegIIIβ modulates the immune response directed against Sal-
monella but not the response against Listeria. Although measured at a single time 
point in the current study, RegIIIβ did not affect the systemic inflammatory response 
as measured by SAA levels in serum. The local inflammatory response in our infection 
models was relatively low, as MPO levels did not increase upon infection in the ileal 
mucosa. This was likely due to the relatively short period that mice were exposed to the 
orally administered pathogens because our focus was on pathogen colonization and 
translocation which normally precedes inflammation. Thus based on our study design, 
we cannot fully exclude absence of effects of RegIIIβ on the inflammatory response. 
However, previous investigations in our lab with a similar Salmonella infection model in 
rats indicated that mucosal inflammation in this infection model is relatively low at day 
4 post infection.25 Further analysis of the collected intestinal tissues from the current 
study might give insight on the role of the innate (immune) response in RegIIIβ related 
protective effects. For example, micro-array analysis of intestinal tissues may identify 
whether and which host defence pathways are associated with protective effects of 
RegIIIβ. Performing additional Listeria and Salmonella infection experiments in mice 
deficient in specific TLRs might reveal the involvement of specific innate immune signal-
ling in RegIIIβ mediated protection against intestinal infection. 
Besides the proposed association of the host response with RegIIIβ related protection 
of intestinal infection, this lectin might also directly and differentially affect Listeria and 
Salmonella. The outer membrane of these pathogens is different, for example Salmo-
nella contains immuno-reactive lipopolysaccharides (LPS) which are absent in Gram-
positive bacteria such as Listeria. This influences host signalling pathways, e.g. TLR rec-
ognition. Our ex-vivo analysis revealed that ileal mucosal RegIIIβ showed binding affinity 
to both Salmonella and Listeria. Bactericidal activities of RegIIIγ depend on binding to 
cell wall peptidoglycan, a molecule exposed on the Gram-positive bacterial surface.4 
This peptidoglycan recognition is determined by the so called Loop1 EPN tripeptide 
motif, which is also present in RegIIIβ.11 This motif is involved in peptidoglycan binding, 
and binding affinity for carbohydrate ligands depends on carbohydrate chain length.11 
Moreover RegIIIβ binds to the Gram-positive Bacillus subtilis peptidoglycan, mannose 
polysaccharides and chitin, which is a long-chain polymer of N-acetylglucosamine.11 Our 
results suggest that RegIIIβ possibly recognizes carbohydrate structures on the bacte-
rial surface of microorganisms which enter the intestinal mucosa. Currently we do not 
know what the specific target of RegIIIβ is on the outer membrane of bacteria. It may 
be related to LPS, which are large molecules consisting of a lipid and a polymeric carbo-
hydrate structure on most gram negative bacteria.26 This may be a binding target for the 
EPN motif in RegIIIβ. This motif is likely, as shown for RegIIIγ, also involved in binding 
of RegIIIβ to Gram-positive bacteria. The molecular mechanism by which RegIIIβ may 
recognize its binding target remains to be determined. Studies with purified RegIIIβ are 
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needed to determine what ligands specifically bind to this protein. To address this ques-
tion it will be necessary to have purified biologically active RegIIIβ protein, and efforts 
are underway to produce and purify this protein in active form. Although binding may 
be crucial for its function it does not necessarily result in a protective effect in vivo, as 
possible binding of RegIIIβ to Listeria in the intestinal mucosa does not result in reduced 
Listeria levels in extra-intestinal organs. This might be caused by another important dif-
ference between the pathogens, which is that Listeria and Salmonella use complex and 
very different mechanisms of cellular attachment and invasion.20, 27 Listeria can invade 
the human intestinal epithelium via the epithelial receptor E-cadherin. A single amino 
acid change in the murine E-cadherin, however, makes mice relatively resistant to in-
testinal infection.28 As also shown in the present study, relatively high doses of Listeria, 
do achieve a significant invasive infection in rodents.28 This probably involves a second 
but less well characterized surface protein of L. monocytogenes Internalin B, which ena-
bles Listeria to enter and survive within epithelial cells via interaction with three differ-
ent epithelial membrane receptors.20, 27 In the case of Salmonella the bacteria are not 
highly adherent, but their invasion machinery is particularly efficient.20 Salmonella has 
another mechanism to invade cells which involves binding to epithelial cells by its type 
III secretory system (TTSS).22, 29 The TTSS allows direct activation of components of the 
host-cell cytoskeleton by intracellular delivery of dedicated bacterial effectors, resulting 
in membrane ruffling and endocytosis. By this event Salmonella invade and reside in an 
atypical acidic compartment called the SCV (Salmonella containing vacuole) and survive 
inside the cell.27 It might be possible that RegIIIβ interferes with the expression or func-
tion of Salmonella pathogenicity island 1 (SPI-1) TTSS invasion machinery. 
In conclusion, RegIIIβ inhibits intestinal bacterial translocation upon oral infection with 
the Gram-negative Salmonella. In contrast, this protein does not have protective effects 
against intestinal infection with the Gram-positive Listeria. Inhibitory effects of RegIIIβ 
on bacterial infection may be linked to its observed binding to pathogens. The protec-
tive mechanism of RegIIIβ in Salmonellosis is not associated with direct bactericidal 
affects but may be related to interference with Salmonella virulence mechanisms or 
host responses to this pathogen. 
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AbstrAct 
RegIIIγ is considered to have a protective role against infection with Gram-positive bac-
teria due to its bactericidal activity, but evidence from in vivo studies is lacking. We 
generated a RegIIIγ-/- mouse, and investigated the effect of lack of RegIIIγ on intestinal 
mucus distribution, the spatial compartmentalization of bacteria and expression of in-
nate immunity genes. Infection studies were also performed with Gram-positive and 
Gram-negative pathogens to investigate the antimicrobial role of RegIIIγ. RegIIIγ-/- mice 
display altered ileal mucus distribution, increased bacterial contact with the epithelium 
and elevated inflammatory markers in the ileal mucosa without histological evidence 
of pathology. Infection response pathway genes were differentially expressed in both 
L. monocytogenes and S. enteritidis infected RegIIIγ-/- and wt mice. Higher amounts of 
MPO were present in the ileal mucosa of RegIIIγ-/- than wt mice, but translocation to the 
organs was unaffected. We concluded that RegIIIγ has a protective role against mucosal 
infection with pathogenic Listeria and Salmonella in vivo. RegIIIγ is equally distributed 
throughout the mucus and its absence results in increased epithelial contact with the 
microbiota resulting in low-grade inflammation. RegIIIγ can bind to both Gram-negative 
and Gram-positive bacteria and influence mucus distribution in the ileum, properties 
which may contribute to mucosal protection. 
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InTRoduCTIon
The mammalian intestine harbours one of the richest and densely populated micro-
bial communities on earth and several adaptations of the host mucosa have evolved 
to maintain this overall beneficial relationship. One of the main mechanisms involves 
sequestering of bacteria in the luminal compartment, to avoid colonisation of the ep-
ithelial cell surface and invasion by opportunistic pathogens. This is in part achieved 
through the secretion of secretory (s)IgA, which protects the epithelium by the immune 
exclusion of microbes1 but also by the continuous production and removal of secreted 
mucin. In the small intestine, the mucus barrier is fortified by the accumulation of sev-
eral Paneth and epithelial cell-produced antimicrobial peptides and proteins (AMP).2 
One key human antimicrobial protein is hepatocarcinoma-intestine-pancreas/pancre-
atitis-associated protein (HIP/PAP) (RegIIIα, GeneID 5068) that has a murine homologue 
designated regenerating islet-derived 3 beta (RegIIIβ).
Mammalian Reg proteins consist of a carbohydrate recognition domain (CRD) and a 
N-terminal secretion signal. Some RegIII family members implicated in host defence are 
expressed predominantly in the small intestine, including mouse RegIIIβ and RegIIIγ3-6 
and human HIP/PAP.7, 8 The main environmental triggers for expression of RegIII proteins 
are intestinal colonization by bacteria,5 infection9, 10 or inflammatory stimuli driven by 
mucosal inflammation and damage4, 11 implicating broad roles of RegIII proteins in mu-
cosal defence and immune homeostasis.
Recombinant and refolded RegIIIγ and the human orthologue HIP/PAP have been re-
ported to be bactericidal to Gram-positive bacteria through binding to peptidoglycan.5 
The bactericidal activity of HIP/PAP is controversial as other authors report that HIP/
PAP from humans and rats is not bactericidal, but can induce bacterial aggregation.12, 13 
Loss of the antimicrobial RegIIIγ function was given as an explanation for the decreased 
spatial separation of commensals from the small intestinal epithelium in RegIIIγ knock-
out mice.14 The only caveat being that this spatial separation was not based on visuali-
sation of the mucus but inferred by fluorescent detection of the bacteria and epithelial 
nuclei. The firm mucus layer can easily become detached from the epithelial surface 
during the histological procedure, something which is only apparent by direct stain-
ing. Therefore it is important to visualise the mucus layer in order to accurately assess 
changes in bacterial exclusion and the extent to which bacteria penetrate the mucus.
The aim of this study was to determine the in vivo contribution of RegIIIγ to protection 
of the mouse mucosa from infection with Gram-positive Listeria monocytogenes and 
Gram-negative Salmonella enteritidis. We first generated and characterised a RegIIIγ-/- 
mouse, including histological and immuno-histochemical investigations of the mucus 
and spatial compartmentalization of bacteria in the intestine. Additionally, we investi-
gated the effects of RegIIIγ deficiency in uninfected and pathogen infected mice using 
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microarray gene expression, qPCR and measurements of bacterial translocation and 
serum biomarkers. 
ReSuLTS
RegIIIγ deficiency increases innate inflammatory markers in the ileal mucosa
In RegIIIγ-/- mice expression of Cre-recombinase leads to deletion of the RegIIIγ cDNA 
cloned between the loxP sites in the targeting vector, thereby bringing the enhanced 
GFP (eGFP) coding sequence under control of the canonical RegIIIγ promoter (sup-
plement and supplementary Fig. S6.1). RegIIIγ-/- mice had a similar appearance to wt 
mice, showing no developmental abnormalities or signs of disease, and similar body 
weights. As expected, RegIIIγ was not expressed in the small intestine of RegIIIγ-/- mice 
(Fig. 6.1A). EGFP was expressed in the small intestine (Fig. 6.1B) and pancreas, but not 
in the liver, spleen or lungs of RegIIIγ-/- mice (data not shown). Intestinal expression of 
RegIIIγ was not altered in RegIIIγ-/- mice (Fig. 6.1C). Interleukin (IL)-22, an inflammatory 
response marker, was significantly increased in the ileum of RegIIIγ-/- mice (Fig. 6.1D). 
Furthermore, increased amounts of myeloperoxidase (MPO), a quantitative marker of 
polymorphonuclear granulocytes, were measured in the ileum of uninfected RegIIIγ-/- 
mice compared to uninfected wild type (wt) mice (Fig. 6.1E). To further investigate the 
immune status, a comprehensive panel of 58 serum biomarkers was measured. Mac-
rophage inflammatory protein-2 (MIP-2) (P=0.0562), monocyte chemotactic protein-1 
(MCP-1) (P=0.0117), and macrophage colony stimulating factor (M-CSF)-1 (P=0.0465), 
all of which are associated with the chemotaxis and development of neutrophils and 
monocytes, were upregulated in RegIIIγ-/- compared to wt mice (supplementary table 
S6.3). Fifteen cytokines measured in the serum of RegIIIγ-/- and wt mice were either not 
significantly different or below detection limit. To determine whether RegIIIγ deficiency 
had an effect on immune responses in mucosal lymphoid tissue, cytokine production 
was measured in ex vivo stimulated immune cells from MLNs. There were no significant 
differences in the production of IL-10, tumour necrosis factor (TNF)α, interferon (IFN)-γ, 
IL-4 and IL-6 between RegIIIγ-/- and wt mice (supplementary Fig. S6.2). Therefore, it 
appears that RegIIIγ-/- mice exhibit an increased innate inflammatory activity in the mu-
cosa without evoking systemic inflammation.
RegIIIγ affects the ileal mucus distribution and spatial separation of microbiota 
The relatively higher amounts of IL-22 and MPO in the ileum of RegIIIγ-/- mice could have 
been caused by increased microbial translocation in absence of RegIIIγ. This prompted 
us to investigate the intestinal morphology and search for deviations from wt mucosal 
morphology and the location of microbiota. Crossmon-stained tissue of wt and RegIIIγ-/- 
mice showed indistinguishable villus-crypt architecture with similar crypt and villus 
lengths (data not shown). Interestingly, PAS/AB (Fig. 6.2A, C) and specific staining of 
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mucin with an anti-MUC2 antibody (Fig. 6.2B, D) showed a different mucus distribution 
in the ileum (Fig. 6.2), but not in the colon (data not shown). In all wt mice an intensely 
stained band of mucus was consistently observed, lying as a ‘blanket’ above the tips of 
the villi, surrounding the ileal content; however, this band was absent in each of the 
RegIIIγ-/- mice. QPCR on ileal tissue showed that this differential mucus distribution was 
not due to differences in expression of Muc2 (data not shown). Moreover, distribution 
of goblet cells appears to be the same in wt and RegIIIγ-/- mice. No other secretory and 
membrane-bound mucins were differentially expressed in the intestinal tissues. 
Figure 6.1. Ileal expression of RegIIIγ, RegIIIβ, eGFP, IL-22 and MPO in RegIIIγ-/- and wt mice. Relative 
mRNA expression determined by qPCR (A-D). ELISA of MPO protein in ileal extracts of control (unin-
fected) mice used in the infection study (E). * = P<0.05; ** = P<0.01.
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In the small intestine, immunofluorescence staining of the mucus and bacteria showed 
that small numbers of bacteria were observed in contact with the epithelium in RegIIIγ-/- 
mice, but not in wt mice (Fig. 6.3A, B); no differences were observed in the colon (Fig. 
6.3C, D). To investigate whether RegIIIγ was present only in the crypts or throughout the 
mucus we used immunofluorescent staining techniques to visualize RegIIIγ in Carnoy 
fixed sections of the ileum (Fig. 6.4). RegIIIγ was detected throughout the mucus in wt 
mice (Fig. 6.4A). 
The findings described above show that in ileum but not in colon, lack of RegIIIγ pro-
tein leads to increased contact of microbiota with host with concomitant absence of a 
specific, darkly stained mucus band near the villus tips. Lack of RegIIIγ did not appear 
to lead to changes in intestinal crypt depth and villus lengths. Since lack of RegIIIγ led 
to increased contact between ileal microbiota and epithelia, we were interested to see 
if lack of RegIIIγ would promote host invasion by an intracellular Gram-positive and 
Gram-negative pathogen.
Mucosal inflammation, but not pathogen translocation to the organs, is increased in 
infected RegIIIγ-/- mice 
During the course of the infection with S. enteritidis and L. monocytogenes body weight 
decreased, but not significantly compared to non-infected controls (supplementary 
table S6.4). The colony forming units (CFU) of L. monocytogenes in faeces were not 
significantly different for RegIIIγ-/- and wt mice. However, significantly higher CFU of 
S. enteritidis were present in the faeces of RegIIIγ-/- mice compared to wt (Fig. 6.5). 
No differences were found in translocation of S. enteritidis or L. monocytogenes to the 
spleen, liver or MLNs (Fig. 6.6A, B). This result was also obtained using a murinized 
L. monocytogenes strain (supplementary Fig. S6.3). As a systemic marker of bacterial 
translocation and inflammation we measured SAA2 levels in serum. In uninfected mice 
the levels of serum SAA2 were below the detection limit of the assay (<7.8 ng/ml) but 
levels increased substantially (>105 ng/ml) after infection with either pathogen. There 
were no significant differences between SAA2 in RegIIIγ-/- and wt infected mice (sup-
plementary table S6.5), supporting similar bacterial translocation levels in all infected 
groups of mice. MPO in ileal tissue was significantly elevated in all infected compared 
to uninfected mice (Fig. 6.7). Furthermore, in infected mice, MPO levels were increased 
more in RegIIIγ-/- than in wt mice.
gene expression profiles of infected mice 
A transcriptomics approach was used to gain more insight into the potential pathways 
or mechanisms that might be modulated in the ileum as a consequence of the absence 
of RegIIIγ during microbial infection. Infection resulted in the differential (p<0.02) ex-
pression of 999 genes by S. enteritidis and 744 genes by L. monocytogenes. Gene ontol-
ogy (GO) enrichment calculations by ErmineJ and gene set enrichment analysis (GSEA) 
showed that infection with either pathogen appeared to induce mucosal pathways in-
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volved in DNA metabolism and cell cycle, interferon signalling and antigen processing 
and presentation, whereas diverse metabolic pathways including pathways involved in 
xenobiotic and fatty acid metabolism, PPARα signalling and peroxisome function ap-
peared to have been suppressed. For detailed network and regulatory pathway analy-
sis, array data were analysed using Ingenuity Pathway Analysis (IPA).
S. enteritidis induces an interferon-driven immune response via IL-1β-Myd88-
STAT1/3-IRF axis
IPA analysis showed that during infection with S. enteritidis, antigen presentation and 
diverse metabolic and disease pathways were significantly modulated, in addition to 
pathways involved in immune cell maturation and differentiation. IPA was also used to 
perform an upstream regulator analysis in order to identify the cascade of upstream 
transcriptional regulators that could explain the observed gene expression changes 
in the S. enteritidis infection dataset. The regulators that were most strongly induced 
during infection were Ifn-γ, Signal Transducer and Activator of Transcription (Stat)1, 
IL-1β, Stat3, Suppressor of cytokine signalling (Socs)1, Myd88 and Interferon regulatory 
factor (Irf)1 suggesting that an interferon-driven immune response via an IL-1β-Myd88-
Stat1/3-Irf axis was a major determinant of the mouse response to infection. The major 
cellular responses were involved in activation of haematological system development, 
immune cell trafficking, cell-cell signalling and interactions, cell fate and an inflamma-
tory response, and a repression of processes involved in infectious disease progression 
including replication of intracellular pathogens.
L. monocytogenes induces an interferon-driven immune response via TLR3-Myd88-
STAT1/3-IRF axis
IPA analysis showed that during infection with L. monocytogenes, metabolic and anti-
gen presentation pathways and interferon signalling were significantly modulated, in 
addition to pathways involved in and driven by Janus kinase (JAK)-STAT signalling, the 
signalling pathway that strongly drives interferon response. Upstream regulator analy-
sis showed that the regulators that were most strongly induced during infection were 
Stat1, Irf1, Stat3, Toll like receptor (Tlr)3 and Myd88 suggesting that an interferon-driv-
en immune response via a Tlr3-Myd88-Stat1/3-Irf axis was a major determinant of the 
mouse response to infection. The major cellular responses were involved in (immune) 
cell fate, an inflammatory response to intracellular pathogens, and a repression of 
processes involved in small molecule biochemistry, lipid metabolism, and progression 
of infectious disease. RNA expression of a few infection-related genes was quantified 
by qPCR, transcription of Ifn-γ, Mip-2 and RegIIIβ were all increased in infected mice 
compared to uninfected mice (Fig. 6.8A-D). In L. monocytogenes infected mice tran-
scription of Ifn-γ was significantly higher in RegIIIγ-/- than in wt mice (Fig. 6.8D).  
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Figure 6.2. Mucus staining in Carnoy’s-fixed ileal sections of wt (A, B) and RegIIIγ-/- (C, D) mice. PAS/
alcian blue staining of ileum (A, C). Immunofluorescent detection of MUC2 (B, D) using an anti-MUC2 
antibody and goat-anti-rabbit Alexa 488. Arrow in A indicates the continues layer of mucus overlaying 
the villus tips. Representative images are shown in each panel. 
Figure 6.3 (next page). Fluorescent microscopy of mucus and microbiota in Carnoy’s-fixed sections of 
ileum and colon from RegIIIγ-/- and wt mice. Representative images of ileal tissue of wt (A) and RegIIIγ-/- 
mice (B); and of colon tissue of wt (C) and RegIIIγ-/- mice (D). MUC2 was detected by immunofluores-
cence using anti-MUC2 and goat-anti-rabbit Alexa Cy3 antibodies (red). Nuclei were visualised using 
DRAQ5 (blue). Bacteria were identified using FISH and the universal Euprobe 388 (green). Arrows in B 
indicate bacteria in contact with the epithelium. 
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Figure 6.3.
Figure 6.4. RegIIIγ staining in Carnoy’s-fixed sections of ileum from wt (A) and RegIIIγ-/- 
mice (B), showing distribution of RegIIIγ throughout the mucus layer in wt animals. A 
RegIIIγ-specific antibody was detected using a goat-anti-rabbit Alexa 488 secondary antibody.
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Figure 6.5. Pathogens excreted (CFU) in the faeces at different time points after infection. One S. 
enteritidis infected wt mouse was not included in this figure because it did not produce faeces. L. 
monocytogenes CFU are shown as squares and S. enteritidis CFU as circles. Open symbols represent 
CFU of RegIIIγ-/- mice and filled symbols CFU of wt mice. Error bars indicate SEM; * = P<0.05, comparing 
S. enteritidis infected RegIIIγ-/- versus wt mice.
Figure 6.6. Pathogens (CFU) in ileum and organs of mice infected with S. enteritidis (A) and L. mono-
cytogenes (B). White bars indicate log CFU/g of tissue from RegIIIγ-/- mice and black bars indicate log 
CFU/g of tissue from wt mice. Error bars indicate SEM.
In RegIIIγ-/- mice the infection response is altered compared to wt mice
To investigate if the transcriptome data revealed relevant differences between infected 
wt and RegIIIγ-/- mice, a protein-protein interaction network was generated in IPA for 
genes with GO terms involved in infectious and bacterial disease. These categories were 
most significantly enriched in the IPA analyses of mice infected with L. monocytogenes 
or S. enteritidis. This network was overlaid with gene expression data of infected wt 
and RegIIIγ-/- mice. The bacterial disease network included the nodes Myd88, Stat1/3, 
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Irf1/8 and Socs1/3 that were regulated both during infection by S. enteritidis and by L. 
monocytogenes. 
In S. enteritidis infected mice the relative expression of 15 of the 80 differentially ex-
pressed network genes (19%) including the genes Ifn-γ, IL-1β and Saa was lower in 
RegIIIγ-/- mice than in wt mice, whereas 2 (3%) of the network genes (i.e. interferon 
gamma induced GTPase and ubiquitin D) were expressed at relatively higher levels in 
RegIIIγ-/- compared to wt mice (supplementary Fig. S6.4). In mice infected with L. mono-
cytogenes, the same comparison showed that 2 of the 39 (5%) differentially expressed 
network genes (Saa and lipocalin 2) were expressed at relatively lower levels during 
infection of RegIIIγ-/- mice, whereas 12 genes (31%) including Ifn-γ, IL-1β, Icam1 and 
Chemokine (C-X-C motif) ligand (Cxcl)9/10, were expressed at relatively higher levels 
(supplementary Fig. S6.5). 
Figure 6.7. Amount of MPO in ileal protein extracts of wt (black bars) and RegIIIγ-/- mice (white bars) 
measured by ELISA. Significant difference between wt infected and uninfected mice, ** P=<0.01, *** 
P=<0.005; Significant difference between infected and uninfected RegIIIγ-/- mice, ## P=<0.01. MPO was 
also significantly different between uninfected RegIIIγ-/- and wt mice (a P=<0.05). Se is S. enteritidis, Lm 
is L. monocytogenes.
dIScuSSIon
To investigate the role and function of RegIIIγ in vivo we generated a RegIIIγ-/- mouse 
model that expresses an eGFP reporter under control of the RegIIIγ promoter. Further-
more, we investigated the hypothesis that absence of RegIIIγ would result in higher 
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susceptibility to infection with Gram-positive L. monocytogenes than to infection with 
Gram-negative S. enteritidis, due to its proposed bactericidal activity towards Gram-pos-
itive bacteria.
Figure 6.8. Relative mRNA expression of immune-related genes in uninfected and infected mice de-
termined by qPCR. RegIIIβ (a); RegIIIγ (b); MIP2 (c) and IFN-γ (d). Error bars indicate SEM. Significant 
difference between infected and uninfected RegIIIγ-/- or wt mice, * P=<0.05; ** significance P=<0.01 
*** P=<0.005. Se is S. enteritidis, Lm is L. monocytogenes. 
Initial phenotypic histological analysis revealed no morphological differences between 
RegIIIγ-/- and wt mice, corroborating another RegIIIγ-/- mouse study.14 However, we ob-
served a significant increase in the relative amounts of IL-22 transcript and MPO protein 
levels in tissue samples from the ileum of RegIIIγ-/- mice relative to wt mice, suggest-
ing elevated innate responses and chemotaxis of neutrophils. Moreover, significantly 
higher amounts of the chemokines MCP-1 and M-CSF-1, both of which are involved 
in monocyte and neutrophil recruitment, activation and differentiation, were found in 
serum. Interestingly, pro-inflammatory cytokines such as IL-1β, IL-12p70, TNF-α and 
IFN-γ, were not different between RegIIIγ-/- and wt mice, or were below detection limit. 
Therefore, it appears that RegIIIγ-/- mice exhibit an increased innate immune cell activity 
in the mucosa that successfully avoids systemic inflammation.
As MUC2, the major intestinal mucin, is highly glycosylated and RegIIIγ, a C-type lectin, 
is able to bind glycans, we hypothesised that loss of RegIIIγ might make the mucus more 
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accessible for bacteria and would allow increased contact between microbiota and epi-
thelia. Indeed, sections of ileal tissue from RegIIIγ-/- mice, but not wt mice, consistently 
showed the presence of small numbers of bacteria at the epithelium, in agreement 
with the study of Vaishnava et al.14 In the colon, increased co-localisation of bacteria 
and epithelial surfaces was not observed, presumably due to the thicker mucus layer15 
and the lower levels of RegIIIγ expression in the large intestine.4 We next investigated 
the distribution and location of the mucus in wt and RegIIIγ-/- mice. Strikingly, mucus vi-
sualization revealed an intensely stained band of mucus consistently located above the 
villi and surrounding the ileal content in wt mice; this band was absent in RegIIIγ-/- mice. 
This was not reported by Vaishnava et al.14 as the mucus was not visualized in that study. 
The changes in mucus were not due to lower expression of MUC2 mRNA in the ileum of 
RegIIIγ-/- mice, suggesting that RegIIIγ may directly affect the structure or the distribu-
tion of mucus in the ileum. As RegIIIγ was shown to be present throughout the mucus 
layer of wt mice, its absence may provide an explanation for the altered distribution of 
mucus in these RegIIIγ-/- mice. Alternatively, RegIIIγ itself may self-assemble into large 
multimeric complexes as previously described for PAP and other Reg family members13 
and stabilize the mucin structure by crosslinking the mucins in the mucus network. In wt 
mice there was a significant decrease in the faecal counts of Gram-negative S. enteritidis 
compared to RegIIIγ-/- mice, which may be due to increased entrapment of S. enteriti-
dis in the mucus by RegIIIγ and subsequent killing by antimicrobial proteins including 
RegIIIβ, which is highly increased in expression after S. enteritidis infection. It is also 
possible that changes in the microbiota of RegIIIγ-/- mice led to less antagonism towards 
luminal S. enteritidis.16
As binding of RegIIIγ to bacteria might be a mechanism to trap bacteria in the mucus we 
investigated whether recombinant RegIIIγ could bind both pathogens in vitro. Indeed 
RegIIIγ could bind to both pathogens and binding was enhanced by proteolytic cleav-
age of the N-terminal propeptide, but no bactericidal effects were measured (data not 
shown). The L. monocytogenes strain used in our study was previously reported to be 
killed by RegIIIγ and HIP/PAP,5 but inconsistencies in the bactericidal effect of RegIIIγ and 
HIP/PAP on Gram-positive bacteria have been described by others.12, 13 This discrepancy 
may be due to the use of different bacteria, possible interference of bacterial aggrega-
tion during viability assays or conformational differences in the refolded proteins lead-
ing to differential proteolytic susceptibility or activity. Lack of RegIIIγ and concomitant 
decreased bacterial entrapment could thereby explain the increased mucosal inflam-
matory responses observed following infection of RegIIIγ-/- mice with either pathogen.
Infection of RegIIIγ-/- mice with either of the pathogens did not result in increased trans-
location to the spleen, liver or MLNs compared to wt infected mice. This result was fully 
reproduced using a ‘murinized’ L. monocytogenes, engineered to increase infectivity in 
murine models.17 Although there was no increased translocation of pathogens in the 
organs of RegIIIγ-/- mice, we did measure increased amounts of MPO in ileal tissue of 
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infected RegIIIγ-/- mice compared to wt infected mice. MPO is produced mostly by neu-
trophil granulocytes, which are attracted to sites of infection suggesting that increased 
numbers of both pathogens translocated into the mucosa of RegIIIγ-/- mice compared 
to wt mice. Taken together these results suggest that the heightened mucosal inflam-
matory response observed in infected RegIIIγ-/- mice was sufficient to inhibit spread of 
the pathogens to the bloodstream and organs. ln agreement with this, loss of RegIIIγ 
did not affect systemic inflammatory responses as no significant differences between 
wt and RegIIIγ-/- in serum SAA2 levels were measured. In line with this notion, it was 
observed that several genes in the infection response network were differentially ex-
pressed in RegIIIγ-/- compared to wt mice. For example, in L. monocytogenes infected 
mice, Ifn-γ, Il-1β, Icam1, Cxcl9 were expressed at relatively higher levels in RegIIIγ-/- mice 
than in wt mice. 
Overall these results suggest that the mucosal inflammatory response, involving mono-
cyte and neutrophil recruitment and activity to pathogen infection was increased in 
RegIIIγ-/- mice. Reduced trapping of the bacteria in the mucus or increased movement 
of bacteria through the mucus might explain the increased mucosal inflammatory re-
sponses to both pathogens in RegIIIγ-/- mice. Our results showing presence of RegIIIγ 
throughout the mucus, altered mucus distribution in the ileum of RegIIIγ-/- mice and 
RegIIIγ binding to both pathogens support this hypothesis.
By generating a new transgenic RegIIIγ-/- mouse model we were able to demonstrate 
that RegIIIγ deficiency leads to altered mucus distribution, increased bacterial-epithelial 
contact and significant increases in the expression of several innate immunity genes in 
the ileum. During infection, RegIIIγ deficiency had no effect on translocation of patho-
genic L. monocytogenes or S. enteritidis to the organs, but resulted in a heightened 
innate response in the mucosa. The increased amount of MPO measured in the mucosa 
of RegIIIγ-/- mice suggests the presence of higher numbers of polymorphonuclear gran-
ulocytes which are important in immunity to both L. monocytogenes and S. enteritidis. 
Additionally, our results suggest that RegIIIγ may have protective effects that go beyond 
direct bactericidal activity, including effects on mucus properties and trapping of bacte-
ria in the mucus network.
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MeThodS
Animals
RegIIIγ-/- mice were generated using a Cre-Lox procedure and the genotype was verified 
by PCR (see supplementary materials and methods and table S6.1 for primer sequenc-
es). Specified pathogen free RegIIIγ-/- and wt mice on a C57Bl/6 background were reared 
on a semi-synthetic standard AIN-93G diet18 (Research Diet Services, Wijk bij Duurstede, 
the Netherlands) and provided with sterilized drinking water ad libitum, unless stated 
otherwise. The animal welfare committee of Wageningen University (Wageningen, the 
Netherlands) approved the experimental protocol.
collection of biological samples for phenotyping
Mice (7-9 weeks old) were anaesthetized by isoflurane, blood was collected after or-
bital removal using BD Microtainer tubes (SSTTM tubes, Becton Dickinson (BD), Franklin 
Lakes, NJ, USA) and mice were killed by cervical dislocation. Serum was analysed by 
Myriad-RBM (Rules Based medicine; Austin, Tx, USA) using the RodentMAP v2.0 plat-
form. Different parts (approximately 1 cm) of the ileum and colon were either fixed in 
Carnoy’s fixative or in 4% (w/v) paraformaldehyde (PFA) and embedded in paraffin. PFA 
fixed tissue sections were stained according to Crossmon, Carnoy’s fixed tissue sections 
were stained with PAS/Alcian Blue (PAS/AB), anti-Muc2 antibody15 or fluorescence in 
situ hybridisation (FISH) to detect bacteria using the universal bacterial probe EUB33819 
(for histological protocols see supplement). Unfixed tissue was snap frozen and stored 
at -80˚C prior to RNA isolation. Mesenteric lymph nodes (MLNs) were collected, the 
cells cultured and stimulated ex vivo for cytokine analysis (supplementary methods). 
Infection studies
Mice (7-9 weeks old) used in the infection study were housed individually from one 
week before the start of the infection and fed a modified diet, to mimic a Western-style 
human diet, by including 200 g/kg fat and reducing the calcium to 30 mmol/kg. The 
amount of calcium in a standard rodent diet is typically very high (124.75 mmol/kg 
feed18) but we lowered this because it has been shown to be protective against infection 
in the intestine of rats20-23, and humans.24, 25 This ‘humanized’ diet was fed to the mice 
from 7 weeks of age. Moreover this diet has been also used in a previous infection study 
using RegIIIγ-/- mice.26, 27
After adaptation, mice were orally infected by gavage with 0.2 ml saline containing 
108 colony forming units (CFU) of Salmonella Enterica serovar enteritidis (S. enteritidis, 
n=12 for RegIIIγ-/- and wt) or Listeria monocytogenes (L. monocytogenes, EGD-e, n=8 
for RegIIIγ-/- and wt). The bacterial strains were passaged in mice and enumerated on 
selective medium as previously described.27 Two groups of mice were sham treated 
(0.2 ml saline, RegIIIγ-/- and wt; both n=6). An additional infection study was performed 
with non-passaged murinized L. monocytogenes17 (see supplement). Body weight was 
measured every two days before infection and daily after infection. Fresh faeces were 
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collected every day after infection.
collection of biological samples and bacterial quantification of infected mice
Mice were sacrificed 2 (L. monocytogenes) or 4 days (S. enteritidis) after infection, the 
time points at which the number of translocated bacteria were highest in the organs.27 
Non-infected control mice were sacrificed 3 days after oral sham treatment. Blood was 
collected as above and after cervical dislocation the distal one third of the small intes-
tine was excised for determining CFU of pathogens (shown as log
10
 CFU per gram wet 
weight of tissue). Approximately 1 cm from the middle of the ileum was cut open longi-
tudinally, briefly flushed in saline, homogenized in sterile saline and plated. Other parts 
of the ileum were treated in the same way and frozen immediately in liquid nitrogen for 
protein and/or RNA isolation (see supplementary for protocols and table S6.2 for prim-
er sequences for qPCR). Furthermore, MLNs, spleen and liver were removed and after 
homogenization in sterile saline, directly used for pathogen quantification.
Myeloperoxidase quantification in ileal mucosa and serum amyloid A2 detection in 
serum
To determine the ileal inflammation status, myeloperoxidase (MPO) was measured in 
ileal protein extracts using the manufacturer’s MPO ELISA protocol (Hycult Biotechnol-
ogy, Uden, the Netherlands). Serum Amyloid A (SAA) 2, was measured to investigate 
systemic inflammation according to the manufacturer’s protocol (Life Diagnostics Inc., 
West Chester, PA, USA).
Microarray and statistical analysis 
Total RNA was extracted from the ileum as described above, pooled (3 animals per 
group, randomly selected) and hybridised to the Mouse Gene 1.1 ST array (Affymetrix, 
Santa Clara, CA, USA). The labelling and hybridization methods, quality control proce-
dures on RNA and datasets generated are described in supplementary methods.
Biological interpretation of expression datasets
Biological interaction networks among regulated genes activated in response to infec-
tion were identified using Ingenuity Pathways Analysis (IPA) (Ingenuity Systems, Red-
wood City, CA, USA) using all differentially regulated genes (p value <0.01 and intensity 
≥20) as input. The output was used to prioritise differentially regulated pathways of 
interest for bacterial infections, to identify cascades of upstream transcriptional regula-
tors that could explain the observed gene expression changes, and to reconstruct pro-
tein-protein networks that could be used to overlay gene expression data. For details, 
see supplementary methods.
Statistics
All statistical tests were performed using GraphPad Prism 5.0 software (GraphPad, San 
Diego, CA, USA). Data shown are the means and the standard errors of the means (SEM). 
Data were tested for normality with the D’Agostino and Pearson normality test. Statis-
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tical analysis of normally distributed data was performed with the two-tailed Student’s 
t-test. Data that did not show normal distribution were analysed with the non-paramet-
ric Mann-Whitney test. The excretion of pathogens in faeces was measured at multiple 
time points, and thus analysed by a repeated-measures two-way analysis of variance 
(ANOVA) (mixed model). Differences were considered statistically significant when 
P<0.05.  
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SuPPLeMenTARy MeThodS
generation of RegIIIγ transgenic mice
LoxP-flanked RegIIIγ mice were generated in collaboration with Ozgene (Bentley DC, 
Australia) as shown in supplementary figure S6.1. Initially a 246 bp fragment containing 
a poly-adenylation site (pA) was amplified from an Ozgene vector and cloned between 
the EcoR1 sites in pBAD (Invitrogen, Life technologies Ltd, Paisley, UK). A DNA fragment 
containing PGK-neo cassette containing a 3’ loxP site was excised from FL Sniper vector 
(Ozgene) using PacI digestion and ligated into the PacI site downstream of pA in pBAD 
to generate pBAD-Neo. A 726 bp DNA fragment flanked by NheI restriction sites and a 
5’ loxP site containing the promoter and exons of RegIIIγ was then generated by spliced 
overlap extension PCR using C57BL/6 genomic DNA and cloned RegIIIγ cDNA as tem-
plates. The complete RegIIIγ promoter/cDNA fragment was then cloned into NheI di-
gested pBAD to generate pBAD-R3. A DNA fragment containing pA and the downstream 
PGK-Neo selection cassette was then removed from pBAD-neo by digestion with EcoRI 
and ligated into the EcoRI site downstream of the RegIIIγ cDNA to generate pBAD-R3/
Neo. A DNA fragment containing the enhanced green-fluorescent protein (eGFP) coding 
sequence and an unique pA site was cloned into pBAD using a similar strategy to that 
described for the RegIIIγ cDNA. The whole RegIIIγ cDNA PGK-neo cassette was then re-
moved from pBAD-R3/Neo by digestion with NheI and ligated upstream of eFGP to gen-
erate pBAD-R3/Neo/eGFP. The final targeting vector contained DNA fragments (approx 
6 Kb) with homology to the chromosomal integration site (homology arms) flanking the 
floxed selection cassette in pBAD-R3/Neo/eGFP. The targeting vector was constructed 
using PCR amplified genomic DNA and a similar cloning strategy to that described for 
the construction of pBAD-R3/Neo/eGFP. All DNA fragments cloned into the final target-
ing vector including the homology arms were verified by DNA sequencing at each stage. 
The targeting vector was linearized by digestion with PvuI and electroporated into 
C57Bl/6 ES cells and grown under selection with G148. Resistant clones were picked 
into 96 well plates for freezing and genomic characterization. Recombinant ES clones 
were identified by Southern Blotting by digestion with BamHI and hybridization to the 
following genomic sequence probes (from C57BL/6 genomic DNA) (i) 5’ homology arm 
nt 15952 to 16401 (supplementary table S1, P1062, (ii) 3’ homology arm nt 30827 to 
31822 (iii) enP nt 22001-22888 (for primers see supplementary table S6.1). 
Correctly targeted ES clones were injected into C57Bl/6 blastocysts, which were 
transferred into pseudo-pregnant foster mothers, resulting in chimera identified by 
coat colour. These mice were crossed to C57Bl/6 mice to obtain heterozygous floxed 
RegIIIγ+/-mice. Heterozygous floxed RegIIIγ+/- mice were crossed to generate floxed 
RegIIIγ-/- homozygotes on a C57Bl/6 background. In the presence of Cre-recombinase 
the sequence between the loxP sites in the targeting vector including the RegIIIγ cDNA 
and neo cassette are removed (supplementary figure S6.1) bringing EGFP under control 
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of the RegIIIγ promoter.  
The genotype of floxed RegIIIγ-/- mice was confirmed by PCR using one primer set spe-
cific for a sequence in the targeting vector (508 bp). The second set of primers was spe-
cific for a fragment spanning the chromosomal homology arm (768 bp) (supplementary 
figure S6.1). 
cre-induced RegIIIγ-/- mice
To generate RegIIIγ-/- mice, floxed RegIIIγ-/- homozygotes were crossed with B6.C-Tg(C-
MV-cre)1Cgn/J mice (The Jackson laboratory, Bar Harbor, ME, USA) expressing Cre re-
combinase in the germ line. To verify the genotype of these mice PCR based genotyping 
was performed on the offspring using Cre-specific primers (The Jackson Laboratory) and 
primers specific for the RegIIIγ targeting vector as described above.
Mesenteric lymph node cell culture and cytokine analysis
Mouse mesenteric lymph nodes (MLNs) were gently disrupted in PBS containing 0.5% 
(w/v) bovine serum albumin (BSA) and 2 mM EDTA to obtain single cell suspensions for 
ex vivo cytokine analysis. 5x106 viable cells/ml were cultured in RPMI-1640 medium 
(Gibco, Life technologies Ltd, Paisley, UK) with GlutamaxTM, 25 mM HEPES, 10% heat 
inactivated FCS (PAA, Pasching, Austria) and 1% penicillin/streptomycin (Sigma-Aldrich, 
St. Louis, MO, USA). The MLN cells were stimulated with the Concanavalin A (ConA) (5 
µg/ml, Sigma-Aldrich) for 24 h at 37˚C and 5% CO
2
. Culture supernatants were stored at 
-80˚C until cytokines were measured by multiplex analysis (Mouse Th1/Th2/Th17 CBA 
kit, Becton Dickinson, BD, Franklin Lakes, NJ, USA) according to the manufacturer’s pro-
tocol on a FACS Canto II (BD) and analysed using BD FCAP software (BD).
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Cloning prim-
ers
pA-F CGAATTCTGTGCCTTCTAGTTGCCAGCC 
    EcoRI
pA-R CGAATTCTTAATTAACCATAGAGCCCACCGCATCC 
    EcoRI      PacI
R3P-F TGCTTATTCACTTTGATGCCCC
R3P-R  GTGATGGTTATACGGGGAAGCATCTTGTCTGTAAGGAAGGAAAAACCAG
R3CDS-F CTGGTTTTTCCTTCCTTACAGACAAGATGCTTCCCCGTATAACCATCAC
R3CDS-R GGCCTTGAATTTGCAGACATAGG
R3cDNA-F CGCTAGCATAACTTCGTATAGCATACATTATACGAAGTTATTGTATTCTTCT-    
NheI                                  loxP                          CATTCCAGAATCAAAGAA
R3cDNA-R  CGCTAGCGAATTCGGCCTTGAATTTGCAGACATAGG  
      NheI     EcoRI
EGFPP-F TGCTTATTCACTTTGATGCCCC
EGFPP-R CCTCGCCCTTGCTCACCATCTTGTCTGTAAGGAAGGAAAAACCAG
EGFPCDS-F CTGGTTTTTCCTTCTTTACAGACAAGATGGTGAGCAAGGGCGAGG
EGFPCDS-R GCAGTGAAAAAAATGCTTTATTGGTGA
EGFPCD-
NA-F
CATCGATGCTAGCTGTATTCTTCTCATTCCAGAATCAAAGAA 
      ClaI        NheI
EGFPCD-
NA-R
CATCGATGGATCCGCAGTGAAAAAAATGCTTTATTTGTGA 
      ClaI       BamHI 
H3-F CAGGCGCGCCATCGATACAAAACCATCATCCTGCCACC 
            AscI          ClaI 
H3-R  CAGGCGCGCCTCCCCTGAATTACAATGCCAGG  
          AscI
H5-F CTACGTACCACACCTGGCTTTTTGTAGCTTG 
    SnaBI
H3-R CTACGTAGGCGCGCCGCATGCTTTTGTTCCCTTCCCCTGGAAAC 
     SnaBI         AscI           SphI    
Southern blot 5’ F TCAAAAAGTTGACCATGAGGGC
5’R CCTGGGAAATGGATTTGTTGTTCC
3’F GCTCTTCTTCAGCAACTCCTCAAC
3’R ATGACAGGGTAGCAAAATCTCCAG
enP F AACGTGAACTCCTTTCTGCCTG
enP R ATGCTCATGCAAGTCAGGGAGG
Genotype KO F TTGCCAGCCATCTGTTGT
KO R GACGTGCTACTTCCATTTGTC
WT F GGGAGAATACCTATCCTCACA
WT R TCCAGAACAGATAGCGTC
Table S6.1. Primer sequences for generating RegIIIγ-/- mice. Restriction sites used for cloning are indi-
cated in bolt. Italic letters indicate homology with the backbone. The grey part indicates the loxP site. 
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histology 
Intestinal tissues were fixed in either Carnoy’s fixative or in 4% (w/v) para-formaldehyde 
(PFA) and embedded in paraffin through a graded series of ethanol (50-100%) and xy-
lene. 
crossmon staining according to Masson
Paraffin sections of ileum and colon (fixed in PFA) were cut at 4 µm and attached to 
slides coated with polylysine (Thermo scientific, Gerhard Menzel GmbH Braunschweig, 
Germany). After overnight incubation at 37˚C, slides were deparaffinised using a series 
going from xylene to distilled water with decreasing ethanol steps. The sections were 
submerged in Mayer’s haemalum (BDH GurrCertistain, BDH laboratory supplies, Poole, 
UK) for 5 min followed by 10 min rinsing in running tap water. Sections were submerged 
for 3 s in acid fuchsin (Rubin S) (Merck KGaA, Darmstadt, Germany) with Orange G 
(Merck KGaA), containing 5 ml acetic acid (glacial) 100% anhydrous (Merck KGaA), 0.33 
g Thymolcryst extra pure (Merck KGaA) and 500 ml of distilled water, followed by a 
washing step for 2 min in distilled water. After this washing step sections were incubat-
ed for 4 min in tungstophosphoric acid (Merck KGaA) and washed for 2 min in distilled 
water. Sections were submerged in a 1% light green SF solution (BDH GurrCertistain) 
and incubated for 10 min, washed 2 times for 1 min in distilled water and placed in 
100% ethanol 3 times for 2 min. After this step the sections were submerged 2 times for 
5 min in xylene and were finally mounted in DPX mounting reagent (BDH GurrCertistain) 
and air dried overnight at 37˚C. Measurements of the villi and crypt length were calcu-
lated from digital images using FIJI (ImageJ) and size calibration bars. Twelve to 15 villi 
or crypts were measured per animal.
Pas/Alcian Blue staining
Paraffin sections of ileum and colon (fixed in Carnoy’s to preserve the mucus layer1) 
were cut at 4 µm and attached to slides coated with polylysine (Thermo scientific, Ger-
many). After overnight incubation at 37 ˚C, slides were deparaffinised using a series go-
ing from xylene to distilled water with decreasing ethanol steps. Sections were stained 
in alcian blue (8GX Acros Organics, New Jersey, USA) for 35 min followed by a rinse in 
running tap water for 2 min and a rinse in distilled water. The sections were submerged 
in periodic acid 0.5% for 10 min and rinsed for 1 min in distilled water. After this washing 
step the sections were incubated in Shiffs reagents (PAS) (Merck, Germany) for 45 min 
and washed in freshly made SO
2
 water (10 ml of 10% K
2
S
2
O
5
 (Merck, Germany), 10 ml 
of  HCl (1 mol/L) and 180 ml of distilled water) for 3 times 2 min, followed by a washing 
step in tap water for 5 min. After this step the sections were submerged 2 times for 3 
min in 100% ethanol followed by a 3 time submersion in Xylene for 5 min and were 
finally mounted in DPX mounting reagent (BDH Gurr Certistain, England) and air-dried 
overnight at 37 ˚C.  
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MuC2 staining
Paraffin sections of both ileum and colon (fixed in Carnoy’s) were cut at 4 µm and 
attached to slides coated with polylysine (Thermo scientific). After overnight incubation 
at 37˚C, slides were deparaffinised as above. An antigen retrieval step was performed 
by heating the sections for 20 min in 0.01 M sodium citrate (pH 6.0) at 95˚C. Sections 
were washed for 3 h in 3 replacements of PBS. A blocking step to reduce non-specific 
binding was included using 5% goat serum (Invitrogen, Life technologies Ltd, Paisley, 
UK) in PBS with 0.1% Triton X-100 for 30 min at room temperature. MUC2 expression 
was detected by incubating the sections with custom designed anti-MUC2 antibody1 
1:500 in PBS containing 1% goat serum and incubated overnight at 4˚C. After primary 
incubation sections were washed 3 times in PBS for 10 min, followed by a secondary 
incubation using goat-anti-rabbit Alexa488 conjugated antibodies (1:1000) (Molecular 
Probes, Life technologies Ltd, Paisley, UK) for 1 hour at room temperature. Sections 
were washed 2 times in PBS for 10 min in the dark and incubated with DRAQ5 (Invi-
trogen) (1:1000) for 1 h at 4˚C to counterstain nuclei. Finally, sections were washed 2 
times in PBS for 10 min, mounted in fluoromount G (SouthernBiotec, Alabama, USA) 
and stored at 4˚C. 
Fluorescence in situ hybridisation (FISh) to detect bacteria 
Paraffin sections of proximal colon and ileum including faecal pellets fixed in Carnoy’s 
were cut at 4 µm and attached to slides coated with polylysine (Thermo scientific). Af-
ter overnight incubation at 37˚C the slides were deparaffinised using series going from 
xylene to 100% ethanol. The tissue sections were incubated with the universal bac-
terial probe EUB338 (5’-GCTGCCTCCCGTAGGAGT-3’) (Isogen Bioscience BV, De Meern, 
the Netherlands) conjugated to Alexa Fluor488. A non-sense probe (5’ CGACGGAGGG-
CATCCTCA-3’) conjugated to Cy3, was used as a negative control.2 Tissue sections were 
incubated with 0.5 µg of probe in 50 µl of hybridization solution (20 mM Tris-HCl (pH 
7.4), 0.9 M NaCl, 0.1% SDS) at 50˚C overnight in a humid environment using a coverslip 
to prevent drying of the sample. The sections were washed in wash buffer (20 mM Tris-
HCl (pH 7.4), 0.9 M NaCl) at 50˚C for 20 min and co-staining was performed using the 
above mentioned protocol for immunostaining of MUC2 with the elimination of the 
antibody retrieval step and the 3 h washing step. Sections were finally mounted using 
fluoromount G (SouthernBiotec) and stored at 4˚C.
RegIIIγ staining
RegIIIγ immune staining was performed similar to the MUC2 staining (see above) in-
cluding the antigen retrieval (1 h) and blocking step. RegIIIγ expression was detected 
by incubating the sections with custom designed anti- RegIIIγ antibody3 1:2000 in PBS 
containing 1% goat serum and incubated overnight at 4˚C. After incubation with the pri-
mary antibody sections were washed 3 times in PBS for 10 min, followed by a secondary 
incubation using goat-anti-rabbit Alexa488 conjugated antibodies (1:1000) (Molecular 
Probes) for 1 h at room temperature. Finally the sections were incubated with DRAQ5 
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and mounted as described above. 
RnA isolation, cdnA synthesis and qPcR
Total RNA was isolated using the RNeasy kit (Qiagen, Venlo, the Netherlands) with a 
DNase digestion step according to the manufacturer’s protocol. One µg of RNA was 
reverse transcribed using a qScript cDNA synthesis kit (Quanta Biosciences, Gaithers-
burg, MD, USA) according to the manufacturer’s protocol. QPCR was performed on a 
Rotorgene 2000 real-time cycler (Qiagen) (see supplementary materials and methods 
and table S2 for primer sequences). 
For qPCR 5 µl cDNA (1:20 diluted from cDNA synthesis mixture) was used, together with 
300 nM forward and reverse primer (for qPCR primer sequences, see supplementary 
table S2), 6.25 µl 2x Rotor-Gene SYBR Green PCR kit (Qiagen, Venlo, the Netherlands), 
and demineralized water up to a total volume of 12.5 µl. QPCR was performed (2 min 
95˚C, then 40 cycles of 15 s at 95˚C, 1 min at 60˚C, and a final step of 2 min at 60˚C) on 
a Rotorgene 2000 real-time cycler (Qiagen). 
Forward primer Reverse primer
GAPDH GGTGAAGGTCGGTGTGAACT CTCGCTCCTGGAAGATGGTG
HPRT GTTAAGCAGTACAGCCCCAAA AGGGCATATCCAACAACAAACTT
RegIIIγ TTCCTGTCCTCCATGATCAAAA CATCCACCTCTGTTGGGTTCA
RegIIIβ ATGCTGCTCTCCTGCCTGATG CTAATGCGTGCGGAGGGTATATTC
eGFP CAGAAGAACGGCATCAAGGT CGGTCACGAACTCCAGCA
IL-22 AGACAGGTTCCAGCCCTACA CAGGTCCAGTTCCCCAATC
MUC2 ACCTGGGGTGACTTCCACT CCTTGGTGTAGGCATCGTTC
IFN-γ TCTTGGCTTTGCAGCTCTTC TGTTGCTGATGGCCTGATTG
MIP-2 CACCAACCACCAGGCTACA GCTTCAGGGTCAAGGCAAAC
Table S6.2. QPCR primer sequences
The raw data was analysed using the Rotorgene Analysis Software V5.0. Changes in 
transcript levels were calculated relative to the housekeeping genes according to the 
following equation: 
Ratio = (Ereference)^ Ctreference /(Etarget)^ Cttarget  
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and hypoxanthine phosphoribo-
syltransferase (HPRT) were incorporated in all qPCR experiments as internal reference 
genes; results were similar following normalization to either gene. Both GAPDH and 
HPRT were not affected by the treatment compared to the sham mice. Non-RT and 
non-template controls were included in all experiments; no amplification above back-
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ground levels was observed for these controls. Specificity of the amplification was en-
sured by checking the melting temperature and profile of each melting curve. The PCR 
product of each template was checked by sequencing. 
Microarray
Quality control of the hybridisations to the Mouse Gene 1.1 ST array and primary data 
analysis were performed according to strict criteria to ensure that the array data were 
of the highest possible quality. RNA quantity and quality was assessed on the total RNA 
obtained from ileum spectrophotometrically (ND-1000, NanoDrop Technologies, Wilm-
ington, DE, USA) and with 6000 Nano chips (Bioanalyzer 2100; Agilent, Santa Clara, CA, 
USA), respectively. RNA was judged as being suitable for array hybridisation only if sam-
ples showed intact bands corresponding to the 18S and 28S ribosomal RNA subunits, 
displayed no chromosomal peaks or RNA degradation products, and had a RIN (RNA 
integrity number) above 8.0. 
The Ambion WT Expression kit (Life Technologies) in conjunction with the Affymet-
rix GeneChip WT Terminal Labelling kit (Affymetrix, Santa Clara, CA) was used for the 
preparation of labelled cDNA from 100ng of total RNA without rRNA reduction. Labelled 
samples were hybridised on Affymetrix GeneChip Mouse Gene 1.1 ST arrays, provided 
in plate format. Hybridisation, washing and scanning of the array plates was performed 
on an Affymetrix GeneTitan Instrument, according to the manufacturer’s recommen-
dations. Detailed protocols can be found in the Affymetrix WT Terminal Labelling and 
Hybridisation User Manual, and are also available upon request.
Quality control (QC) of the datasets obtained from the scanned Affymetrix arrays was 
performed using Bioconductor4 packages integrated in an on-line pipeline.5 Various 
advanced quality metrics, diagnostic plots, pseudo-images and classification methods 
were applied to ascertain that only arrays that passed the most rigorous quality controls 
were used in the subsequent analyses.6 An extensive description of the applied criteria 
is available upon request. The more than 825.000 probes on the Mouse Gene 1.1 ST 
array were redefined according to Dai7 utilising current genome information. In this 
study, probes were reorganised based on the Entrez Gene database, build 37, version 
1 (remapped CDF v13). Normalised expression estimates were obtained from the raw 
intensity values using the Robust Multiarray Analysis (RMA) pre-processing algorithm 
available in the Bioconductor library affyPLM using default settings.8
Differentially expressed probe sets were identified using linear models, applying mod-
erated t-statistics that implemented empirical Bayes regularization of standard errors9 
using Bioconductor’s limma package. The moderated t-test statistic has the same inter-
pretation as an ordinary t-test statistic, except that the standard errors have been mod-
erated across genes, i.e. shrunk to a common value, using a Bayesian model. To adjust 
for both the degree of independence of variances relative to the degree of identity and 
the relationship between variance and signal intensity, the moderated t-statistic was ex-
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tended by a Bayesian hierarchical model to define an intensity-based moderated T-sta-
tistic (IBMT).4 IBMT improves the efficiency of the empirical Bayes moderated t-statis-
tics and thereby achieves greater power while correctly estimating the true proportion 
of false positives. Probe sets with raw expression intensity >20 and p values <0.01 were 
considered to be significantly regulated. The p<0.02 cut-off was chosen as this resulted 
in a set of genes with Gene Ontology (GO) annotations matching the global outcome of 
ErmineJ and gene set enrichment analysis (GSEA) in Ingenuity Pathways Analysis (IPA) 
(Ingenuity Systems, Redwood City, CA, USA) (see below).
Biological interpretation of expression datasets
Biological interaction networks among regulated genes activated in response to con-
ventionalisation were identified using IPA. The IPA output includes modulated signal-
ing pathways with statistical assessment of the significance of their modulation being 
based on a Fisher’s Exact Test. IPA analyses included comparison of differentially regu-
lated genes in the ileum following bacterial infection of wt or RegIIIγ-/- mice, in each case 
relative to expression observed in the sham-inoculated mice. The input was all differ-
entially regulated genes (p value <0.01 and intensity ≥20). The output was used among 
others to prioritise differentially regulated pathways of interest for bacterial infections, 
and to reconstruct protein-protein networks that could be used to overlay gene expres-
sion data, either fold-change based on the limma statistics5 or as ratio data of expres-
sion in RegIIIγ-/- versus wt mice. For IPA analysis, gene expression ratios x between 0 
and 1 were transformed to negative fold-changes using the formula fc =-1/(ratio x). We 
also performed an IPA upstream regulator analysis to identify the cascade of upstream 
transcriptional regulators that can explain the observed gene expression changes in a 
user’s dataset, which can provide insights into the biological activities occurring in the 
tissues or cells being studied.
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SuPPLeMenTARy FIguReS
Figure S6.1. A) Schematic representation of the targeting vector used to generate RegIIIγ-/- mice.
Upper scheme: The six exons of mouse RegIIIγ and homology arms cloned into the targeting vector to 
promote recombination in the genome; exon 1 is not translated. 
Middle scheme: The targeting vector showing loxP sites for Cre-mediated recombination, the cDNA for 
RegIIIγ, the selection cassette (PGK Neo), enhanced green fluorescent protein cDNA (eGFP), poly-ade-
nylation (pA), splice acceptor (SA), splice donor (SD) and instability signal (IS) and homology arms that 
recombine with homologous genomic DNA to replace exon 2 with the vector sequences (between 
dotted lines). 
Lower scheme: Schematic representation of the RegIIIγ locus after Cre-mediated excision of the DNA 
between the loxP sites showing absence of exon2. 
B) Genotyping of transgenic mice. Genotyping of the mice was done by PCR, generating a band of 508 
bp in case of a RegIIIγ-/-, 768 bp for a wild type and both bands in case of a heterozygote. NTC means 
non-template control, where demineralised H
2
O was used instead of DNA. 
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Figure S6.2. Cytokines produced by ConA stimulation of MLN cells isolated from RegIIIγ-/- and wt mice. 
Cells isolated from MLNs were stimulated with ConA and after 24 hour incubation the supernatant 
was removed after which levels of secreted IL-4 (A), IL-6 (B), IL-10 (C), IFN-γ (D) and TNF-α (E) were 
measured. Error bars indicate SEM. 
Figure S6.3. Pathogen colony forming units (CFU) in ileum and organs of mice infected with ‘murinized’ 
L. monocytogenes.6 White bars indicate log CFU/g from RegIIIγ-/- (n=6) mice and black bars indicate log 
CFU/g from wt mice (n=8). Error bars indicate SEM. This murinized strain possesses a mutated form 
of Internalin A, which can bind to mouse E-cadherin at the tips of the villus where cell extrusion takes 
place7 or at the goblet cells where E-cadherin is exposed during mucus secretion,8 thereby increasing 
infectivity in murine models.
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Figure S6.4. Network representation of interacting proteins encoded by differentially expressed genes 
(P <0.02) that are involved in responses to infectious disease and bacterial infection. The colour over-
lay represents genes that were expressed at higher (intenser shades of red) or lower (intenser shades 
of green) ratios for the comparison “S. enteritidis infection of RegIIIγ-/- mice vs S. enteritidis infection of 
wt mice”. Coloured figures can be found in the pdf version of this thesis. 
Figure S6.5. Network representation of interacting proteins encoded by differentially expressed genes 
(P <0.02) that are involved in responses to infectious disease and bacterial infection. The colour over-
lay represents genes that were expressed at higher (intenser shades of red) or lower (intenser shades 
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of green) ratios for the comparison “L. monocytogenes infection of RegIIIγ-/- mice vs L. monocytogenes 
infection of wt mice”. Coloured figures can be found in the pdf version of this thesis. 
Biomarker description             Mean Ko            Mean WT       p value
Eotaxin Enhanced in allergic in-
flammation
349.80 pg/ml 511.00 pg/ml 0.0079
c-reactive 
protein (cRP 
Mouse)
Acute phase reactant, 
used as biomarker for 
inflammatory diseases, 
infections, and neoplastic 
diseases
3.68 µg/ml
 
5.00 µg/ml
 
0.0114
Monocyte 
chemotactic 
Protein 1 
(McP-1)
Involved in recruitment of 
monocytes to site of inju-
ry and infection
58.60 pg/ml
 
33.20 pg/ml
 
0.0117
Serum Amy-
loid P-compo-
nent
Precursor of amyloid com-
ponent P. Acute phase 
reactant
19.60 µg/ml
 
26.20 µg/ml
 
0.0273
Macrophage 
colony stimu-
lating factor-1
Cytokines that act in he-
matopoiesis by controlling 
the production, differ-
entiation, and function 
of granulocytes and the 
monocytes-macrophages
6.28 ng/ml
 
5.46 ng/ml
 
0.0465
Macrophage 
Inflammato-
ry Protein-2 
(MIP-2)
Potent neutrophil attrac-
tant and activator
12.12 pg/ml
 
8.88 pg/ml
 
0.0562
Table S6.3. Measurement of serum biomarkers reveals few changes between RegIIIγ-/- and wt mice. 58 
serum biomarkers were measured by RBM (see methods). The only five significantly changed markers 
are indicated and MIP-2 which was approaching significance at P=0.05. Cytokines measured in the se-
rum were not different between RegIIIγ-/- and wt mice (IL-1a, IL-5 and IL-18) or below detection limits 
(IL-1b, IL-2, IL-3, IL-4, IL-6, IL-7, IL-10, IL-11, IL-12p70, IL-17a, IFN-γ and TNF-α).
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Wild type RegIIIγ-/-
Pre-infection 21.93 (+/- 3.00) 21.65 (+/- 2.70)
S. enteritidis infection 20.73 (+/- 3.26) 22.05 (+/- 2.52)
L. monocytogenes infection 20.10 (+/- 3.84) 20.61 (+/- 2.62)
Uninfected controls 22.53 (+/- 2.19) 22.35 (+/- 2.04)
Table S6.4. Average body weight of infected and control groups of RegIIIγ-/- and wt mice in grams. +/- 
indicates SD. No significant difference was observed between the mean body weights of the different 
groups. 
Wild type RegIIIγ-/-
S. enteritidis infection 1.33 (+/- 0.30) 1.46 (+/- 0.41)
L. monocytogenes infection 2.31 (+/- 0.75) 1.99 (+/- 1.03)
Table S6.5. Serum Amyloid A2 levels in serum of infected wt and RegIIIγ-/- mice. In uninfected animals 
the levels were below detection limit. +/- indicates SD. Levels are shown in mg/ml. 
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Interest into the biology of the mammalian family of RegIII proteins increased substan-
tially when it was shown that during active pancreatitis, human RegIIIα, commonly 
known as HIP/PAP  (hepatocarcinoma-intestine-pancreas/pancreatitis-associated pro-
tein), was one of the most abundant proteins in pancreatic secretions.1 Nearly two de-
cades later, it was found that in inflammatory bowel disease (IBD) patients, increased 
HIP/PAP transcription and serum levels of the protein were correlated with disease se-
verity.2 About the same time, using experimental mouse models, it was shown that 
RegIII proteins are expressed in the intestine and induced after conventionalization of 
germ free mice3, 4 and in the colon of severe combined immune-deficient (SCID) mice 
after bacterial colonization.5 In mice there are two intestinally expressed RegIII proteins, 
RegIIIγ and RegIIIβ that are both induced after weaning, in colitis and by intestinal in-
fection.4, 6
Expression of RegIIIγ during infection was shown to be dependent on Myeloid differen-
tiation primary response gene 88 (MyD88), a Toll like receptor (TLR) signalling adapter 
protein, and clearance of Listeria monocytogenes from the intestine of MyD88 knock 
out (-/-) mice is impaired compared to corresponding wild-type (WT) mice.6 More re-
cently, MyD88-/- mice were also shown to be more susceptible to Salmonella typhimuri-
um infection than WT mice, but transgenic expression of MyD88 in the Paneth cells of 
MyD88-/- mice restored RegIIIγ expression, and reduced S. typhimurium counts in the 
mesenteric lymph nodes (MLNs).7 Antibiotic treatment of mice with vancomycin de-
creases RegIIIγ gene expression, presumably due to a reduction in MyD88 dependent 
signalling by the resident microbiota, favouring growth of vancomycin-resistant entero-
cocci.8 RegIIIγ and RegIIIβ gene expression is completely abolished in mice lacking in-
terleukin (IL)-22, which is a T cell-derived cytokine that plays a role during the acute 
phase response. When ex vivo colon cultures of IL-22-/- mice were incubated with IL-22, 
expression of RegIII genes was restored, demonstrating the requirement for IL-22 in 
the regulation of RegIII expression. IL-22 is produced by Th17 cells and is among others 
required for protection of mice against Citrobacter rodentium. In IL-22-/- mice, recombi-
nant RegIIIγ reduced mortality and weight loss after infection of mice by C. rodentium, 
demonstrating the specific role of this protein in protection from colitis caused by this 
pathogen, possibly by exerting anti-inflammatory effects.9
As for mice, the rat PAP orthologues are also thought to have anti-inflammatory ac-
tivity, as administration of anti-PAP antibodies in an experimental model of taurocho-
late-induced acute pancreatitis in rats was associated with increased inflammation.10 
In human inflammatory bowel diseases (IBD) patients, secretion of proinflammatory 
cytokines in colonic tissue of patients with active Crohn’s Disease (CD) was inhibited 
by addition of purified native human HIP/PAP.2 In vitro experiments with human mono-
cytes, epithelial cells and endothelial cells revealed its anti-inflammatory effects to be 
Chapter 7
170
due to attenuation of nuclear factor-kappa light chain enhancer of activated B cells 
(NF-κb) activation by tumour necrosis factor-alpha (TNF-α). Furthermore, human PAP 
decreased expression of surface receptors involved in leukocyte recruitment in endo-
thelial cells suggesting that PAP could dampen inflammatory responses by limiting leu-
kocyte recruitment into the intestine.2 However, intravenous injections of PAP induced 
inflammation in the lung, concurrent with increased TNF-α expression in the liver11 but 
prevented leukocyte-mediated pulmonary vasoconstriction and oedema formation,12 
suggesting that the biological effect of PAP might differ between organs. Clearly, the bi-
ological function(s) of RegIII proteins in maintaining and promoting tissue homeostasis 
are broad and depend on the organ. 
The overarching goals of this thesis were:
- To investigate the protective role of RegIIIβ and RegIIIγ in the intestine
- To explore their role in colitis and in infection with enteropathogens
- To investigate whether RegIIIβ and RegIIIγ might be potential biomarkers of 
intestinal health 
The approaches included both in vitro experiments using purified, recombinant RegIII 
proteins and in vivo studies using mouse models of colitis and experimental infections 
with bacterial pathogens in knockout mice. The insights gained from this research are 
discussed in the following sections.
expression of RegIII proteins in the intestine and their role in colitis 
RegIIIβ and RegIIIγ are both upregulated within a few days after conventionalization or 
infection of mice and in mouse colitis, and PAP is upregulated in human CD patients.2, 4 
These findings suggest that the upregulation of RegIII or PAP could have been induced 
by increased proximity of bacteria to epithelial cells, possibly as a consequence of lower 
integrity of the mucus barrier. To gain more information on the location and expression 
of mouse RegIII proteins and the possible involvement of mucus barrier, we investi-
gated expression of RegIIIγ and RegIIIβ in the colon and small intestine of WT mice 
and Muc2-/- mice, using a combination of microarray gene expression profiling, in situ 
hybridization and histological techniques, at 2, 4 and 8 weeks (Chapter 2 and 3). After 4 
weeks, Muc2-/- mice showed histological changes characteristic of other murine colitis 
models and the clinical symptoms of human IBD. As Muc2 is the major secreted mucin 
produced in the intestine, its absence leads to increased contact of the microbiota with 
the epithelium.13 In Muc2-/- and WT mice, we observed that expression of RegIII genes 
and proteins was substantially higher in the ileum than in the colon, confirming previ-
ous work in humans and mice.2, 3, 4, 14 Highest production of RegIII genes and proteins 
was observed in Paneth cells; these cells are absent in the colon, explaining the low ex-
pression of RegIII in the distal intestine. Expression of RegIII proteins was also observed 
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in enterocytes, mainly around the crypt-villus junction (Chapter 2). Interestingly, in 2 
week-old mice staining of RegIII proteins was evident in goblet cells but this decreased 
after weaning, perhaps due to a developmental switch in gene regulation. Neverthe-
less, this showed for the first time a new function of goblet cells in innate immunity, at 
least in young developing animals.  
The Muc2-/- mouse model was used to explore expression of RegIIIγ and RegIIIβ prior to 
and after the onset of colitis. Muc2-/- mice develop colitis in the colon after 4 weeks as 
evidenced by the increased thickness of the mucosa, an abnormal mucosal morpholo-
gy, flattening and ulceration of the epithelial cells accompanied by blood in the faeces 
and weight loss.13 Microarray analysis showed that expression of RegIIIγ and RegIIIβ was 
increased in the proximal colon and ileum at week 2, 4, and 8, even prior to the onset 
of colitis (Chapter 3). Highest expression of both RegIII genes was in the ileum and was 
significantly induced compared to WT mice. Furthermore, the pathways involved in TLR 
signalling, cytokine and chemokine production (e.g. TNF-α, IFNγ (interferon gamma), 
Ltb (lymphotoxin B), IL-1β), NF-κb activity and other immune pathways related to B 
and T cell activity and antibody production were induced in the colon of Muc2-/- mice 
compared to WT mice. Additionally, there was increased expression of the T cell mark-
ers CD4 and CD3e in the colon of Muc2-/- mice, which is consistent with the mild influx 
of immune cells that we observed by histology. Furthermore, 14 out of a panel of 32 
IBD-related genes were differentially expressed in the proximal colon of Muc2-/- mice 
at week 8. Fifteen of these IBD-related genes were also differentially expressed in the 
same way in the mouse DSS-colitis model due to increased contact of the epithelium 
with microbiota.15, 16 Defensin genes were not upregulated in the colon of Muc2-/- mice. 
This could have been due to the effect of inflammatory cytokines and nitric oxide on 
protein folding, which causes the accumulation of unfolded proteins inside the endo-
plasmic reticulum and concomitant induction of the unfolded protein response, which 
affects the function and localization of several proteins including defensins.17 
In contrast to what we observed in colon, the ileum of Muc2-/- mice showed no histolog-
ical signs of damage. This was not due to differential expression of three other secreted 
mucins, Muc5AC, Muc5B and Muc6. However, an increase in villus length was observed 
in the ileum suggesting hyperplasia. This was in agreement with increased expression 
of pathways involved in cell cycle and mitosis, protein translation and the altered ex-
pression of the S100a family of genes that are involved in cell division and differenti-
ation (Chapter 3). Strikingly, TLR and (innate) immune signalling pathways including 
B and T cell receptor signalling were down-regulated compared to WT mice. During 
the inferred down-regulation of immune signalling pathways, expression of RegIIIβ and 
RegIIIγ was significantly increased in the ileum of Muc2-/- mice. This is compatible with 
the increased expression of the gene encoding LtB, which is required for production of 
IL-22, which induces epithelial RegIII expression in enterocytes.18 
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Given the demonstrated anti-inflammatory properties of human PAP it is tempting to 
speculate that the mouse RegIII proteins may have played a role in the suppression 
of inflammatory pathways in the ileum where their expression is highest. Apart from 
suppression of inflammation, the lack of damage in the ileum may also have been as-
sociated with lower bacterial burden as numbers of bacteria are 102-104 times lower in 
ileum compared to colon. Increased expression of RegIII proteins might further lower 
the number of bacteria in the ileum.4, 19 However, the in vitro bactericidal properties of 
RegIII proteins are not consistently reported in the literature,9 suggesting that the activ-
ity is dependent on the preparation of the protein and the assay conditions.  
Lessons from in vitro and in silico studies on recombinant RegIII proteins 
RegIIIγ has been proposed to kill Gram-positive bacteria upon binding to peptidoglycan 
(PGN) via unknown mechanisms. One possibility is that binding of RegIIIγ to PGN inter-
feres with PGN biosynthesis, by binding to precursors causing osmotic cell lysis. Alter-
natively, RegIII proteins may kill bacteria by activating bacterial two-component stress 
response defence systems as described for other innate PGN binding proteins.20 Howev-
er, not all the groups investigating these proteins, have found bacterial killing by RegIII 
proteins or their human orthologue HIP/PAP. To further investigate anti-inflammatory 
and possible antimicrobial activities of RegIIIβ and RegIIIγ proteins, we expressed and 
purified recombinant forms of these proteins and tested their activities in vitro (Chap-
ter 4). Expression of RegIIIβ and RegIIIγ in E. coli leads to formation of inclusion bodies 
as described previously for RegIIIγ.21 This facilitates initial purification but requires de-
naturation and refolding of the proteins to obtain soluble protein, with the risk of losing 
or reducing the activity of native protein. Nevertheless, refolded RegIII proteins have 
shown bactericidal activities.4, 22 We tried to crystalize refolded RegIII proteins produced 
in E. coli, but our attempts were unsuccessful, presumably due to the heterogeneity of 
the protein conformations in the final preparations. To overcome some of these prob-
lems expression in Pichia pastoris (yeast) and insect cells using the baculovirus system 
were explored. Production in P. pastoris did not yield purified, soluble RegIIIβ, but in-
sect cells did secrete soluble RegIIIβ protein albeit in low yields compared to E. coli. As 
expected, the size of RegIIIβ produced in insect cells and in E. coli showed that RegIIIβ 
had not been post-transcriptionally modified by glycosylation, as shown before.21 If no 
reducing dithiothreitol (DTT) was used, all of the purified RegIII proteins formed multi-
mers as previously reported.23-26 
Human PAP and mouse RegIIIβ and RegIIIγ proteins contain an N-terminal pro-segment 
that is cleaved by trypsin, resulting in enhanced PGN binding and bactericidal activity of 
RegIIIγ and PAP towards Listeria monocytogenes.27 This may be a mechanism to allow 
the host to restrict the binding activity of RegIII proteins to the lumen and to avoid det-
rimental effects inside host cells during storage or secretion. We demonstrated that the 
predicted pro-segment was also cleaved from recombinant RegIIIβ by trypsin as previ-
ously described for RegIIIγ.27 Immunoblotting showed that trypsin treatment of soluble 
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baculovirus produced RegIIIβ generated a single major protein whereas refolded RegIIIβ 
produced in E. coli appeared to be cleaved into at least 3 polypeptides of different sizes 
(Chapter 4). Analysis of the potential trypsin cleavage sites within the RegIIIβ primary 
protein sequence indicated several possible cleavage sites, which may have become 
accessible to trypsin in alternative protein conformations. These results suggest that 
refolding of RegIIIβ may have increased its susceptibility to proteolysis by trypsin. In 
contrast to RegIIIβ, refolded RegIIIγ protein yielded a single protein band upon cleavage 
with trypsin as previously described.27 One explanation for the difference in trypsin di-
gestion patterns of RegIIIβ and RegIIIγ might be the fewer number of potential trypsin 
cleavage sites in RegIIIγ. For this reason the soluble RegIIIβ protein, secreted by insect 
cells, was used in the bactericidal and binding assays, although refolded RegIIIβ was 
included in some assays for comparison (Chapter 4).     
   
The published work on the bactericidal effects of RegIIIβ report around 80% reduction 
in colony forming unit (CFU) after incubation with most of the sensitive bacteria, which 
is a relatively weak bactericidal effect, compared to antibiotics and defensins.22 Tryp-
sin processing of baculovirus produced, soluble RegIIIβ led to enhanced binding to L. 
monocytogenes and S. enteritidis as determined by flow cytometry. However, in con-
trast to earlier reports,19 RegIIIβ produced in our lab was not bactericidal for S. enteriti-
dis during logarithmic or stationary phase, although similar buffers, protein concentra-
tions and methods were used as reported by others (Chapter 4).19, 21, 22 Immunoblotting 
showed that the lack of bactericidal activity was not due to degradation of our recom-
binant RegIII proteins during storage, but it is possible that the proteins loose activity 
over time. Differences in the bacterial strain or unreported details in the procedures 
for handling or purification may also have led to different results. Inconsistencies in the 
bactericidal activity of RegIII proteins have been reported by others as well,28 suggesting 
that these proteins may be unstable or that their activity may be highly dependent on 
unknown assay conditions.         
 
RegIII proteins may protect mice against bacteria by pathways that do not depend on 
bactericidal activity. For instance, RegIIIγ was not bactericidal for Gram-negative Citro-
bacter rodentium in vitro but when administered to IL-22-/- mice, that do not produce 
RegIII proteins, although it reduced mortality and severity of colitis.9 Purified native rat 
PAP aggregated E. coli, but was not bactericidal29 and recombinant human PAP purified 
and refolded from E. coli lacked bactericidal activity against B. subtilis.28 Recombinant 
PAP from rat was also reported to lack bactericidal activity against Salmonella enterit-
idis and Listeria monocytogenes.30 We were also unable to demonstrate a bactericidal 
effect of refolded RegIIIγ on the Gram-positive L. monocytogenes, in contrast to what 
had been reported by Cash et al.,4 using the same methods and bacterial isolate. The 
N-terminal processed RegIIIγ did however show binding of RegIIIγ to L. monocytogenes 
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and, somewhat unexpectedly, even more strongly to Gram-negative S. enteritidis and 
E. coli. This suggested that RegIIIγ can also bind to lipopolysaccharide (LPS), a property 
common to many animal PGN binding proteins involved in innate immunity.31-33
One factor that may account for the inconsistent results obtained with recombinant 
RegIIIβ and RegIIIγ could be the use of CFU counts to measure bactericidal activity, as 
this method does not take into account bacterial aggregation by RegIII proteins. Aggre-
gation of bacteria by RegIII proteins may depend on correct folding, something that is 
likely to be influenced by the refolding method and might even vary from one protein 
preparation to another. For this reason we performed some bacterial killing assays us-
ing flow cytometry and fluorescent live/dead staining techniques and microscopy. We 
observed weak bactericidal effects of RegIIIβ on logarithmically growing E. coli VE7108 
(25% killed) and on E. coli Nissle (6%) in the absence of any histological evidence for 
bacterial aggregation. 
In addition to the bactericidal assays we tested whether RegIIIβ and RegIIIγ were bac-
teriostatic by adding N-terminally processed and unprocessed RegIII proteins to low 
density bacterial cultures of L. monocytogenes and S. enteritidis. This had no effect on 
bacterial growth over 8 hours. The added RegIII proteins could still be detected in the 
supernatant after completion of the growth curve measurements, ruling out their deg-
radation. However we cannot exclude the possibility that the RegIII proteins are not 
active in bacterial culture medium.       
 
To gain more insight into the binding sites of RegIII proteins and their known ligands, 
we unsuccessfully attempted to crystallize the mouse RegIII proteins. However, it was 
possible to generate models of the tertiary structure using the protein sequence of 
human PAP for which a protein crystal structure was available.34 The structural models 
of RegIIIβ, RegIIIγ and PAP closely resemble each other in terms of the overall protein 
fold, and the amino acid sequences have between 67% and 71% identity. The structur-
al models show the external N-terminal pro-peptide sequence that is proteolytically 
processed in the lumen to increase the binding activity of the proteins.27, 28 Further-
more, docking experiments revealed a model that predicts RegIIIβ and RegIIIγ binding 
to bacterial PGN, as was shown in binding assays with insoluble PGN4, 19 (this thesis, 
data not shown). This would explain why RegIIIβ can bind L. monocytogenes in our bind-
ing assays and had a bactericidal effect on Clostridium butyricum, although the other 
Gram-positive species tested, namely Lactobacillus murinus and Enterococcus faecalis, 
were resistant to killing.22 The reasons for differential killing of Gram-positive bacteria 
are not clear but might involve PGN modifications or increased D-alanine-substitution 
on wall teichoic acids, which might inhibit binding of RegIIIβ.35, 36    
       
RegIIIβ can bind LPS via the lipid A component19 and docking experiments with this 
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ligand suggested that binding occurs at a different site on the protein than binding to 
PGN (Chapter 4). The interacting residues responsible for this lipid A binding were in an 
area with low conservation in RegIIIγ, suggesting that RegIIIβ and RegIIIγ have different 
specificities or affinities for ligands (Fig. 7.1). The interacting residues in the PGN-bind-
ing site were conserved in RegIIIβ and RegIIIγ, which is compatible with reports describ-
ing binding of both proteins to this ligand. 
As PAP was previously shown to attenuate NF-κb signalling in human monocytes and 
epithelial cells,2 we tested RegIIIβ for potential anti-inflammatory effects. Incubation of 
mouse BMDC (bone marrow derived DCs) with and without RegIIIβ and with or with-
out a stimulus (lipopolysaccharide (LPS) or Pam3CysSerLys4 (Pam3CSK4), a TLR2 ligand) 
showed no anti-inflammatory effect of RegIIIβ on surface activation markers or cyto-
kine secretion (not shown). Considering the binding of RegIIIβ to LPS, it is possible that 
RegIIIβ proteins sequester LPS, thereby reducing LPS concentrations and avoiding LPS 
entering cells and contributing to maintaining homeostasis.37 In addition, to investigat-
ing potential anti-inflammatory effects of RegIIIβ, we also tested whether RegIIIβ had 
an effect on the trans-epithelial resistance (TER) in a Caco2 (human colonic cell line) cell 
culture. Pre-incubation of cells or bacteria with RegIIIβ did not have an effect on the 
decrease of the TER when S. enteritidis or pathogenic E. coli LF82 were added to the 
Caco2 cells, but RegIIIβ alone significantly increased the TER of the cells (not shown) in 
3 independent experiments. Messenger RNA of several tight junction proteins was not 
upregulated as was shown by qPCR. Exactly how the TER is increased by RegIIIβ is not 
known yet, but it might involve modification of TJ complexes by binding of RegIIIβ to 
receptors or other extracellular molecules located on the apical membrane. 
Infection studies in RegIIIβ and RegIIIγ knockout mice 
At the beginning of this research project, we set out to study the phenotype of RegIIIβ 
and RegIIIγ knockout (RegIIIβ-/- and RegIIIγ-/-) mice and their sensitivity to infection with 
Gram-positive and Gram-negative pathogens. To obtain and breed specific pathogen 
free (SPF) RegIIIβ-/- mice took several months and the generation of our own RegIIIγ-/- 
mouse took more than two years. Nevertheless, the results obtained with these models 
have been very enlightening and generated new ideas about the function of these pro-
teins in vivo, as discussed below. 
The mice used for the RegIIIβ infection experiment were bred on a mixed background 
(C57Bl/6 and 129O1a). These strains differ in their susceptibility to Salmonella infection 
due to a mutation in the natural resistance-associated macrophage protein (Nramp) 
1 gene encoding the Slc11a1 transporter. Mice bearing specific alleles of Nramp1 are 
more resistant to S. enterica serovar typhimurium infection since production of specific 
transporters impairs growth of S. enterica in macrophages via stimulation of expression 
of lipocalin-2, an antimicrobial iron scavenger.38 All control and S. enteritidis infected 
mice were genotyped and were shown to be homozygous for the Nramp1 susceptibility 
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allele, ruling out the possibility that the Nramp status would influence the results. Un-
challenged RegIIIβ-/- mice have a normal appearance and body weight. However, when 
challenged with virulent S. enteritidis, higher numbers of S. enteritidis were present in 
colon, mesenteric lymph nodes (MLN), spleen and liver of infected RegIIIβ-/- mice com-
pared to WT mice, indicating that the adherence, and translocation and dissemination 
of S. enteritidis is increased in the absence of RegIIIβ (Chapter 5). The MLN drain the 
small intestine, which is a main site of S. enteritidis invasion.39 Therefore reduced levels 
of S. enteritidis in the MLNs of WT mice suggest protective effects of RegIIIβ on S. enter-
itidis translocation via the ileum. We did not observe differences in S. enteritidis counts 
in the ileal tissues of RegIIIβ-/- and WT mice. However, the investigated ileal tissue did 
not contain Peyer’s patches (PP) and M cells, which are considered, in addition to ab-
sorptive enterocytes, to be important sites of S. enteritidis translocation.40, 41 Together, 
the experimental infection data strongly suggest that RegIIIβ inhibits S. enteritidis trans-
location from the gut lumen into extra-intestinal tissues but does not kill S. enteritidis 
bacteria at-a-distance in the gut lumen. These results are supported by recent findings 
of Dessein et al., who showed that genetic ablation of RegIIIβ did not affect the bacte-
rial load of the Gram-negative pathogen Yersinia pseudotuberculosis in the intestinal 
lumen14 but significantly increased bacterial burden in the PP, which are the main route 
of entry for this pathogen. 
In contrast, lack of RegIIIβ did not appear to influence resistance to infection with the 
Gram-positive Listeria monocytogenes, as identical numbers of this pathogen were re-
covered from intestinal and extra-intestinal tissues in RegIIIβ-/- and WT mice in our infec-
tion study (Chapter 5). This is compatible with our in vitro data showing no bactericidal 
effect of RegIIIβ on L. monocytogenes, although recombinant RegIIIβ appeared to bind 
both S. enteritidis and L. monocytogenes in vitro, suggesting that RegIIIβ might have a 
different function, such as trapping bacteria in the mucus instead of direct killing. 
After infection with both S. enteritidis and L. monocytogenes, myeloperoxidase (MPO) 
protein levels in ileal scrapings were not different between RegIIIβ-/- and WT mice, in-
dicating a low local inflammatory response. In absence of a differential inflammatory 
response, we cannot infer if RegIIIβ could have anti-inflammatory effects, as reported 
for human PAP. Further analysis of the collected intestinal tissues from this study might 
give insight on the role of the innate (immune) response in RegIIIβ related protective 
effects. For example, micro-array analysis of intestinal tissues may identify whether 
specific host defence pathways are associated with protective effects of RegIIIβ. In the 
future L. monocytogenes and S. enteritidis infection experiments in mice deficient in 
specific TLRs could be used to investigate their potential involvement in RegIIIβ-mediat-
ed protection against intestinal infection. 
contributions of RegIIIγ to mouse innate immunity
To investigate the in vivo role and function of RegIIIγ we generated a RegIIIγ-/- mouse 
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model that expresses an enhanced green fluorescent protein (eGFP) reporter under 
control of the RegIIIγ promoter (Chapter 6). Furthermore, based on its proposed bac-
tericidal activity towards Gram-positive bacteria,4 we investigated the hypothesis that 
absence of RegIIIγ would result in higher susceptibility to infection with Gram-positive 
L. monocytogenes than to infection with Gram-negative S. enteritidis using infection 
studies in our RegIIIγ-/- mice.
We first compared the phenotypes of uninfected RegIIIγ-/- and WT mice. No morpho-
logical differences between RegIIIγ -/- and WT mice were found by phenotypic histolog-
ical analysis. However, we observed a significant increase in the relative amounts of 
IL-22 transcript and MPO protein levels in ileum samples of RegIIIγ-/- mice relative to WT 
mice (Chapter 6), suggesting elevated innate responses and chemotaxis of neutrophils. 
Moreover, significantly higher amounts of the chemokines monocyte chemotactic pro-
tein (MCP)-1 and macrophage colony stimulating factor (M-CSF)-1, both of which are 
involved in monocyte and neutrophil recruitment, activation and differentiation, were 
found in serum of RegIIIγ-/- mice. Interestingly, pro-inflammatory cytokines such as IL-
1β, IL-12p70, TNF-α and IFN-γ were not different between RegIIIγ-/- and WT mice, or 
were below detection limit in serum. Therefore, it appears that RegIIIγ-/- mice exhibit an 
increased innate immune cell activity in the mucosa that successfully avoids systemic 
inflammation. Theoretically, the heightened inflammatory status of the mucosa might 
have been due to increased contact between the luminal bacteria and the epithelium, 
or because of an anti-inflammatory effect of RegIIIγ as previously proposed by Vaish-
nava et al.42 and Zheng et al.9 Therefore, to assess the distribution of bacteria in the 
mucus layer, we performed FISH staining on ileum and colon sections. Sections of ileal 
tissue from RegIIIγ-/- mice, but not WT mice, consistently showed the presence of small 
numbers of bacteria on the epithelium, in agreement with the study of Vaishnava,42 
who independently generated a RegIIIγ-/- mouse. In the colon, increased co-localisation 
of bacteria and epithelial surfaces was not observed. This supports the possibility that 
the increased IL-22 and MPO levels in the ileal mucosa of RegIIIγ-/- mice were due to 
decreased spatial segregation of bacteria resulting in increased innate inflammatory 
signalling. These results do not rule out possible anti-inflammatory effects of steady 
state levels of RegIIIγ in vivo. 
Infection of RegIIIγ-/- mice with either of the pathogens did not result in increased trans-
location to the spleen, liver or MLNs compared to WT infected mice (Chapter 6). This 
result was fully reproduced using a ‘murinized’ L. monocytogenes strain, engineered 
to increase the epithelial route of infection in murine models.43 Although there was no 
increased translocation of pathogens in the organs of RegIIIγ-/- mice, we did measure 
increased amounts of MPO in ileal tissue of infected RegIIIγ-/- mice compared to WT 
infected mice. MPO is produced mostly by neutrophil granulocytes, which are attracted 
to sites of infection suggesting that increased numbers of both pathogens had trans-
located into the mucosa of RegIIIγ-/- mice compared to WT mice. These results suggest 
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that the heightened mucosal inflammatory response observed in infected RegIIIγ-/- mice 
was sufficient to inhibit spread of the pathogens to the bloodstream and organs. ln 
agreement with this, loss of RegIIIγ did not affect systemic inflammatory responses as 
no significant differences in serum SAA2 levels were measured between RegIIIγ-/- and 
WT mice.
Overall, the results suggest that the mucosal inflammatory response, involving mono-
cyte and neutrophil recruitment and activity to pathogen infection was increased in 
RegIIIγ-/- mice. As suggested above, trapping of bacteria in the mucus or increased 
movement of bacteria through the mucus might explain the increased mucosal inflam-
matory responses to both pathogens in RegIIIγ-/- mice. 
Figure 7.1. Space filling model of RegIIIβ showing the two different predicted binding sites for lipid A 
and PGN. Regions of RegIIIβ protein conserved in RegIIIγ are shown in grey and the variable regions 
are shown in purple. 
RegIIIβ is predicted to have two ligand-binding sites and can bind to glycans on human 
mucin 
We observed that an intensely stained band of mucus consistently located above the 
villi and surrounding the ileal content in WT mice was absent in RegIIIγ-/- mice, while 
the expression of Muc2 mRNA was not altered. We also showed that RegIIIγ was pres-
ent throughout the mucus layer of WT mice (Chapter 6). If binding of RegIIIγ in the 
mucus layer can alter the structure or the distribution of mucus in the ileum it would 
provide an explanation for the altered distribution of mucus in RegIIIγ-/- mice. To in-
vestigate possible interactions of RegIII proteins with glycans we performed in vitro 
glycan binding arrays, initially with recombinant RegIIIβ produced by baculovirus, as 
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this protein was secreted in soluble form. Purified RegIIIβ was fluorescently labelled 
and hybridized to a glycan array of purified mucin and host glycans. Strikingly, RegIIIβ 
significantly bound several different fucosylated glycans, as well as purified human co-
lonic mucin (Chapter 3). Docking approaches were used to predict the RegIIIβ binding 
sites of these ligands using models of the tertiary structure described above (Chapter 
4). In RegIIIβ two binding sites were identified; binding site 1 (BS1) binds to PGN and 2 
different fucose-containing glycans while binding site 2 (BS2) binds to lipid A, a part of 
the LPS layer in Gram-negative bacteria, and to two other glycans ligands on the array, 
suggesting that RegIIIβ may be able to bind to both mucins and PGN. (Fig. 7.2), From 
this model, it follows that RegIIIβ could be distributed throughout the mucus and could 
bind to mucins while at the same time, maintaining the ability to bind PGN exposed 
on Gram-positive bacteria. As RegIIIβ and RegIIIγ can self-assemble into large multim-
eric complexes as previously described for PAP and other Reg family members28innate 
immunity, lectin-like protein, N-terminal proteolytic processing, pancreatitis-associat-
ed protein (PAP it may crosslink mucins thereby stabilizing mucin structure or altering 
penetrability by bacteria. Interestingly, fucosylated glycans on the epithelial surface can 
serve as receptors for pathogenic viruses and bacteria.44 Thus the induction of RegIIIβ 
and RegIIIγ expression during infection might help to prevent colonisation of the gut 
epithelium by pathogens, by reducing availability of receptor binding sites that could be 
bound by these pathogens.
Figure 7.2. Hypothetical model of the two different binding sites on RegIIIβ, based on docking results 
obtained in this study. 
current hypotheses about the role of RegIIIβ and RegIIIγ  
Our phenotyping study in RegIIIγ-/- mice strongly supports a protective role for RegIIIγ 
in compartmentalizing commensal bacteria in the lumen. Loss of this protein increased 
expression of mucosal innate inflammatory markers but not of systemic inflammatory 
Binding site1
Binding site2
Glycans
e.g. Fucosylated 
mucin
Glycans
e.g. Lipid A
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markers. The increased inflammatory response was modest, presumably due to the re-
dundancy of innate defence factors including RegIIIβ, and the absence of pathogens in 
our SPF mice. Vaishnava et al.,42 concluded that the spatial segregation of bacteria was 
due to bactericidal effects of RegIIIγ on Gram-positive bacteria. However, infection stud-
ies in our RegIIIγ-/- mice showed that mucosal inflammation was significantly increased 
when mice were infected with both Gram-positive L. monocytogenes and Gram-nega-
tive S. enteritidis. This does not exclude a bactericidal effect on L. monocytogenes, but 
it suggests that RegIIIγ has protective effects that go beyond direct specific bactericidal 
activity towards Gram-positive bacteria, including having an effect on mucus properties 
or trapping of Gram-positive as well as Gram-negative bacteria in the mucus network. 
Similar in vivo studies on the possible effects of RegIIIβ deficiency on the spatial segre-
gation of bacteria are currently on going. 
The expression of two closely related RegIII proteins in the mouse intestine suggests a 
(partially) different function for each of these proteins. One could speculate about two 
proteins, each having a specific bacterial target (i.e. Gram-negative or Gram-positive), in 
case of purely anti-microbial properties. However, when looking at the results obtained 
in this thesis (Chapters 4, 5 and 6) and work on the rat and human proteins published 
by others2, 28, 29 this appears not to be the case. There are inconsistencies on bactericidal 
effects of RegIII proteins in the different published studies as well as our own data that 
suggest that RegIII proteins may bind to bacteria without inducing killing. The infection 
studies show that the two mouse RegIII proteins studied in this thesis have different 
functions to one another. RegIIIβ protects against S. enteritidis infection and transloca-
tion to the organs but not against L. monocytogenes infection. However, RegIIIγ seems 
to confer protection against both pathogens as infection of RegIIIγ-/- mice with either S. 
enteritidis or L. monocytogenes leads to heightened mucosal inflammation. Even in un-
challenged RegIIIγ-/- mice the MPO levels were elevated in the ileal mucosa, which could 
be due to increased contact of bacteria with the epithelium (Chapter 6). An increase 
in MPO levels was not observed in uninfected RegIIIβ-/- mice compared to WT. There-
fore, we might not find the same altered spatial compartmentalization of bacteria ob-
served in the RegIIIγ-/- mice. The different results obtained in the infection studies with 
RegIIIβ-/-  and RegIIIγ-/- mice might be partially caused by differences in the microbiota 
composition and their different antagonistic effects on the pathogens (i.e. colonization 
resistance).45, 46 Thus, determining the microbial composition in RegIIIβ-/- and RegIIIγ-/- 
mice and abundance of specific bacterial species might give us more information on the 
possible targets of both RegIIIβ and RegIIIγ. Analogously, the microbiota composition in 
the Muc2-/- model could give us more information on the possible impact of presence 
or absence of specific bacterial groups on colitis. Attempts are underway to analyse the 
microbial composition in both the colon and the ileum of these models. One promising 
future tool is an inducible RegIIIγ-/- mouse model. In this model, RegIIIγ gene deletion is 
mediated through intra-peritoneal administration of tamoxifen, which induces cre-me-
diated deletion via recombination of loxP sites flanking RegIIIγ, bringing eGFP under 
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control of the cognate promoter. This model was recently generated and preliminary re-
sults look promising (Fig. 7.3). Administration of tamoxifen in different concentrations, 
increased relative expression of eGFP and significantly decreased relative expression of 
RegIIIγ.
Figure 7.3. RegIIIγ and eGFP mRNA expression levels in the distal ileum of tamoxifen induced animals. 
mRNA expression data of 4 mice per group are shown relative to the housekeeping gene HPRT. Ex-
pression ratios are shown as log values. * indicates P<0.05, compared to the OIL control group, and 
significant for both reference genes.
More research needs to be done on this model before it can be used for studying the 
effect of RegIIIγ on the microbiota. To closely monitor potential changes in microbiota 
compositions due to the deletion of RegIIIγ, littermates should be used and gene dele-
tion could be induced at different time points.
Although RegIIIβ and RegIIIγ appear to have protective effects, their absence does not 
cause disease in mice up to 8 weeks of age as the knock out animals appear normal and 
healthy. Based on in vivo studies to date (Chapter 5 and Dessein et al.14), RegIIIβ seems 
to specifically protect against infection with Gram-negative bacteria, but a broader pan-
el of pathogens including multiple Gram-negatives and Gram-positives should be tested 
to confirm this hypothesis. RegIIIγ seems to reduce mucosal inflammation caused by in-
fection with either Gram-positive or Gram-negative pathogens, suggesting it has a more 
general anti-microbial or protective activity. In addition to this protection to bacteria, 
RegIIIγ may possess an anti-inflammatory activity, as higher amounts of inflammatory 
markers were measured in uninfected RegIIIγ-/- mice than WT mice. The antimicrobial 
effect of RegIIIγ might be due to binding to pathogens as shown in vitro (Chapter 4) or 
Chapter 7
182
a bactericidal activity although this is somewhat controversial as discussed above. The 
demonstration that RegIII proteins bind to mucus and are predicted to have more than 
one ligand binding site adds weight to the notion that trapping of bacteria in the mu-
cus layer could be an important protective property. However, one should be cautious 
about drawing firm conclusions from in vitro data as the in vivo activity of RegIII proteins 
may require mucus or other secretory factors/conditions that are not reproduced in 
vitro.  
The ability to produce secreted RegIII proteins in mammalian cells would be a signif-
icant advantage for further studies, as the function of refolded proteins may be dif-
ferent to the function of native proteins. The importance of the conformational struc-
ture of these proteins was shown previously by Hassanain et al.47 who demonstrated 
that aggregated proteins could have a different function than non-aggregated proteins. 
Aggregation could take place after enzymatic processing of the N-terminus, possibly 
giving processed and unprocessed RegIII proteins multiple functionalities. To date, no 
one has succeeded in producing secreted RegIII protein in mammalian cells; our own 
attempts were also unsuccessful. Several groups produced RegIII in pancreas cells after 
inducing pancreatitis in those cells in vitro,48-50 but we were not able to show any RegIII 
production in LPS-stimulated colonic and small intestinal epithelial cell lines. Also CHO 
and HEK293 cells, transfected with a construct coding for RegIIIβ or RegIIIγ under the 
control of a CMV promoter, did not secrete either of the two RegIII proteins (data not 
shown). One could speculate that cofactors such as chaperones or microRNAs need to 
be present, e.g. to stabilize RegIII mRNA. What might be worth to try in the future is to 
stimulate intestinal epithelial cells with IL-22, a natural inducer of RegIIIγ production 
and secretion.9  
The possible mechanisms of RegIIIβ and RegIIIγ are summarized in figure 7.4, including 
the untested hypothesis that RegIII opsonizes bacteria thereby enhancing phagocytosis 
through binding to glycans on the antigen-presenting cells (APCs; panel A). In panel B 
we show the effect of RegIII proteins on TJs and the anti-inflammatory effect. An in-
crease in the TER of Caco2 cell monolayers was reproducibly measured in presence of 
RegIIIβ (data not shown), but it is not known whether this is a direct effect of RegIIIβ on 
TJs, or due to cell signalling and effects on TJ composition. Nothing has been published 
on host receptors for RegIII proteins so we can only speculate about internalization of 
RegIII proteins and the resulting signalling pathways, but anti-inflammatory effects have 
been shown by several groups. The reported anti-inflammatory effect involves the stim-
ulation of SOCS3 and the inhibition of NF-κb.2, 10, 51, 52
We have shown RegIII binding to bacteria (Chapter 4), to mucus and glycan structures 
(Chapter 3 and 6), and formation of RegIII multimers (Chapter 4) suggesting pro-
tein-protein interactions. These possible activities are summarised in panel C, where 
binding of RegIII to bacteria and glycans on mucins immobilizes bacteria in the mucus 
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layer (indicated by 1). Immobilisation of bacteria in the mucus would protect the host 
by preventing bacterial contact with epithelial cells. For RegIIIβ this is plausible as the 
structural models (Chapter 4) show two different ligand binding sites. Alternatively, 2) 
indicates a network of multimeric RegIII proteins and the mucus layer, forming a net-like 
structure preventing bacteria from establishing contact with host epithelia; this net-
work-like structure including RegIII multimers and mucus thus exerts a protective effect. 
This hypothetical model is based on the observations that RegIII proteins can occur as 
multimers and can be bound to mucus.  A precedent for this idea comes a recent publi-
cation showing that human beta defensin 6 forms a net-like structure.53 Another possi-
bility is indicated in 3) which is the killing of bacteria by RegIII proteins. Even though we 
did not measure substantial killing in vitro, and our in vivo results do not support biolog-
ically relevant instances of bacterial killing by RegIIIγ and RegIIIβ, we cannot ignore the 
literature about this topic. Panel D shows binding of RegIIIβ to fucosylated glycans that 
can be present on the membrane bound mucins of the glycocalyx, thereby hindering 
adherence of pathogens that utilize these carbohydrates for colonization. 
Figure 7.4. An overview of the possible protective mechanisms of RegIIIβ and RegIIIγ.
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Future perspectives
The novel insights described in this thesis show that RegIII proteins are induced in the 
intestine under conditions of stress (i.e. infection or colitis) and have a protective func-
tion. They may have functions beyond the bactericidal effects described in the litera-
ture, including the ability to bind mucus and bacteria, which together with defensins 
and other factors appears to have a role in keeping microbes at a distance from the 
epithelium. Future research on the effect of the RegIII proteins on the microbiota, for 
example using the inducible knockout described above, would provide insights into the 
potential effects of RegIII proteins on microbiota composition and distribution. More 
effort is needed to produce RegIII proteins in mammalian expression systems and char-
acterise their ligand binding and specificity in vitro. For example, competitive binding 
studies using different ligands could be used to identify binding sites for each of the 
RegIII proteins and could be used to confirm the potential of RegIIIβ and RegIIIγ to bind 
both mucus and bacteria. More research is also warranted on identifying host recep-
tors; this is a prerequisite for unravelling the mechanisms via which anti-inflammato-
ry effects and effects on TJs are modulated by RegIIIβ and/or RegIIIγ. Note that even 
for the well-studied human PAP protein, host receptors are unknown. As a first step 
to identify host receptors, it may be possible to demonstrate binding of dye-coupled 
RegIII proteins to epithelial or immune cells in ex vivo tissue, using the methods that 
were successfully used in the glycan array experiments (Chapter 3). Furthermore tissue 
explants can be used to study proposed anti-inflammatory effects of RegIII proteins, 
e.g. by measuring cytokine expression in Ussing chambers. Candidate receptors binding 
to RegIII might be identified by analysis of signalling pathways using cell reporters or 
transcriptomic studies and investigated further using blocking antibodies or binding of 
labelled RegIII proteins to protein fractions separated by SDS-PAGE. 
The role of RegIII proteins in protecting against intestinal inflammation also warrants 
further study as they may ultimately have therapeutic potential. In the Muc2-/- mouse 
model, colitis was most severe in the distal colon where concentrations of RegIII are 
relatively low, in contrast to ileum where tissue damage was not observed and where 
RegIII concentrations are highest. We hypothesised that RegIII proteins play a key role in 
preventing inflammation-mediated tissue damage in the ileum. This could be tested by 
breeding a RegIII knock out on the Muc2-/- background. As RegIII production is highest 
in the ileum, it would be very interesting to see whether the lack of RegIIIβ or RegIIIγ 
would give a more severe pathology in ileum. External supplementation of RegIIIβ or 
RegIIIγ should also be investigated as a possible way to reverse inflammatory tissue 
damage. It could also be tested if protection against tissue damage is also dependent 
by killing of specific bacterial taxa; the other possible mechanisms outlined in figure 7.4 
could also be evaluated using a RegIII-/- Muc2-/- mouse model. 
As RegIIIβ and RegIIIγ are upregulated in mice suffering from gut barrier defects, for 
instance in the ileum of Muc2-/- mice, and during other intestinal inflammatory or stress 
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conditions, RegIII proteins have potential as biomarkers of intestinal health. Further 
research could be aimed at developing methods to accurately measure RegIII protein 
in faecal and blood samples and to evaluate usefulness of these measurements as bio-
markers, first in mouse models and later in humans. 
More research is warranted on the effects of RegIII proteins on different types of host 
cells including proliferating effects. Ultimately, these proteins may have therapeu-
tic potential for diverse applications, for example as oral biologics or via strategies to 
stimulate their production including probiotics. They may even have possible systemic 
applications in the treatment of severe inflammatory conditions such as sepsis, e.g. 
as scavengers of toxic LPS molecules or immunogenic peptidoglycan-lipoprotein frag-
ments. Clearly there is still a lot to be discovered about the functions of these fascinat-
ing proteins and in the future this may lead to novel applications in medicine. 
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Summary 
Mammalian RegIII proteins are expressed in the intestine and in the pancreas in re-
sponse to inflammation or infection. In the mouse intestine, expression of RegIIIβ and 
RegIIIγ is increased by microbial colonization, inflammation and infection. At the out-
set of this thesis human PAP and mouse RegIIIγ were reported to be bactericidal for 
Gram-positive bacteria. Additionally, human PAP had been shown to attenuate NF-κb 
signalling in human monocytes and epithelial cells and administration of anti-PAP an-
tibodies increased inflammation in an experimental rat model of acute pancreatitis. 
The overarching goals of this thesis were to find out more about the protective role of 
mouse RegIIIβ and RegIIIγ in the intestine and explore their protective role in colitis and 
bacterial infection. 
In Chapter 2 we investigated expression of RegIIIβ and RegIIIγ in intestine of Muc2 
knockout (-/-) mice, which develop colitis after about 4 weeks, due to the absence of 
a secreted mucus layer in the small intestine or colon. RegIII proteins were expressed 
in Paneth cells, enterocytes and goblet cells pointing to a new function for goblet cells 
in innate immunity. Ang4 expression was confined to Paneth cells and goblet cells. Ab-
sence of Muc2 increased expression levels of RegIIIβ, RegIIIγ, and Ang4 and colitis ap-
peared first in the distal colon where the RegIII expression is lowest. 
In Chapter 3 we investigated the distinct phases of colitis development in Muc2-/- mice 
from before weaning to 4 and 8 weeks of age, also taking into account the effect that 
mucin deficiency has in the ileum. Gene set enrichment approaches showed increased 
expression of innate and adaptive immune pathways associated with colitis over time, 
whereas in the ileum many immune signalling pathways were down-regulated. Never-
theless, RegIIIβ and RegIIIγ were significantly upregulated, suggesting their proposed 
antimicrobial and/or anti-inflammatory activities might be related to the suppression 
of immune pathways and avoidance of immune-mediated damage. Furthermore, we 
showed that RegIIIβ could specifically bind to mucin and fucosylated glycans in vitro, 
which may serve to inhibit bacterial binding to membrane bound mucins on the epithe-
lium, and also enable RegIIIβ to be retained in the secreted mucin. 
An in vitro approach was used in Chapter 4, where we investigated the activities of 
RegIIIγ and RegIIIβ by expressing and purifying recombinant proteins. Both proteins 
were insoluble when expressed in E. coli but RegIIIβ could be expressed and secreted 
in baculovirus as a soluble protein. As previous work reported that RegIII proteins were 
bactericidal even when produced as inclusion bodies in E. coli and refolded, we followed 
similar procedures to obtain soluble RegIII proteins. In our hands both the E. coli and 
baculovirus produced proteins bound strongly to both Gram-positive and Gram-nega-
tive bacteria after processing of an N-terminal pro-peptide by trypsin, but lacked any 
appreciable bactericidal activity. Furthermore these proteins did not influence the 
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growth of Salmonella enteritidis and Listeria monocytogenes. Attempts to crystallize 
the proteins were unsuccessful but structural models of the protein were generated 
based on the crystal structure of human PAP. These models were used to dock known 
ligands of RegIIIγ or RegIIIβ. Only one ligand is known for RegIIIγ, which is peptidogly-
can, but for RegIIIβ the ligands include peptidoglycan, lipid A and the fucose-containing 
glycans identified in chapter 3. RegIIIβ was predicted to have two different binding sites 
which would allow it to bind to mucins and bacteria simultaneously, thereby preventing 
penetrating of the mucus. 
In Chapter 5 a RegIIIβ-/- mouse was used to study the role of the protein during in-
fection with Gram-negative Salmonella enteritidis or Gram-positive Listeria monocyto-
genes. Whereas recovery of S. enteritidis or L. monocytogenes from faeces was similar 
in RegIIIβ-/- and wild type (WT) mice, significantly higher numbers of viable S. enteritidis, 
but not L. monocytogenes, were recovered from the colon, mesenteric lymph nodes, 
spleen, and liver of the RegIIIβ-/- than the WT mice. The results suggest that mouse 
RegIIIβ plays a protective role against intestinal translocation of the Gram-negative bac-
terium S. enteritidis but not against the Gram-positive bacterium L. monocytogenes.
In Chapter 6, the generation of a RegIIIγ-/- mouse is described. One of the main phe-
notypic differences between the RegIIIγ-/- and WT was an altered distribution of the 
ileal mucus and increased bacterial contact with the epithelium. Additionally, measure-
ment of innate immune markers in the mucosa suggested heightened inflammation 
in the RegIIIγ-/- mice.  Compared to WT mice, RegIIIγ-/- mice infected with S. enteritidis 
and L. monocytogenes showed an increase of mucosal inflammatory markers indicating 
protective, anti-microbial roles of RegIIIγ in defense against both Gram-positive and 
Gram-negative bacteria. 
Chapter 7 summarizes and discusses the key results of the thesis in the context of the 
wider literature and possible directions for future research.
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Samenvatting
RegIII eiwitten komen in de darm en de alvleesklier van zoogdieren tot expressie als 
reactie op een ontsteking of infectie. In de darm van muizen neemt de expressie van 
RegIIIβ en RegIIIγ toe na microbiële kolonisatie, ontsteking of infectie. Aan het begin 
van het in dit proefschrift beschreven onderzoek was het bekend dat het humane eiwit 
PAP en een muizen variant hiervan, RegIIIγ, antimicrobieel was voor Gram-positieve 
bacteriën. Daarnaast was het bekend dat humaan PAP de NF-κb signalering in (humane) 
monocyten en epitheel cellen kan verzwakken en dat de toevoeging van antistoffen te-
gen PAP alvleesklier-ontsteking deed toenemen in ratten. Het uiteindelijke doel van dit 
proefschrift was om meer over de beschermende rol van muizen RegIIIβ en RegIIIγ in de 
darm te weten te komen, en om de beschermende rol van deze eiwitten tijdens colitis 
(ontsteking van de dikke darm) en bacteriële infectie te onderzoeken. 
In hoofdstuk 2 hebben we naar de expressie van RegIIIβ en RegIIIγ in de darm van Muc2 
knock out muizen gekeken. Deze muizen hebben geen beschermende mucus laag in 
de darm, en ontwikkelen als gevolg daarvan colitis op een leeftijd vanaf ongeveer 4 
weken. In dit hoofdstuk hebben we gevonden dat RegIII eiwitten worden geproduceerd 
door zowel Paneth cellen, enterocyten als slijmbeker cellen, wat mogelijk duidt op een 
nieuwe rol voor slijmbekercellen in de aangeboren immuniteit. De expressie van Ang4, 
een ander antimicrobieel eiwit, vond plaats in Paneth cellen en slijmbekercellen. De 
afwezigheid van Muc2 induceerde een toename van RegIIIβ, RegIIIγ en Ang4, en daar 
waar de expressie van de RegIII eiwitten het laagst is, namelijk in laatste deel van de 
dikke darm, ontwikkelt de colitis het eerst.
In hoofdstuk 3 hebben we gekeken naar de verschillende fases van de colitis ontwikke-
ling in de Muc2 knock out muis, waarbij we ook gekeken hebben naar het effect van de 
afwezigheid van Muc2 in de dunne darm. Transcriptoom analyse liet toegenomen ex-
pressie van genclusters betrokken bij aangeboren en adaptieve immuniteit zien, terwijl 
in de dunne darm veel clusters van immuun genen juist een afgenomen expressie lieten 
zien. Desondanks waren RegIIIβ en RegIIIγ significant toegenomen, wat kan duiden op 
een mogelijke onderdrukking van ontstekingen door deze eiwitten. Daarnaast hebben 
we in vitro laten zien dat RegIIIβ specifiek kan binden aan mucine en gefucolyseerde 
suikers. Dit zou de binding van bacteriën aan de suikers op het cel membraan kunnen 
remmen, en er daarmee voor zorgen dat RegIIIβ aanwezig blijft in de mucus laag. 
We hebben een in vitro methode gebruikt in hoofdstuk 4, waar we de activiteiten van 
RegIIIβ en RegIIIγ onderzocht hebben door recombinant eiwit te produceren en te zuiv-
eren. Beide eiwitten werden onoplosbaar geproduceerd door E. coli maar RegIIIβ werd 
als een oplosbaar, uitgescheiden eiwit geproduceerd door baculo virus. RegIII eiwitten 
lieten in eerdere studies antimicrobiële activiteit zien, zelfs wanneer ze als onoplosbaar 
geproduceerd waren in E. coli en hervouwen werden, dus hebben we vergelijkbare pro-
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tocollen gebruikt om oplosbaar eiwit te verkrijgen. In onze experimenten bonden zowel 
het hervouwen als het oplosbare eiwit sterk aan Gram-positieve en Gram-negatieve 
bacteriën, maar was er geen antibacteriële activiteit. Daarnaast lieten de eiwitten geen 
effect zien op de groei van Salmonella enteritidis en Listeria monocytogenes. Pogin-
gen om de eiwitten te kristalliseren zijn niet gelukt maar er zijn wel modellen gemaakt 
gebaseerd op de kristal structuur van humaan PAP. Deze modellen zijn gebruikt om te 
voorspellen waar liganden van RegIIIβ en RegIIIγ zouden kunnen binden. Er is tot nu toe 
maar één ligand bekend voor RegIIIγ, te weten peptidoglycan, maar voor RegIIIβ zijn de 
liganden peptidoglycan, lipid A en enkele fucose bevattende suikers bekend. Het model 
voorspelde dat RegIIIβ twee verschillende bindingsplaatsen zou hebben, wat zou kun-
nen leiden tot binding aan mucines en bacteriën tegelijkertijd. Hiermee zou voorkomen 
kunnen worden dat de bacteriën de mucus laag penetreren. 
In hoofdstuk 5 hebben we een RegIIIβ knock out (-/-) muis gebruikt om de rol van dit ei-
wit tijdens een infectie met de Gram-negatieve Salmonella enteritidis en de Gram-posi-
tieve Listeria monocytogenes te bestuderen. De aantallen S. enteritidis en L. monocyto-
genes die werden teruggevonden in de feces van de muizen was vergelijkbaar tussen de 
RegIIIβ-/- muizen en de wild type (normale) muizen. Daarentegen zijn significant hogere 
S. enteritidis aantallen aangetroffen in de dikke darm, de lymfe klieren, milt en lever 
van de RegIIIβ-/- muis vergeleken met de wild type muis. Deze resultaten wijzen op een 
beschermende rol van RegIIIβ in de translocatie van de Gram-negatieve S. enteritidis in 
de muis, maar niet in de translocatie van de Gram-positieve L. monocytogenes.   
In hoofdstuk 6 is de ontwikkeling van een RegIIIγ knock out muis beschreven. Een van 
de grootste fenotypische verschillen van dit model vergeleken met de wild type muis 
is een andere distributie van de mucus laag in de dunne darm en een verhoogd con-
tact van bacteriën met het darm epitheel. Daarnaast zijn een aantal markers voor het 
aangeboren immuun systeem verhoogd in de darm, wat duidt op een verhoogde mate 
van ontsteking in de RegIIIγ-/- muis. Vergeleken met de wild type muis laat de RegIIIγ-/- 
muis ook een verhoogde mate van mucosale ontstekingsmarkers zien na infectie met S. 
enteritidis en L. monocytogenes, wat wijst op een beschermende antimicrobiële rol van 
RegIIIγ in een infectie met deze bacteriën. 
Tot slot worden in hoofdstuk 7 de belangrijkste bevindingen van dit proefschrift bes-
chreven en bediscussieerd en in een bredere context geplaatst, met aanbevelingen 
voor toekomstig onderzoek. 
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